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The publication of Our Invisible Addicts in 2011 represented an 
important landmark in recognising the extent of substance-related 
health problems amongst older people and that the special service 
needs to deal with the complexity of such problems, which often 
involve co-morbid mental and physical health problems, polypharmacy 
and psychosocial adversity.
Since then, our knowledge concerning the clinical and public mental 
health aspects of substance misuse in older people has continued to 
advance but substance misuse amongst older people continues to 
grow as the population of “baby boomers” ages, increasing both the 
number of older people and the percentage of the older population 
with experience of substance misuse.  
Given the further experience and knowledge we now have and the 
growing need, it is now timely to readdress the issue and to review 
and revise the original report and build on its recommendations. With 
this revision, we seek to build on the progress made over the past 
six years and to emphasise anew that including older people with 
substance problems in national policies is imperative and that there 
is a need for organisational reform to tackle this burgeoning issue.
The complex constellation of risks that older people with addictions 
face and create can result in presentation to a variety of services 
such as older people’s mental health, addictions, primary care, 
acute hospital settings, social care, housing, criminal justice and the 
voluntary sector. In many cases the staff in these settings have little 
specialist knowledge of how to deal with such complexity.
As a result, in this revision we consider and advocate the further 
development of a clinical workforce with the appropriate knowledge, 
skills and attitudes to provide identification, assessment, treatment, 
and assist in recovery and referral for substance misuse in an older 
population. In particular, we see a need to reverse the loss of multi-
professional specialist training in addictions that has taken place in 
recent years. 
We also explain how the problem can be best addressed though 
an approach that is multi-professional, involving psychiatry, nursing, 
pharmacy, occupational therapy, psychology, social work and the 
voluntary sector (including peer support). 
This report also addresses the important public mental health aspect. 
The public is poorly informed about the relationship between drinking 
and health risks in older people. There is also a need to improve 
Foreword 
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knowledge and awareness around the increasing use of illicit and 
prescription drugs, as well as the harm caused by novel psychoactive 
substances, substances acquired using the internet, and other 
addictions accompanying substance misuse such as gambling.
Improving health and social outcomes for older people with substance-
related disorders requires a rigorous approach and this report collates 
the most up-to-date information relevant to practising psychiatrists, 
their teams and other colleagues.   
There is a need for best practice to be implemented and extended to 
all relevant settings including the criminal justice system and end of life 
care. As we do so, we should continue to research the effectiveness of 
the different approaches taken, using both qualitative and quantitative 
measures to evaluate this.  
This report, which has been developed with representation from 
a patient, the Royal College of Psychiatrists, the Royal College of 
General Practitioners and the British Geriatrics Society, provides the 
latest milestone on the journey towards developing the best possible 
response to this important problem.  
Professor Wendy Burn, President 
Professor Colin Drummond, Chair of the Faculty of Addictions
Dr Amanda Thompsell, Chair of the Faculty of Old Age Psychiatry
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Introduction Notes and thoughts from a 
patient 
This report has harnessed the collective 
knowledge, skills and experience of health 
professionals and others with experience in 
the field of substance misuse.  
 
It presents an up-to-date and evidence-
based revision of Our Invisible Addicts, with 
the following terms of reference:
 z Portraying lived experience of substance 
misuse
 z Examining public health aspects
 z Emphasising the importance of 
comprehensive assessment
 z Highlighting the relevance of alcohol 
related brain damage and physical 
complications
 z Detailing the nature, range and benefits 
of age-sensitive treatment approaches
 z Exploring best practice in service 
delivery and implementation
 z Developing education and training to 
improve workforce competencies
 z Suggesting future areas for research 
and development
 z Clarifying the role and relevance of 
ethical and legal aspects of care. 
 z Public campaigning should be expanded 
to reduce the stigma associated with 
alcohol problems.
 z There should be greater recognition of 
the enormity of the problem – detailed 
research and publication of statistics 
should be widely marketed.
 z Early identification of the problem 
should be keenly promoted through 
training of general practitioners. 
 z There should be provision of more 
alcohol treatment centres generally 
including those specifically for older 
people.
 z There should be a substantial increase 
in provision of aftercare services.
 z More health professionals (including old 
age psychiatrists) should be trained to 
deal specifically with alcohol problems, 
and there should be more addiction 
psychiatrists.
 z Education at all levels should be 
developed.
 z The economic impact of alcohol should 
be determined by detailed research 
and publication of how it affects the 
economy, what revenues and what 
expenses are affected and by how 
much.
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Public health and substance misuse in older people
 z The proportion of older people with 
substance misuse continues to rise more 
rapidly than can be explained by the rise 
in the proportion of older people in the UK. 
 z The “baby boomer” population born 
between 1946–1964 (now aged between 
53 and 71 years old) is at the highest risk 
of substance misuse which is rising within 
the older population.
 z The misuse of illicit drugs such as 
cannabis and amphetamines, prescription 
painkillers such as morphine and 
buprenorphine, as well as gabapentinoid 
drugs is now recognised as a growing 
public health problem. 
 z Substance misuse in older people is 
associated with reduced life expectancy 
and accelerated ageing, which is further 
compounded by socio-economic 
deprivation
 z Death rates in older people with substance 
misuse are higher than the general older 
population.
 z Deaths related to poisoning from 
substances in older people have more 
than doubled over the past decade.
 z Recent revision of lower risk drinking 
guidelines for all age groups may still be 
too high for some older people, especially 
those who have accompanying physical 
and mental disorders and who are 
receiving medication.
 z Older people with mental disorders such 
as depression, anxiety, and personality 
disorder have higher rates of substance 
misuse than those without mental 
disorders.
 z Psychosocial factors such as social 
isolation, financial problems, retirement, 
life events, pain and insomnia have strong 
associations with alcohol misuse
 z There is strong evidence for the potential 
effectiveness of minimum unit pricing in 
reducing alcohol-related harm, particularly 
in people with both harmful alcohol use 
and socio-economic deprivation.
 z Awareness of alcohol units among older 
people is improving but there is a general 
lack of health awareness around lower 
risk drinking limits among the public. This 
also includes practitioners assessing older 
people with alcohol misuse.
 z There is large gap in evidence for both 
the prevention of alcohol misuse in older 
people and evidence assessing the impact 
of public health interventions to reduce 
cognitive decline or preventing dementia.
 z Prevention of alcohol misuse needs to be 
balanced carefully against the role played 
by alcohol in maintaining social cohesion 
among older people.
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Assessment of substance 
misuse
Alcohol-related brain 
damage and physical 
complications of substance 
misuse 
 z When presenting to clinical services, 
all older people should be screened 
for alcohol and tobacco misuse and be 
asked about other substance use and 
misuse.
 z Older people misusing substances 
should be offered a full assessment 
of their substance misuse in mental 
health services and offered referral to 
specialist substance misuse services, if 
required.
 z There should be user-friendly and 
special consideration of older people’s 
distinctive needs, with assessment 
considering the physical, psychological 
and social changes consequent on 
ageing.
 z Assessment may need to be ongoing 
and frequently reviewed, and involve the 
collaboration of health and social care 
professionals, families and carers over 
the longer term.
 z Major life events, presentation 
with physical and psychological 
symptomatology (particularly if 
unexplained), and inconsistencies or 
contradictions in the presentation, 
should prompt re-screening or 
assessment.
 z Although applying the standard criteria 
for the diagnosis of dependence to 
older people may be useful, this must be 
undertaken thoughtfully as they may not 
always be applicable.
 z Current services are poorly equipped in 
the assessment, treatment and care of 
older people with alcohol-related brain 
damage (ARBD).
 z ARBD has a wide range of mechanisms 
involved in its development, with 
Wernicke-Korsakoff Syndrome and 
alcohol-related dementia being the most 
common clinical presentations.
 z Rising rates of hospital admissions 
for ARBD has implications for clinical 
service provision.
 z Assessment, diagnosis, harm reduction 
and recovery require specialist skills 
and involve a joint approach between 
health and social care professionals, as 
well as families, carers and Third Sector 
providers.
 z Reduction of, or abstinence from, 
harmful drinking may be associated with 
partial reversibility in cognitive function.
 z Long-term care is not a substitute for 
appropriate rehabilitation.
 z Substance misuse is associated with a 
wide range of physical complications 
that require appropriate assessment, 
treatment and aftercare.
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Treatment
 z There is a paucity of UK-based research 
and evidence for treatment interventions 
and services relating to the management 
of substance use disorders in older people. 
 z The evidence to date indicates that many 
older people with substance misuse 
want to abstain and have the capacity to 
change.
 z Older people benefit from treatment, and 
in some cases, can have better outcomes 
than younger people. 
 z Older people respond well to brief advice 
and motivational enhancement therapy.
 z Pharmacological treatment should always 
be provided as part of a management plan 
which includes psychosocial interventions. 
 z Pharmacological treatments should be 
used judiciously and monitored frequently.
 z Treatment of co-existing psychological and 
physical conditions is critical to achieving 
optimal effectiveness of treatment for 
substance misuse.
 z Age-specific programmes demonstrate 
positive outcomes for older adults. 
 z Intensive treatments tend to focus on 
abstinence as an outcome, and overall 
success rates at 6-12 months compare 
favourably with younger populations. 
 z Generally, the more treatment delivered, 
the better the outcome.
 z Key components of treatment are to 
be supportive, non-judgmental, non-
confrontational, flexible, sensitive to 
gender and cultural differences, focused 
on client functioning and on coping and 
social skills, and holistic. 
 z Close liaison between practitioners and 
agencies, as well as family and carers, 
who are involved in the care of the patient 
is vital. 
 z Future research requires standardisation 
of age range, diagnostic tools and 
assessment instruments, treatment 
options and style of delivery in order to 
enhance comparability.
 z The inclusion of older adults in all treatment 
intervention studies in substance misuse 
should be the norm.
 z Older people should not be excluded 
from treatment because of their age: 
treatment should be available, attainable 
and accessible.
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Service delivery and 
implementation 
Education and training
 z Improved access to, and the availability 
of services – age should not be a bar to 
receiving high quality care for substance 
misuse.
 z Improve collaboration, communication 
and cooperation between health and 
social care professional teams, families 
and carers at all stages of treatment and 
recovery.
 z Develop care pathways for substance 
misuse within mental health services 
for older people and mental health 
treatment for older people within 
substance misuse services.
 z Specify operational definition(s) of 
integrated care and models of care. 
 z Review addiction psychiatry and old age 
psychiatry services to formulate a plan 
for change. 
 z Ensure “mainstreaming” of skills in the 
management of substance misuse within 
mental health services for older people.
 z Encourage the development of 
innovative models of service delivery for 
older substance misusers.
 z Improve public and professional 
education about the need for, and role 
of, the specialist through education, 
training and workforce development.
 z Education and training at all levels are 
central to addressing the challenges 
posed.
 z Key skills for managing addiction and 
substance misuse in older people can 
be readily incorporated into new models 
of medical training, and training of other 
health professionals.
 z An expansion in healthcare staff with 
skills in addictions will be needed to 
improve education and training across 
health and social services, and the 
public, third and private sectors.
 z The Royal College of Psychiatrists has 
a major role as a source of expertise 
and to aid the medical allied health 
professionals and others who can 
be expected to do the majority of 
work in primary and secondary care. 
An expansion of the numbers of 
psychiatrists skilled in working with 
older people with addictions is required 
in order to deliver the necessary wider 
services.
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Ethical and legal 
considerations for older 
people with substance 
misusestance misuse
 z Older people with substance misuse 
should not be assumed to lack capacity 
even if they make what may be perceived 
as unwise decision(s).
 z Consider ‘substance misuse’ as a possible 
cause in any older person with fluctuating 
mental capacity or elder abuse.
 z All practicable steps including timely and 
planned review should be undertaken 
to optimise the ability to demonstrate 
capacity in older adults which is time- and 
task-specific.
 z Apart from situations where mental health 
interventions are covered by statute, all 
adults can refuse medical procedures 
contemporaneously or in advance when 
they are capacituous.
 z If a healthcare professional suspects 
substance misuse in an older person, 
joint working with other teams and social 
care involvement should be undertaken to 
assess capacity and proactively identify 
any associated safeguarding concerns. 
 
Research and development 
 z For too long, research into this subject 
has been ignored.   
 z Older people need to be included in 
addiction research as they are under-
represented in research studies.    
 z Barriers to recruitment and retention of 
older people in research studies include 
lack of motivation, poor health, sensory 
impairment, cognitive impairment, mood 
disorders, mobility problems and frailty. 
Evidence for strategies to enhance 
participation is limited.   
 z Research will inform engagement and 
retention with treatment and service 
responses.   
 z Greater understanding of the economic 
impact of alcohol and other substances 
on individuals, families, communities 
and society is needed.
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 z The older substance misuser is poorly 
represented in the range of policy 
initiatives, though this may be very 
gradually changing.   
 z Greater value needs to be placed on 
the requirements and wishes of older 
substance misusers.   
 z Diverse approaches are required to 
minimise the health, social and economic 
consequences for a population of 
“baby boomers” who have the fastest 
increase in rates of substance misuse 
in the population. These include raising 
awareness, limiting availability of, and 
access to, substances, and improving 
access to care.
 z Campaigning is required to reduce the 
stigma associated with alcohol and 
substance misuse among the public and 
professionals.
 z Greater recognition of the scale of the 
problem should be promoted via wider 
dissemination of up-to-date research. 
 z Evaluation of the economic impact of 
substance use in older people should 
be initiated.
 z Given the distinctive features of 
substance misuse in older people, 
identification of how some of their 
special health and social needs differ 
from younger adults should be reflected 
in policy.
 z Due to the strong relationship between 
substance misuse and mental and 
physical health in older people, it 
needs to be acknowledged in policy 
development that management of 
complex comorbidities is the norm. 
Conclusion
 z Approaches to treatment and rehabilitation 
need to be tailored and adapted from those 
found to be effective in younger people, 
and development of novel approaches 
needs to be prioritised.
 z There needs to be provision of more 
addiction services focussed on the needs 
of older substance misusers. 
 z Enhancing training at all levels including 
training more addiction psychiatrists 
and old age psychiatrists with specialist 
knowledge to manage the specific needs 
of older substance misusers. 
 z Due to a dearth of research, there is 
scarce specific evidence to inform policy 
decisions in older people who misuse 
substances. There is a lack of research 
on policies that specifically target the 
older person’s substance misuse and 
associated harms.
 z To meet older substance misusers’ 
needs and develop coherent integrated 
policies, a concerted effort is required 
by stakeholders including the National 
Health Service, independent sectors, 
mental health charities and other relevant 
charitable organisations, and older 
people themselves with financial support 
and direction by government to develop 
coherent integrated policies.
 z A national strategy focusses on older 
substance misusers should be developed 
that is imaginative, viable, sustainable and 
evidence-based.
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Key recommendations
General
For too long, the topic of substance misuse in older people has been 
ignored. A new approach, that is non-discriminatory, comprehensive 
and needs-led, is now essential.  We recommend that a national 
strategy outlining cohesive integrated policies devised by stakeholders, 
with financial support and direction by government, and driven at 
local, regional and national levels be developed and implemented.
This can be achieved in the following ways:
 z Promote public and professional education to increase awareness 
of, and reduce stigma around, substance misuse in older people 
by working with patients and carers, the media, health and 
social care providers, Royal Medical Colleges and Allied Health 
Professionals.
 z Recognise that older people have distinctive needs. The treatment 
and care of this invisible, complex and vulnerable group should be 
reflected across public health, clinical, service delivery, research 
and development, educational, legal, ethical and policy domains 
by working with patients and carers, health and social care 
providers, educational, charitable and research organisations, 
Royal Medical Colleges and Allied Health Professionals.
 z Improve dissemination of up-to-date information about substance 
misuse in older people to improve understanding of the scale of 
the problem by informing patient and carer groups, the media, 
professional and charitable organisations. 
 z Encourage further debate with professional, charitable and 
research organisations on, and defining what constitutes, 
“older people”, in recognition that older substance misusers 
are a heterogeneous group with different sub-groups requiring 
diverse responses from services, for professional training, and 
for research policy.
 z Emphasise the mental health, physical health, and social and 
financial implications for public health and society as a whole from 
not meeting the needs of older people with substance misuse 
by working with health and social care providers, charitable and 
research organisations, Public Health England and NHS England.
College report CR211 16
Public health
 z Further improve communication with the media, the Faculty of 
Public Health and NHS England to improve public education in 
recognising that current lower risk drinking limits in older people 
may in fact be too high for some older people, particularly those 
with complex mental and physical health problems.
 z Support the implementation of minimum unit pricing (which has a 
strong evidence base for reducing alcohol-related harm) across 
the United Kingdom through joint working with the Alcohol Health 
Alliance and the British Medical Association.
Assessment and treatment 
 z Forge closer links between health and social care services, as 
well as family and carers who are involved in the care of the 
patient to ensure that optimal outcomes are achieved.
 z Support reduction or cessation of substances in older people 
through partnerships with the media, patients and carers, 
health and social care providers in the NHS, independent and 
charitable sectors, NICE, Department of Health, BMA and the 
British Psychological Society.
 z Improve the recognition and treatment of co-morbid mental 
disorders, physical disorders and substance misuse to improve 
health and social outcomes through liaison with medical, 
psychiatric and social care providers.
 z Develop partnership working between old age and substance 
misuse services. Develop training supported by Royal Medical 
Colleges to ensure comprehensive assessment of substance 
misuse in all older people presenting to older people’s mental 
health services and of alcohol misuse in memory clinics and 
dementia services.
 z Improve case finding, assessment, re-assessment and review 
of substance misuse in older people across all health and social 
care settings by collaborative working arrangements and training 
which are supported by Royal Medical Colleges, allied health 
professionals and social care professionals.
 z Ensure that pharmacological treatment is frequently monitored 
and should almost always be part of a treatment plan. This should 
be delivered by a multidisciplinary team versed in collaborative 
working developed by services responsible for the management 
of older people with substance misuse problems.
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 z Ensure that practitioners working with older substance 
misusers are knowledgeable about recent relevant findings 
and appropriately trained, supported, supervised by training 
opportunities developed by local, national or international service 
and training organisations.
Service delivery
 z Ensure that all services are user-friendly and non-judgemental, 
flexible and consider the individual needs of older people at all 
points of the treatment journey in conjunction with patient and 
carers groups with the Royal College of Psychiatrists. 
 z Improve access to and the availability of services – age should not 
be a bar to receiving high quality care for substance misuse and 
this can be achieved by forging closer links with commissioners 
and treatment providers.
 z Ensure collaboration, communication and cooperation between 
health and social care professional teams, families and carers 
at all stages of treatment and recovery. 
 z Share best practice in existing care pathways for substance 
misuse within mental health services for older people and mental 
health treatment for older people within substance misuse 
services across NHS and third sector providers. 
 z Specify operational definition(s) of integrated care and models 
of care through closer collaboration with NHS improvement.
 z Review existing addiction psychiatry services in terms of 
consideration given to the particular needs of older people in 
partnership with the Faculty of Addictions. 
 z Ensure “mainstreaming” of skills in the management of substance 
misuse and other innovative models of service delivery within 
mental health services for older people in partnership with the 
Faculty of Old Age Psychiatry.
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Education, training and workforce 
development
 z Improve public and professional awareness of the need for, and 
role of, specialist services for substance misuse by working with 
the media, patient and carer groups, medical schools, Royal 
Medical Colleges, the British Medical Association, British Geriatrics 
Society, British Psychological Society, Royal College of Nursing, 
pharmacists, British Association of Psychopharmacology, Society 
for the Study of Addiction.
 z Train all staff across health and social care in case finding for 
older people with substance misuse by joint working with Royal 
Medical Colleges, Department of Health, British Psychological 
Society, Deaneries, health and social care providers.
 z Substantially increase training numbers for addiction psychiatry, 
including those with skills in assessing and treating older people 
with substance misuse by working with the Department of Health 
and Deaneries.
 z Increase the numbers of old age psychiatrists with skills in 
addiction psychiatry by a programme of postgraduate training 
developed by the Royal College of Psychiatrists. 
 z Expand the Royal College of Psychiatrists’ role in providing 
expertise in training at all levels including continuing professional 
development for psychiatrists as well as geriatricians, general 
physicians, GPs and other health care professionals (e.g. nurses, 
social workers, allied health professionals and those working in 
the voluntary sector).
Research and development
 z Encourage, support and fund research and research training 
into older people with substance misuse which can better inform 
policy decisions through working with the Research Councils, 
NIHR, NICE, Society for the Study of Addiction, British Medical 
Association, Department of Health and PHE (and the equivalent 
in Scotland, Wales and Northern Ireland).
 z Encourage inclusion of older people in all qualitative, descriptive 
and analytical research studies about substance misuse including 
prevention, epidemiological and clinical interventions through 
patient and carer groups, NICE, the Research Councils, NIHR 
and addiction research charities and journals which focus on 
older people and/or substance misuse.
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 z Undertake rapid reviews on important research findings relevant 
to older people and disseminate to practitioners involved in care 
through NICE, DrugScience, Society of Study of Addiction, Public 
Health England, Alcohol Research UK and the International 
Society of Addiction Journal Editors (ISAJE).
 z Encourage research on the economic impact of substance 
misuse in older people, including the health and social costs 
of misuse and cost effectiveness of treatment in collaboration 
with NICE, the Research Councils, NIHR and addiction research 
charities.
Ethical and legal aspects
 z Emphasise the obligations of all health and social care 
professionals in considering ethical and legal aspects of care 
for older people with substance misuse through encouraging 
improved Continuing Professional Development within the NHS, 
social care and through joint working with the British Medical 
Association.
 z Ensure planned reviews relevant to circumstances and context 
of the review to optimise the identification of capacity in older 
people with substance misuse.
 z Encourage joint working with other teams and services in health 
and social care to assess capacity and proactively identify 
safeguarding concerns.
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Introduction
Key messages
This report has harnessed the collective knowledge, skills and 
experience of health professionals and others with experience in the 
field of substance misuse. 
It presents an up to date, evidence-based revision of Our Invisible 
Addicts, with reference to the following terms of reference:
 z Portraying lived experience of substance misuse.
 z Examining public health aspects.
 z Emphasising the importance of comprehensive assessment.
 z Highlighting the relevance of alcohol-related brain damage and 
physical complications.
 z Detailing the nature, range and benefits of age-sensitive treatment 
approaches.
 z Exploring best practice in service delivery and implementation.
 z Developing education and training to improve workforce 
competencies.
 z Suggesting future areas for research and development.
 z Clarifying the role and relevance of ethical and legal aspects of 
care.
Background
Since the publication of Our Invisible Addicts in 2011 (Royal College of 
Psychiatrists, 2011), as a response to unexpected interest in the field 
and further developments, we have continued to progress our work 
in epidemiology, training and education, research and policy. This has 
been reinforced by the unparalleled rise in rates of substance misuse in 
“baby boomers”, who are all now aged over 50 (Rao & Roche, 2017).
We have published ‘An Information Guide’ to support practitioners 
(RCPsych 2015); a book on Substance Misuse and Older People 
(Crome et al 2015) which collates up-to-date information internationally. 
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We have also run annual courses at the Royal College of Psychiatrists, 
published in the scientific arena (Crome & Crome, 2018; Rao and 
Draper, 2018, Rao and Jones, 2018; Rao, 2018a; Rao, 2018b; Rao & 
Crome 2016; Rao et al, 2016; Rao, 2016, Crome et al, 2015a; Bhattia 
et al, 2015; Wadd & Rao, 2015; Crome et al, 2015b; Rao, 2014; Rao 
et al, 2014) and contributed extensively to media and press coverage 
of substance misuse in older people.   
When we came to review the original report, so much had changed 
that although we could retain some elements of the original version, 
the structure and content required considerable and extensive revision. 
We have produced this report that includes updated information on 
the epidemiology of substance use in older people; discussion of 
minimum unit pricing; detailed consideration of the ethical aspects 
of substance use in older people; alcohol-related brain damage; end 
of life care; medical prescribing of cannabis; educational and training 
needs in relation to workforce planning; collaboration of several 
multidisciplinary teams such as primary care, addiction psychiatry, 
geriatric medicine (because of the clinical complexity of this group); 
and research options and priorities.
Our working group represented professionals from a wide range of 
clinical specialities as well as a patient, who has provided thoughtful 
insights.   
Terminology
The terms ‘drug’ or ‘substance’ will be used to cover substances 
that are licit (tobacco and alcohol) as well as illicit ones. The latter 
includes cannabinoids (tetrahydrocannabinol or THC and cannabidiol), 
central nervous system depressants such as opiates and opioids 
(e.g. heroin and methadone), stimulants (e.g. cocaine, crack cocaine, 
amphetamines and 3,4-methylenedioxymethamphetamine, known 
as MDMA or ecstasy), lysergic acid diethylamide (LSD), khat and 
magic mushrooms. These terms will also be used to describe ‘street’ 
use, use of prescribed medication such as benzodiazepines, opiate, 
opioid and gabapentinoid drugs used in a manner not indicated or 
intended by a medical practitioner, and similar use of over-the-counter 
preparations such as codeine-based products (e.g. cough medicines, 
decongestants). It also includes drugs bought over the internet and 
novel psychoactive substances.
Clinical experience and a growing literature base indicate that 
older people may use a combination of licit and illicit substances, 
as well as prescribed and over-the-counter medications taken in 
accordance with medical practitioners’ instructions. This so-called 
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‘polypharmacy’, ‘polydrug misuse’ or ‘polydrug dependence’ is a 
particular problem in older people who have comorbid physical and 
psychological problems. Patients may be offered, borrow or share 
out-of-date medications. They may also take foods and/or drugs 
and/or medications that interact with each other and they may store 
medications inappropriately.
With low mood, anxiety and/or poor memory, they may forget to 
report what they have taken, forget that they have taken it at all and/
or take more than has been prescribed. With the growing complexity 
of the range of substances available by a number of routes or means, 
this becomes a major risk faced by all teams working within mental 
health, acute and primary care settings (Crome & Rao, 2018).
Changing our attitudes to older people with substance misuse should 
not simply mean changing terminology as a “veneer” (Hamilton, 
2018). Having the right words must also mean having the right values 
(Gallinger, 2015). 
In this report, we have consistently aimed to use terms acceptable 
to patients and professionals with whom we have consulted. For 
example, the term “older people” is used in preference to “elderly” or 
“geriatric”.  If we have used words that could sometimes be construed 
as inaccurate or conveying a different meaning, it is hoped that the 
right values can still be discerned.
Both the public and professionals encountering and caring for older 
people require a deeper understanding of how and why an older 
person came to change their substance use to misuse. This will 
involve empathic reflection leading to attitudinal change that realises 
the capacity for a path to recovery. The journey may be long and so 
requires an approach that is patient, persistent and proactive. It is a 
journey that, if successful, will mean better engagement, assessment, 
treatment and above all, a better quality of life.
It is with these thoughts and reflections in mind that we begin our 
report with the first chapter by a patient.
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Key messages
 z Public campaigning should be expanded to reduce the stigma 
associated with alcohol problems.
 z There should be greater recognition of the enormity of the 
problem – detailed research and publication of statistics should 
be widely marketed.
 z Early identification of the problem should be keenly promoted 
by training of general practitioners.
 z There should be provision of more alcohol treatment centres 
generally including those specifically for older people.
 z There should be a substantial increase in provision of aftercare 
services.
 z More health professionals (including old age psychiatrists) should 
be trained to deal specifically with alcohol problems, and there 
should be more addiction psychiatrists
 z Education at all levels should be developed.
 z The economic impact of alcohol should be determined by detailed 
research and publication of how it affects the economy, what 
revenues and what expenses are affected and by how much.
Notes and thoughts from a 
patient
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Overcoming denial
I’m Diane, a recovering alcoholic and patient. If it 
hadn’t been for NHS service provision and its help 
in battling my alcohol problems, I wouldn’t be alive 
writing this today.
Let me briefly tell you what happened to me. I’m 
now in a relatively good place but only after a very 
difficult time.  
My drinking started innocuously enough but slowly 
and invidiously took hold and eventually became 
all-important – the only thing that mattered.  At the 
beginning it was fine – I drank for social reasons and 
for business entertaining, with alcohol facilitating 
those sometimes difficult meetings. As time went 
on, alcohol steadily increased in importance and 
began to take its grip. A succession of mild medical 
conditions arose, such as skin disorders, memory 
loss, some trembling and various accidents. I went 
to see my GP for all of these conditions separately 
and at some point she asked me how much I 
drank. I lied, reducing the amount by half (or more). 
My physical problems increased and by then my 
GP was regularly asking about my alcohol intake. 
Losing control
One day I had had enough of denial and 
acknowledged that perhaps alcohol could be a 
factor. Here, I should say that I was lucky that I 
always saw the same GP in the practice where 
I was a regular patient. She identified a pattern 
in the various conditions that I went to see her 
about and correctly deduced that alcohol was a 
fundamental issue. When I agreed that my alcohol 
consumption was probably too much, she quickly 
referred me to an alcohol treatment centre. Once 
there, I was initially questioned about my drinking, 
and for the first time I didn’t lie about how much I 
drank.  I was assigned a key-worker whom I saw 
on a weekly basis – part of an excellent team with 
the lead clinician being an addictions psychiatrist. 
When asked what my goal was, I replied ‘controlled 
drinking’. The lead clinician told me that in his view 
that wouldn’t be possible, given the amount I drank 
and the length of time I had been drinking. But I 
insisted on controlled drinking (you can’t force a 
patient to do what they don’t want to do) and after 
six months of being treated by the centre I got my 
drinking down to a very reasonable amount and, 
against advice, discharged myself.  Big mistake. 
My controlled drinking lasted for about three 
months and then I was back to my old drinking 
ways but much, much worse than before. I shall 
gloss over the next several alcohol-fuelled years 
which were not my finest and included my sleeping 
in the street because I couldn’t get my key in the 
door and being hospitalised at various times.  In 
short, I became a different person and a stranger 
to my family and friends.  
Back in treatment 
It took me five long years to go back to my (now 
different) GP and beg for help. She immediately 
referred me to the same alcohol treatment centre 
where, unbelievably, there was mostly the same 
team that I had seen before including the lead 
clinician. I knew then that for me there was no 
alternative but to detox as by that point my drinking 
had become totally unmanageable. Again, the team 
to which I was assigned was excellent and the lead 
clinician – the addictions psychiatrist – in particular 
knew ‘which buttons to press’ to convince, help 
and motivate me through the process.  We were 
now agreed that I should detox but my final 
battle was to insist that I did this at home and not 
in-house. The detox wasn’t easy by any means, 
but I managed it and thereafter attended a relapse 
prevention course at the treatment centre.  
Following that I then started attending a supervised 
monthly aftercare session at the centre with other 
patients. That was incredibly useful and supportive 
as we could all talk about our lives and, with the 
help of a trained facilitator, try to resolve any 
problems. Having grabbed this opportunity with 
both hands, I was really upset when the centre had 
to close, having lost its bid for funding. I managed to 
find another centre which ran supervised monthly 
aftercare sessions, but this too subsequently 
closed down for funding reasons. It was at this 
point very difficult to find support, but eventually I 
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located another centre which treated both alcohol 
and drugs together. Personally, I don’t think that 
these two substances should be treated together, 
but it was better than nothing at all, and it was 
good to have monthly meetings once more with 
people who were in recovery and needed support 
as I did.  Anyway, that centre also closed. It’s a 
pity that aftercare no longer seems to be available. 
I really don’t understand it as it does help and if 
a person relapses and goes back to square one, 
the costs involved are surely far greater than the 
costs for providing aftercare.  
Reflections 
Through my experiences I have learned several 
things. Probably the most important aspect is the 
early identification of an alcohol problem and 
this would usually start at the GP’s surgery (or from 
a home visit if they still happen).  It would be good 
if GPs could automatically ask a few questions 
about their patients’ drinking habits without it 
being seen as intrusive. Perhaps a process could 
be devised for facilitating this, with guidance on 
how to ask the questions or how to draw out the 
patient.  Incentive payments for GPs to implement 
the process regularly could then be considered. 
Certainly, seeing my GP was the first step in my 
seeking help for an alcohol problem, although I did 
not initially visit her with that specifically in mind. 
Had she asked me questions sooner than she did, 
I might have gone to the alcohol treatment centre 
earlier and things would not have got to the awful 
stage they did.  It’s obviously important that GPs 
refer to their notes of previous visits, particularly 
if the patient does not see the same GP all of the 
time. My GP did refer to the notes and so was able 
to understand that alcohol was the common thread 
that linked all of the symptoms. Again, perhaps this 
could be part of the above process.
Equally important is the provision of aftercare 
services. Many people who have treatment to 
try to control their drinking, or detox and become 
abstinent, find it difficult to continue this without 
aftercare and support.  I really think that aftercare is 
essential and should always be made available as 
long as the patient wants or needs it, but certainly 
for a number of months after changing their 
drinking pattern. Again, I was lucky in that I could 
attend aftercare centres for support, although 
I had to really search for them as several were 
being closed down. Eventually there was none 
left to go to so that assistance disappeared. How 
much more difficult it must be at the moment 
for someone just embarking on recovery. In my 
opinion, the provision of aftercare services is not 
only essential – it also makes economic sense. 
Treating alcoholism is a huge drain on the NHS 
services, so preventing relapse means that the 
person will no longer require treatment for the 
various conditions arising from alcohol abuse.    
In the same vein, I was lucky to be referred to 
an excellent alcohol treatment centre with its 
sympathetic and firm but supportive staff. Where 
are all the alcohol treatment centres now? Have 
a lot of them been put together with drug clinics 
(which I don’t think works nearly as well)? There 
is certainly the need for them. It’s probably even 
more difficult if you live outside a big city. Again, 
apart from adding to a huge problem of alcohol 
abuse, this also makes economic sense.
Stigma plays a part too. In fact, it may be why 
you don’t want to tell people about your alcohol 
problem. This has to be addressed if early 
identification and treatment is to be achieved. 
To give just one example, at a conference about 
addictions I was talking to someone who worked at 
a hospital.  After 10 minutes’ friendly conversation, 
he asked me where I worked. I replied that I was 
a patient and with that he was silent for a minute 
or two and then abruptly turned away and started 
talking to someone else. I felt humiliated. Had I 
changed because I was now known to be a service 
user?  Did he not know what to say? Was the 
answer so unexpected?  You can see that this 
attitude must change, even if this particular incident 
was down to an individual’s character. Having 
alcohol problems or being addicted to alcohol can 
happen to anyone.  No one knows (and I certainly 
don’t) why some people become addicted, but it 
certainly shouldn’t lead to stigma.
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Some do’s and don’ts
I mentioned that the lead clinician was an addictions 
psychiatrist and that he, more than anyone, got 
through to me to a point where I wanted to be 
helped. I think it’s good if I tell you things that I 
liked about his interaction with me as it may apply, 
in my opinion, to anyone who is in a one-to-one 
treatment session. Here are, in my view, are a 
few personal do’s and don’ts when interviewing 
a patient: 
 z Listen to what the person has to say. Make 
them feel they are important, what they say 
is important and that they are being heard. 
 z Use your skills to sum up your patient. All 
patients need handling differently and some 
can take, or may need, a tougher line than 
others. 
 z Help the person to restore their self-image. 
Point out what they have to offer. 
 z Remain professional however emotional the 
case may make you feel. But remain human 
and approachable. 
 z Remember how vulnerable your patient is. 
Their outward show of strength, or aggression 
even, may hide what’s inside. 
 z Remember that however many meetings you 
may have, whatever time of day it is, this one 
is the patient’s special appointment and is 
hugely important to them. They have probably 
been psyching themselves up for this meeting 
with you. 
 z Never try and force a patient to do what they 
don’t want to do – it will end in tears and you’ll 
be back at square one. 
I’m sure there are many more points to mention, 
but those above will do for a start
Final thoughts
I do recognise that there are ethical dilemmas when 
treating people with alcohol problems. With the 
NHS in a funding crisis, should expensive medical 
treatment be given to someone who chooses to 
drink too much?  Personally, I do think treatment 
should be given – I don’t know how I ended up 
being addicted to alcohol – when it migrated from 
being a sociable, fun and enjoyable activity (even 
becoming my friend) into something that I couldn’t 
control and which caused much harm not only to 
me but also to my family and to those with whom 
I interacted.  As I have said before, on a purely 
economic front, the money spent on my treatment 
and aftercare is much less than it would have 
cost to address the future medical problems and 
hospital treatments caused by excessive alcohol 
intake.  Consider also the money spent on policing 
public areas frequented by excessive drinkers and 
the clean-up required afterwards.
What about advertising?  Is it right to actively 
market a substance that causes harm? Should 
advertisements link enviable lifestyles to the 
consumption of alcohol? Does this mean that the 
vulnerable are being targeted? Or is it right because 
it can be rationalised to people having freedom of 
choice to consume alcohol? The same discussion 
was had several years ago regarding tobacco 
and advertising was stopped. Perhaps alcohol 
advertising should also be stopped. Perhaps the 
packaging for alcohol should carry health warnings 
in a similarly dramatic manner as that of tobacco 
and not carry a much softer warning?
Another ethical dilemma is that of organ transplant. 
Should, for example, a new liver be given to 
someone who has destroyed their own liver 
through excessive alcohol use?  I don’t have the 
answer – one does what one thinks is right based 
on all sorts of factors.
I’ve said earlier how important education is in both 
understanding how alcohol can have effects on 
people and in understanding the effects it creates. 
Patients and their families experience this at first 
hand and so are well-positioned to pass on the 
knowledge they have of everyday living with the 
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problems. This makes it extremely desirable 
for them to participate in the construction of 
educational programmes and the establishment 
of policies in the field of alcohol addiction. They 
have real-life experience.
The importance of 
families
We also need to find a way of involving of family 
members more. I don’t feel that enough research 
has been undertaken on how families (the whole 
family) are affected by living with someone who 
has an alcohol problem and how their lives are 
changed. Alcohol abuse tears families apart, 
ruins relationships, and establishes long-term 
psychological effects on family members.  Indeed, 
many relationships simply do not survive and 
many children grow up to have significant issues 
in later life. My alcohol problem certainly caused 
issues in my relationship with my husband who 
effectively became my carer whilst I was in the 
grip of addiction, but then his role completely 
changed when I became abstinent. I became my 
own person once again rather than someone who 
had to be constantly looked after. It created a great 
deal of friction and difficulty and we were lucky 
to have been able to adjust and survive.  It’s also 
important to understand that the carer in the family 
will probably not have the opportunity to deal with 
their own life problems as their energy and focus 
will be on the person with alcohol problems.
From the above, it becomes clear that when 
deciding polices and designing services, 
involvement of patients and family members would 
be of immense value – from the establishment of 
the policy/service through its process and then 
through to final acceptance.
Last but not least
In conclusion, let me say that I have tried to show 
what it means to be someone with an alcohol 
problem. From initial denial, through to grudging 
acceptance, seeking help, and facing up to the 
issue.  It wasn’t easy but I’m so glad that I did 
it. When I look back now I find it distressing that 
I couldn’t use my mind. Indeed, I didn’t want to 
use it – it was just a waste of drinking time. One 
of the most gratifying aspects of being sober is 
that I can now enjoy using my mind again rather 
than squinting at life through a heavy veil. In fact, 
I would go so far as to say that having my mind 
back, thinking clearly, is the aspect that I cherish 
the most.  
Not everyone is the same, of course, and many 
people may have alcohol problems of different 
severity (either less or more) than mine. While 
services that help are available, there are not nearly 
enough of them and they are difficult to find, in 
particular aftercare services. Just as important is 
the early identification of issues which can only be 
addressed by more and better education combined 
with active campaigning to show the extent of the 
problem and how it can be addressed.  
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Key messages
 z The proportion of older people with substance misuse continues 
to rise more rapidly than can be explained by the rise in the 
proportion of older people in the UK. 
 z The “baby boomer” population born between 1946-1964 (now 
aged between 53 and 71 years old) is at highest risk of rising 
substance misuse in the older population.
 z The misuse of illicit drugs such as cannabis and amphetamines, 
prescription painkillers such as morphine and buprenorphine, 
as well as gabapentinoid drugs is now recognised as a growing 
public health problem.
 z Substance misuse in older people is associated with reduced 
life expectancy and accelerated ageing, which is further 
compounded by socio-economic deprivation.
 z Death rates in older people with substance misuse are higher 
than in the general older population.
 z Deaths related to poisoning from substances in older people 
have more than doubled over the past decade.
 z Recent revision of lower risk drinking guidelines for all age groups 
may still be too high for some older people, especially for those 
who have accompanying physical and mental disorders and who 
are receiving medication.
 z Older people with mental disorders such as depression, anxiety, 
and personality disorder have higher rates of substance misuse 
than those without mental disorders.
 z Psychosocial factors such as social isolation, financial problems, 
retirement, life events, pain and insomnia have strong associations 
with alcohol misuse.
Public health and 
substance misuse in older 
people
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 z There is strong evidence for the potential effectiveness of 
minimum pricing in reducing alcohol-related harm, particularly 
in people with both harmful alcohol use and socio-economic 
deprivation.
 z Awareness of alcohol units among older people is improving but 
there is a general lack of health awareness around lower risk 
drinking limits among the public. This also includes practitioners 
assessing older people with alcohol misuse.
 z There is a large gap in evidence for both the prevention of alcohol 
misuse in older people and evidence assessing the impact 
of public health interventions to reduce cognitive decline or 
preventing dementia.
 z Prevention of alcohol misuse needs to be balanced carefully 
against the role played by alcohol in maintaining social cohesion 
among older people.
Introduction
Since the publication of Our Invisible Addicts in 2011, the rise of 
substance misuse in the cohort of baby boomers born between 1946 
and 1964 has remained a significant public health problem (Rao et 
al, 2015). In terms of the percentage of years of life lost to disability 
in England, alcohol rose from 16th to the fifth highest risk factor in 
people aged 50 to 69 between 1990 and 2013. Smoking remains 
the top risk factor in this age group (Institute of Health Metrics and 
Evaluation, 2015).
The prevalence of substance misuse in England (11.2%) is one 
of the highest in Europe (Andreas et al, 2017), with the burden of 
disease attributable to substance misuse influenced markedly by 
socioeconomic deprivation. Although this figure covers all substances, 
alcohol misuse accounts for the largest burden among older people 
in the UK. For people aged 50 to 69 in the most deprived quintile of 
England, tobacco smoking confers the largest burden, accounting 
for 20% of the risk. Alcohol and drug use ranks fifth, accounting for 
7.1% of the risk. For the least deprived quintile, raised body mass 
index accounts for the highest proportion of the disease burden, with 
tobacco accounting for 11% of the risk. Alcohol and drug use ranks 
sixth at 4.6% of the risk (Institute of Health Metrics and Evaluation, 
2015). 
In Europe and the UK, the number of people over 65 needing treatment 
for substance misuse is expected to more than double between 2001 
and 2020 (Gossop and Moos, 2008; European Monitoring Centre for 
Drugs and Drug Addiction, 2010).  
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In the United States, it is expected to treble (Colliver et al, 2006; Han 
et al, 2009). Given that the proportion of the population aged 65 or 
above in Europe is projected to rise to 1 in 4 of the population by 
2050 (European Monitoring Centre for Drugs and Drug Addiction, 
2008), the inevitable rise in older people with substance misuse has 
considerable implications for public health.
Clinical services in Europe define older people as being 65 and over. 
However, for illicit drugs, a lower cut-off point of 40 years of age has 
been considered as more valid in defining older people. It is known that 
substance misuse involving opioid drugs such as heroin can increase 
cardiovascular risk and accelerate premature ageing (Beynon, 2009). 
Adverse psychosocial factors add to this risk (Bachi et al, 2017). 
Taken together with the baby boomer cohort being a population at 
increasing risk of substance misuse, in this report “older people” will 
be defined as those aged 50 and over.
Trends in substance misuse 
among older people
Alcohol
Over the past 10 years in the UK, people aged 65 and over have shown 
a 20%increase in the proportion exceeding recommended drinking 
limits on any one day over the previous week (Office of National 
Statistics, 2017a). The 55-74 age group is the only one in which the 
percentage of people drinking over lower risk limits has increased 
over the past 5 years (NHS Digital, 2017a). Between 2016 and 2017, 
people aged 65 and over formed 30% of hospital admissions in 
England related primarily to alcohol (Public Health England, 2018). 
This proportion has risen by more than 100% when compared to 
admissions between 2010 and 2011, when this age group formed 
14% of these admissions (Office of National Statistics, 2012). Over 
the same timeframe, the proportion of alcohol-related admissions in 
the 16−44 age group fell by 20%.
Tobacco
11%of men and 10%of women aged 60 and over smoke tobacco 
(NHS Digital, 2017a). Unlike alcohol misuse, smoking rates have 
decreased by 15% in both men and women over the past 10 years. 
However, use of e-cigarettes among 50-59-year-olds increased 30% 
(from 5 to 6.5%) between 2015 and 2016, compared with a 9 per 
cent rise (from 6.5 to 7.1%) in the 35-49 age group (Office of National 
Statistics, 2017b).  
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Illicit Drugs
Lifetime use of illicit drugs in older people has increased sharply 
over the past 15 years. 
 
Table 1  UK Adult Psychiatric Morbidity (NHS Digital, 2016)
Lifetime use 2000 2014
 55-64 65-74 55-64 65-74
Cannabis 8.5% 0.9% 19.5% 6.8%
Amphetamines 1.7% 0.4% 2.8% 0.8%
In the United States, cannabis misuse in people aged 65 and over 
the previous 12 months rose from 0.15% in 2003 to a high of 2.04% 
in 2014 (Salas-Wright, 2017).  
Between 2016 and 2017, people aged 65 and over formed 8% of 
hospital admissions in England related primarily to poisoning by illicit 
drugs (NHS Digital, 2018). This proportion has risen by 33% when 
compared to admissions between 2010 and 2011, when this age 
group formed 6% of these admissions (Office of National Statistics, 
2012). Over the same timeframe, the proportion of such admissions 
in the 16-44 age group fell by 6%.
Prescription Drugs
With increasing longevity, misuse of prescription medication in older 
people is another growing problem in older people (Maxwell, 2015; 
Dhalla et al, 2011). This refers to inappropriate prescribing in dose, 
duration or clinical indication. Such inappropriate prescribing occurs in 
up to 20%of older people, with opioids and benzodiazepines being the 
most common drugs of misuse (Gottlieb, 2004; De Wilde et al, 2007). 
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Mortality from substance misuse
People with dual diagnosis have higher mortality rates than the 
general population matched for age, race and gender (Moos et al, 
1994). For those aged 65 and over, it is still two times higher than the 
general population (Chang et al, 2010). This also applies to substance 
misuse accompanying psychotic disorders, where mortality rates are 
2.5 times higher than the general population (Renininghaus 2015). 
 
Tobacco
Tobacco smoking is associated with the highest number 
of premature deaths in the UK for any single substance, 
but this has decreased from 106,000 to 79,000 per 
annum deaths over the past 10 years (NHS Digital, 2017b). 
 
Alcohol
In 2017, the relationship between alcohol and mortality in the UK was 
made more stringent in introducing a new classification of alcohol-
specific deaths, where alcohol has a clearer association with cause 
of death. This continues to include mental and behavioural disorders 
from alcohol use (Office of National Statistics, 2017c). 
The number of alcohol-specific deaths in people aged 50 and over has 
risen by 45%over the past 15 years (5,208 deaths in 2016, compared 
with 3,582 deaths in 2001). Over the same timeframe, the number 
of alcohol-specific deaths in people aged between 15 and 49 has 
remained the same (2,118 deaths in both 2001 and 2016).  
An indication of how alcohol misuse in the baby boomer cohort has 
influenced alcohol-specific mortality is evidenced by the 60−64 age 
group having the highest rate of alcohol-specific deaths at 29 per 
100,000 in 2015. In 2001, the highest alcohol-specific death rate was in 
the 50−54 age group, which was lower at 25 per 100,000. For the over 
50s, the age group with the highest rise in the rate of alcohol specific 
deaths over the past 15 years is people aged 80 to 84, showing a 
60% rise from 5.3 per 100,000 in 2001 to 8.5 per 100,000 in 2015. 
 
Illicit and prescribed drugs
In England and Wales, the number of deaths related to poisoning from 
all drugs in people aged between 50 and 69 has increased by 122% 
over the past 10 years, compared with an increase of 22% in the 
30−39 age group (Office for National Statistics, 2017d).  For any opioid, 
this difference is even starker, with rises of 30% and 192% in the 
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30−39 and 50−69 age groups respectively over the same timeframe. 
Although the differences between these age groups are less striking 
for poisoning from cocaine, amphetamines and benzodiazepines, 
there is still a comparatively higher rise in the 50−69 compared to the 
30−39 age group (Office of National Statistics. 2017d). 
These rises are mirrored by drug-related deaths in Scotland, where 
the average annual number of deaths in the 55-64 age group 
rose fivefold from 9 between 2002 and 2006 to 47 between 2012 
and 2016. The corresponding figures for the 35 to 44 age group 
was an average annual increase of just over threefold from 104 to 
327 during this time frame (National Records of Scotland, 2017e). 
 
Prescription drug misuse
Older people receive the highest proportion of prescribed medication 
dispensed in the UK, with 10% of these likely to be inappropriately 
prescribed (De Wilde et al, 2007). Approximately a third of men and 
women aged 65 living independently take four or more prescribed 
medicines regularly (Falaschetti et al, 2002).  
Inappropriate prescribing can be divided into overprescribing for 
a medication that is not clinically indicated and misprescribing a 
clinically-indicated medication (Schepsis and McCabe, 2016). The 
latter can be further divided into drug choice (more suitable alternatives 
available); dosage (too high for patient characteristics such as weight 
and renal function); duration of therapy (too long); duplication of drugs 
with the similar pharmacological profiles or a lack of consideration 
of interactions with other drugs used for the treatment of co-morbid 
disorders (Kaufmann et al, 2014).    
The most commonly prescribed drugs with the potential for misuse 
are benzodiazepines (for insomnia and anxiety), “Z” drugs zaleplon, 
zolpidem and zopiclone (for insomnia) − so called because they share 
the same first letter, opioids (for pain) and gabapentinoids (for pain and 
anxiety). Older people may also use opioids for cough and diarrhea. 
Long-term prescribing (more than 30 days) is more common for each 
type of Z drug in older patients than younger patients (Farias et el, 2017). 
 
Opioid misuse
The most commonly prescribed opioids in primary care with the 
potential for misuse are buprenorphine, fentanyl, morphine and 
oxycodone (Zin, Chen, Knaggs, & Chen, 2014). Patients aged between 
66 and 80 years are the most likely to receive an opioid prescription, 
followed by those aged 80 and older.
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The number of opioids prescribed for all age groups has risen by 20% 
in England over the past 5 years (Health and Social Care Information 
Centre, 2017a). In Scotland, between 2000 and 2015, there was a 
20%increase in prescribing for opioid drugs in older people (Hughes 
et al, 2016).
Past year rates of inappropriate prescribing for opioids and drugs for 
anxiety and insomnia have increased by between 40 and 50%over 
the past 10 years, with one study finding an increase of between 50 
and 70% for older people (Schepsis and McCabe, 2016). The rise 
in inappropriate prescribing of opioids in older people is likely to be 
attributable to a combination of an increased risk of substance misuse 
in the baby boomer cohort and a lower threshold for prescribing 
opioids for pain in older people (Kuo et al, 2016
Benzodiazepines
For benzodiazepines, the average age of people being prescribed 
these drugs is 66. In 2015, approximately 40% of benzodiazepine 
long-term prescribing was for people aged over 80. This compared 
to approximately 20% for people in their twenties and thirties (Farias 
et el, 2017).
The prescription of benzodiazepines has fallen over the past 20 years, 
but the percentage of people with benzodiazepine misuse in Europe 
is between 3% for younger and 17% for older people (Chatterjee et 
al, 2017). The risk of benzodiazepine addiction is more likely to occur 
in women and people with low income, chronic pain, difficulty with 
everyday activities, social isolation and anxiety (Chatterjee et al, 2017). 
Gabapentinoids
There is now also growing evidence for increasing rates of inappropriate 
prescribing of gabapentinoid drugs (pregabalin and gabapentin). 
In 2014, there were nine million prescriptions for gabapentinoids 
(Stannard, 2016). Most of these were prescribed for their licenced 
use in the alleviation of anxiety and for treating pain. Pain has been 
under-recognised in older people, so some increase may be due to 
increased treatment of genuine pain.
The number of prescriptions for pregabalin for all age groups has 
risen by 132% in England over the past 5 years (Health and Social 
Care Information Centre, 2017b). The number of deaths involving 
gabapentinoids has increased from less than one a year before 
2009 to 137 in 2015; with 79% of these deaths also involving the 
accompanying misuse of opioids (Lyndon et al, 2017). Pregabalin 
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is also the second most expensive drug to manufacture among all 
drugs prescribed in the NHS (NHS Digital, 2017c). 
In the United States, pregabalin is a controlled drug. In the UK, it 
is licensed for the treatment of generalised anxiety disorder. Some 
6.6% of the total reported adverse drug reports of misuse, abuse or 
dependence are associated with this drug, with a fivefold increase 
in the number of these reports since 2010 in developed countries 
(Chiappini et al, 2016). Vigilance is needed when co-prescribing 
pregabalin with opioid drugs, with an increased risk of drowsiness, 
sedation, respiratory failure. Consequently, Public Health England and 
NHS England (NHS England, 2014) jointly highlighted its potential for 
misuse. The Advisory Council on the Misuse of Drugs has called for 
the drug to re-classified as a controlled drug (AMCD, 2016).  Although 
there is no data available on the misuse of gabapentinoid drugs in 
older people in the UK, this is an area that requires increased vigilance 
over the coming years.
Psychiatric and physical 
comorbidity
The prevalence of dual diagnosis (mental disorders in older people 
that co-exist with substance misuse) ranges from 21% to 66%, with 
higher rates seen across in-patient settings (Bartels et al, 2006). In 
older people, Depression and cognitive impairment are the most 
common types of mental disorder in dual diagnosis, with the latter 
mostly referring to alcohol-related brain damage.   
Depression has a strong association with alcohol misuse (Atkinson 
2002, Brennan et al, 2016). Older adults with depression are three 
to four times more likely to have alcohol-related problems than 
those without (Devanand, 2002), with higher risk of suicide and 
social/functional impairment (Davis et al, 2008). Depression is also 
associated with a higher risk of past year cannabis and cocaine use 
in people aged 50 and over (Blazer and Wu, 2009).  Although most 
older people aged 65 and over in the UK are aware of the physical 
effects of drinking alcohol and have discussed their drinking with a 
health professional, this age group is least aware of the association 
between alcohol and depression (Office of National Statistics, 2010). 
Alcohol misuse in people aged 60 and over is also associated with 
anxiety, antisocial personality disorder and post-traumatic stress 
disorder (Sacco et al, 2009; Pietrczak et al, 2012; Chou et al, 2011; 
Bolton et al, 2009).  
Heroin and methadone users aged 50 and over have considerable 
accompanying physical co-morbidity ranging from 11% for diabetes 
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mellitus to 54% for hypertension. Other co-morbid disorders within this 
prevalence range associated with substance misuse include arthritis, 
cirrhosis, hepatitis C, lung disease and cardiac disease (Rosen et al, 
2011). With the ageing of heroin users, the numbers of older people 
with comorbid physical disorders such as lung and heart disease, 
and hepatitis are likely to increase (European Monitoring Centre for 
Drugs and Drug Addiction, 2010), adding to the public health burden.
Substance misuse and suicide
Alcohol reduces anxiety and inhibitions, as well as increasing 
impulsivity. Alcohol use disorders are at least five times more likely 
in older people with attempted suicide compared with the general 
population (Morin et al, 2013). During 2016, there were 5965 suicides 
in the UK, 2477 (42%) of which were in the 50 and over age group. 
In this age group, the highest suicide rate was in the 50−54 and the 
90 and over age bands (Office for National Statistics 2017f). 
The relationship between per capita alcohol consumption and 
suicide in older people in the UK is not as strong as in countries 
such as Sweden, Belgium and Portugal (Ramstedt 2001), but there 
are risk factors common to all age groups that need to be taken 
into consideration for those at risk of suicide. These often cluster 
together in risk profiles and they include male gender, family history 
of psychiatric disorder, previous attempted suicide, more severe 
depression, hopelessness and comorbid anxiety and alcohol misuse 
(Hawton 2013).
Premature ageing and mortality
Substance misuse is associated with damage to individual organs at 
a cellular level as well as with systemic toxicity (Shalev et al, 2013). 
This biological ageing may lead to premature vascular damage and 
neuronal toxicity that further compounds chronological ageing. In 
baby boomers, substance misuse is also associated with high rates 
of unprotected sex or intravenous drug use that increase exposure to 
infections (Kott, 2011). Low socio-economic status may compound 
the above processes through limited use of health services, lack of 
sleep, insufficient exercise, and poor nutrition (Jancovic et al, 2014). 
Substance misuse reduces life expectancy by between 9 and 24 years 
for illicit drugs and alcohol (Chang et al, 2010. For tobacco smoking, 
the reduction is between 8 and 10 years (Chesney et al, 2014).  
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Risk factors for substance 
misuse in older people
There is comparatively more known about factors for alcohol misuse 
in older people, given that it is the most commonly used substance 
in older people. 
Alcohol misuse
Although higher socio-economic status is known to be associated 
with higher average weekly alcohol consumption (Rao et al, 2015), the 
added burden of co-morbidity from physical and mental disorders in 
areas of high deprivation may explain why alcohol misuse contributes 
to poorer health outcomes in areas of higher socio-economic 
deprivation (Katikireddi et al, 2017).
Early versus late onset alcohol misuse
Up to a third of people aged 65 and over with alcohol misuse will 
have developed this after the age of 50 (Fink et al, 1996). Compared 
with younger people, people developing alcohol misuse for the first 
time after the age of 45 are less likely to have a family history of 
alcohol misuse, less likely to have a history of alcohol-related injuries 
or nicotine dependence and have a lower number of accompanying 
alcohol-related medical disorders (Wetterling et al, 2003). Older people 
aged 50 and over are also less likely to have a history of drink driving 
convictions (Mulford and Fitzgerald, 1992). Older people are as likely 
as younger people to have a history of mental disorder (Wetterling 
et al, 2003). However, psychosocial problems are more common in 
older people (Atkinson, 1994), and warrant closer attention.
Psychosocial risk factors for alcohol misuse
Not being in regular contact with other people through social interaction 
(Khan et al, 2006), having fewer responsibilities, experiencing 
bereavement, feelings of loneliness (Britton and Bell, 2015), increased 
financial strain (Shaw et al, 2011) and social isolation (Coyle and 
Dugan, 2012) are all risk factors for alcohol misuse. Homelessness 
also has a strong association with alcohol misuse in older people 
(Crane and Warness, 2012).
Retirement is a major life event for older people and is associated 
with an increased risk of alcohol misuse (Perreira and Sloane, 2001), 
particularly if not taken voluntarily (Henkens et al, 2008). The risk 
period for ongoing alcohol misuse may last for as many as 4 years. 
An accompanying lack of role is also independently associated with 
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alcohol misuse in older people (Kuerbis and Saccho, 2012; Bacharach 
et al, 2004). However, these findings have contrasted with others that 
have observed both increasing and decreasing drinking trajectories in 
the same cohort (Syse et al 2017, Bobo et al 2011, Bobo et al 2013).
A recent study with a follow-up period of between 4 and 12 years 
in Finland explored risky drinking (more than 24 units per week for 
men and more than 16 units for women) in older men and women. 
Risky drinking had positive associations with male sex, depression, 
smoking and working in an urban area (Halonen et al, 2017). 
The misuse of alcohol in response to stress is more commonly seen 
in older women, who more commonly use alcohol to self-medicate 
(Carney et al, 2000). As well as a reaction to life events and stress, 
anxiety disorders carry with them a higher risk of alcohol misuse 
(Wolitsky-Taylor et al, 2010).
Chronic pain has a consistent association with alcohol misuse in 
older people (Gilson et al, 2017) and a strong predictor of relapse 
(Witkiewitz et al, 2015), although this is not consistently associated 
with the extent of the pain (Brennan et al, 2011).
Insomnia is also known to be associated with alcohol misuse (Sproule 
et al, 1999). As many as 26% of older people use alcohol for medicinal 
purposes such as insomnia (Aira et al, 2008). 
Reducing alcohol-related harm 
Prevention of alcohol misuse in older people
The limited evidence from preventing the development of alcohol 
misuse in older people shows mixed results. However, personalised 
feedback of drinking has been shown to promote both healthy drinking 
behaviours and reduce harm from alcohol misuse (Lafortune et al, 
2017). There have been no studies examining the impact of harm 
reduction or health promotion interventions aimed at preventing the 
onset of cognitive impairment or progression of dementia (Lafortune 
et al, 2017). This a key gap in the evidence base.”
Changes to alcohol pricing
The affordability of alcohol in the UK has increased by 2%over the past 
10 years, but alcohol is still 60% more affordable than it was in 1980 
(Office of National Statistics, 2016). This may have had a bearing on 
spending by older people on alcohol, as alcohol has become more 
inexpensive as they have grown older. 
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As alcohol remains accessible, available and affordable for older 
people, there is a growing body of evidence accumulating for reducing 
alcohol-related harm at a population level through an increase in 
price. There are two distinct implications from introducing changes to 
alcohol pricing. The first reflects changes in spending for all drinkers 
incurred by any increase in alcohol price. The second is the overall 
benefit to society in reducing adverse alcohol-related health and 
social outcomes.
A study from Canada examining alcohol pricing and sales over 11 
years found that a 10% increase in the minimum price of alcohol 
reduced consumption relative to other drink types by 16%. The 
greatest reduction was for drinks with comparatively higher alcohol 
by volume content such as cider, wine and spirits compared to beer 
(Stockwell et al, 2012).
Of the different options available to reduce harm through reduced 
affordability, minimum unit pricing is estimated to have the largest 
potential for reduction in alcohol-related deaths among the heaviest 
drinkers in lower socio-economic groups. This population is known 
to have the highest risk of alcohol-related harm (Meier et al, 2016).
In the UK, both Westminster and Scottish governments committed to 
minimum unit pricing (H.M Government, 2012; Scottish Government, 
2012), but only the Scottish government that has finally ruled to pass 
this into law. It may be that the Westminster Government will now 
consider following the same implementation of minimum unit pricing, 
given that this has remained under consideration since 2012 (Home 
Office, 2013).  
The decision to implement minimum unit pricing in Scotland was 
based on detailed modelling, which found that a minimum unit price 
of 50 pence would lead to a reduction in alcohol-related deaths and 
hospital admissions. It also found that annual spending in moderate 
drinkers (drinking no more than 21/14 units per week for men/
women, according to previous drinking guidelines) would be largely 
unaffected, irrespective of socio-economic status. Among harmful 
drinkers (drinking more than 21/14 units per week for men/women, 
according to previous drinking guidelines), those defined as being in 
“poverty” (60% or below the average income) and at highest risk of 
alcohol-related harm would reduce their annual spending on alcohol 
by an average of £88 (Angus et al, 2016). 
Similar outcomes from minimum unit pricing on reducing adverse 
health outcomes and reducing spending on alcohol in harmful 
drinking among people with lower income have been found in a 
study modelled for England (Holmes et al, 2014). However, there 
is scope for re-modelling the above studies according to current 
lower risk drinking guidelines and for lower guidelines that may more 
applicable to older people.
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The potential benefits of minimum unit pricing also apply to older 
people. It is estimated that a 50 pence minimum unit price for England 
would lead to 49,000 fewer alcohol related illnesses 10 years after 
policy implementation. 
Most of the harm reduction would arise in chronic disorders in people 
aged 45 years and older, especially for hypertension, but also for 
mental and behavioural disorders associated with alcohol (Purshouse 
et al, 2010).
In summary, there is compelling evidence that minimum unit pricing 
is effective in reducing alcohol-related harm in a way that has the 
greatest impact on heavy drinkers (including reduced spending on 
alcohol in people with low income who are drinking at harmful levels). 
There are also likely to be short and long-term economic savings 
on health and social care costs. There remains considerable scope 
for further modelling to explore the potential health and social care 
benefits of minimum unit pricing in older people.
Lower risk drinking limits for 
older people 
There has been much speculation over the putative health benefits of 
alcohol on health. Interpreting causality between moderate drinking 
in later life and benefits to health (particularly to cardiovascular and 
cerebrovascular function) remain unproven. 
It is likely that that the proposed health benefits or lack of harm from 
alcohol have been over stated when comparing groups with heavy 
to those with moderate drinking or who are abstinent. Many older 
people reduce alcohol consumption over their life course if their health 
declines, thereby introducing a group of more unhealthy non-drinkers 
or moderate drinkers. There may also be under-reporting of alcohol 
consumption in those in groups who may be drinking heavily. 
Deaths from alcohol misuse may also lead to those who have survived 
their alcohol misuse being classified as healthy, when in fact they do 
not form a nationally representative sample of drinkers. 
The overall impact may be a false positive finding of “health benefits” or 
“protection” in a target group of drinkers at increasing risk of alcohol-
related physical harm (Stockwell et al, 2016; Naimi et al 2017).  
For alcohol-related brain damage, there is similarly no consistent 
evidence for preventing cognitive decline through alcohol consumption. 
A large observational cohort study conducted over 30 years found 
that older people consuming an average of over 30 units of alcohol a 
College report CR211 41
week were 6 times more likely to develop brain hippocampal atrophy 
compared with abstainers. Those drinking between 14 and 21 units 
per week had three times the risk. There was additionally no protective 
effect from light drinking (1-7 units/week) over abstinence (Topiwala 
et al, 2017).
Our Invisible Addicts (Royal College of Psychiatrists, 2011) 
recommended that ‘at-risk’ drinking for people aged 65 and over be 
defined as drinking no more than 11 units of alcohol per week and 
no more than 3 units per day for both men and women. Guidelines 
developed in the United States in 2005 (National Institutes of Health, 
2015) advise no more than 7 “drinks” per week for people aged 65 
and over. 
As one US “drink” is equivalent to 14 grammes and one UK unit is 
equivalent to 8 grammes of alcohol, seven US drinks is equivalent to 
12 UK units per week, or an average of 1.75 UK units per day.
Recognising that there is no safe limit that can be applied across 
all population groups, revised UK guidelines in 2016 replaced the 
term “safe” drinking with “lower risk drinking”. The new guidelines 
considered the evidence-base for harm attributable to alcohol at a 
population level. Lower risk drinking in the UK now states an upper 
limit of no more than 14 units per week for both men and women 
(Department of Health, 2016). 
A study across 7 European Countries (not including the UK) found 
that, for all age groups combined, a higher rate of mortality for drinkers 
occurred in men drinking above 2.5 UK units per day and women 
drinking above 1.25 UK units per day (Shield et al, 2017). This equates 
to 17.5 units for men and 8.75 units for women per week.
More recent evidence extracted from national data of alcohol 
consumption in the UK found no evidence of increased mortality 
for older women drinking an average of no more than 1.25 units of 
alcohol per day (Knott et al, 2015). 
However, any perceived health “benefits” may be attributable to 
inappropriate selection of a reference group and weak adjustment 
for confounders. 
The revised UK guidelines (DH 2016) may still need to be applied 
more cautiously to older people, who are likely to be more sensitive 
to alcohol-related harm through the effects of ageing, having more 
complex physical and mental health problems, a higher risk of 
interactions with prescribed and other medications and a higher 
likelihood of the cognitive impairment than younger people. 
Given both the validity of assessing alcohol intake in older people using 
traditional rating scales and variable reliability of self-report, improving 
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the measurement of alcohol intake and gauging risks associated 
with alcohol use may be better served through measuring blood 
alcohol concentration (BAC) (Crome et al, 2012). This may give a 
more accurate picture of the precise relationship between blood BAC 
and alcohol-related harm.
Health awareness
haviour of 16,710 people aged 50 and over found that 82% were 
confident that they could calculate alcohol units and 59% were 
confident or very confident in their ability to keep track of these units. 
Some 91% were very confident or confident that they could reduce 
their alcohol use if required. However, only 26% could correctly identify 
recommended drinking limits (Holley-Moore and Beach, 2016).    
Wine remains the most popular alcoholic drink in people aged 65 
and over, being the main type of alcohol consumed in over 50% of 
this age group (Office of National Statistics, 2017a). Given that the 
average size of wine glasses continues to rise (Zupan et al, 2017), 
the lack of awareness of lower risk drinking limits in older people has 
implications for public education if progress is to be made in reducing 
alcohol-related harm in older people at a population level (Rao and 
Roche, 2017). 
However, it should be acknowledged that alcohol use is closely linked 
to maintaining social function and routines. Interventions aimed at 
reducing alcohol-related harm, therefore, need to consider the role that 
alcohol plays in maintaining both social cohesion and identity (Kelly 
et al, 2018). This can only be achieved by a clearer understanding 
of the health risks associated with alcohol misuse from both clinical 
and public health perspectives.
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Assessment of substance 
misuse
Key messages
 z All older people should be screened for alcohol and tobacco 
misuse and should be asked about other substance use and 
misuse when presenting to clinical services.
 z Older people misusing substances should be offered a full 
assessment of their substance misuse in mental health services 
and offered referral to specialist substance misuse services if 
required.
 z They should be user friendly and special consideration of older 
people’s distinctive needs, with assessment considering the 
physical, psychological and social changes consequent on 
ageing.
 z Assessment may need to be ongoing and frequently reviewed, and 
involve the collaboration of health and social care professionals, 
families and carers over the longer term.
 z Major life events, presentation with physical and psychological 
symptomatology (particularly if unexplained), and inconsistencies 
or contradictions in the presentation, should prompt re-screening 
or assessment.
 z Although applying the standard criteria for the diagnosis 
of dependence to older people may be useful, this must be 
undertaken thoughtfully as they may not always be applicable.
Introduction
A comprehensive assessment of substance use and misuse in older 
people is fundamental to optimal management. Indeed, it is the first 
stage of treatment but also requires appropriate knowledge, skills and 
attitudes that are central to developing a therapeutic relationship and 
longer-term engagement. Before starting this process, screening is 
first required. This is feasible within all health and social care settings 
if the relevant training is provided. Although both screening and 
assessment are carried out in addiction services, the provision of 
College report CR211 44
comprehensive assessment should also be possible within older 
people’s mental health services.
In this section, we have provided an outline of the screening and 
assessment process, barriers to identification of substance misuse, 
diagnostic criteria for substance use disorders, limitations of such 
criteria in older people, and a framework for assessment. It can 
be extremely difficult to capture the relevant relationships between 
substance use, mental symptoms, physical problems and social 
dysfunction.  We have drawn on the following material in constructing 
the information in this section:
 z Royal College of Psychiatrists 2011 Our invisible addicts (RCPsych 
2011).
 z Royal College of Psychiatrists 2015 Substance misuse in older 
people: an information guide (RCPsych 2015).
 z Crome IB Wu L Rao R Crome P (Eds) 2015 Substance use and 
older people Wiley Blackwell.
 z Rao R Crome IB 2016 Assessment in the older patient in Eds 
Sullivan MA and Levin FR Addiction in the Older Patient Oxford 
University Press Oxford pp 173-209. 
 z Society for the Study of Addiction website.
Background 
All healthcare staff need to be equipped to detect substance misuse. 
This may also include non-medical professionals such as social 
workers or care home staff, as well as liaison nurses within acute 
hospital settings.    
It is important to adopt a non-judgemental and non-ageist approach, 
with respect for dignity, privacy and autonomy. 
Fluency in the patient’s first language will influence the validity of 
the assessment and may require an interpreter. The pacing of the 
interview needs to take into consideration factors such as seating 
comfort, sensory impairment, clouding of consciousness, level of 
comprehension, cognitive impairment, and privacy. 
Assessors should be aware of underreporting of substance use 
through denial, stigma, lack of awareness or memory impairment. 
A slower pace is needed, with more than one assessment usually 
required.
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The framework outlined in Figure A1.1, known as the “5 As”: Ask, 
assess, advise, assist, arrange (Raw et al 1998) is a useful guide to 
the phases involved in the assessment and treatment process. During 
all stages, the options should be “tailor-made” to the individual (US 
Department of Health and Human Sciences 2005).   
To some extent, the decision as to what treatment is required will be 
determined by the setting to which the patient presents.    
Screening and assessment are the first components of the process 
of effective management, i.e. to ask every patient about substance 
use. However, screening and assessment are not the same thing; 
they are different processes. Screening should be undertaken for 
all new patients and reviewed at regular intervals. Its main aim is to 
document use and misuse.  
If screening identifies substance misuse, it will be appropriate to 
proceed to assessment, i.e. eliciting more detail. This will inform a 
diagnosis of substance abuse or dependence, which will, in turn, 
lead to the formulation of a treatment plan.
Screening and assessment of substance misuse in older people 
requires appropriate knowledge, skills and attitudes relevant to ageing 
and to the use and consequences of such substances misuse. There 
also needs to be consideration of atypical presentations, difficulties in 
applying conventional diagnostic tools for misuse and dependence, 
as well as greater emphasis on social and physical aspects of 
assessment compared with younger people.   
Presentation to services
Substance use in older people often goes undetected. This may be 
because people are not routinely asked but also because health and 
social care professionals do not recognise symptoms or behaviours 
that may be indicative of substance use.  
Patients experiencing “ups and downs”, those with inconsistencies 
and contradictions in the history and presentation, and particularly 
those who do well in hospital but poorly at home, are of concern and 
should alert practitioners. Common presentations in older people 
misusing substances may be the result of changes in behaviour and 
unexplained symptoms, and include the following:
 z Changes in self-care, eating habits and sleep pattern
 z Changes in mood, memory and concentration 
 z Changes in mobility, social activities and activities of daily living 
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 z Changes in compliance with medication
 z “Masking” by other disorders (e.g. depression, Parkinson’s 
Disease)
 z Unexplained (e.g. vomiting) and persistent (e.g. pain) symptoms 
 z Convulsions
 z Slurred speech  
 z Liver-function test abnormalities
It is therefore essential that all health and social care services working 
with older people screen for substance use and misuse.
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Barriers 
There may also be many barriers to assessment of substance 
misuse in older people (Table 2). Assessments may need to 
be multiple and frequent with the key objective of engaging the 
patient and their families and carers. There is often considerable 
embarrassment and ambivalence about admitting to substance 
use. There may also be a degree of discomfort in practitioners 
asking about it. For these reasons and those specified below, there 
should always be a high degree of clinical suspicion. Detection can 
be tricky due to complex pathology and atypical presentations. 
It should be noted that older people often do ntableot get 
the treatment they deserve because of a reluctance to refer 
appropriately even if substance misuse is detected (O’Connell et al 
2003). 
 
Table 2: Barriers to identification of substance misuse in older people  
(Royal College of Psychiatrists, 2011)
Practitioner barriers Individual barriers
• Ageist assumptions
• Failure to recognise symptoms 
• Lack of knowledge about 
screening
• Discomfort with topic
• Lack of awareness of 
substance misuse in older 
people (‘If you don’t think 
about it, you won’t see it’)
• Misuse traditionally considered 
to be rare in old age
• Symptoms may mimic or 
be hidden by symptoms of 
physical illness
• Unwillingness to ask 
• Absence of informants
• Attempts at self-diagnosis
• Symptoms attributed to ageing 
process or other illness
• Many do not self-refer or seek 
treatment
• Perceived stigma of the word 
‘addiction’
• Reluctance of patients to 
report – shame, denial, desire 
to continue using, pessimism 
about recovery
• Cognitive problems – 
substance-induced amnesia, 
underlying dementia
• Unwillingness to disclose 
• Collusion of informant(s) 
• Screening
Screening
Screening should be carried out in a friendly manner and be sensitive 
to emotional, social and physical needs. Special note should be taken 
of recent life events. Screening may be achieved by interview, pencil 
and paper or electronic methods. It should involve questions about 
quantity and frequency of substance use, symptoms of misuse 
and dependence and indirect proxy questions such as the CAGE 
questionnaire. Screening instruments for substance misuse in older 
people are confined to those that identify alcohol misuse (Royal 
College of Psychiatrists, 2015). 
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The CAGE (Felt that you should Cut down; Annoyed by others 
criticising drinking; Feel Guilty about drinking; Have an Eye-opener 
on waking to get rid to steady nerves) questionnaire allows a rapid 
screen to detect the core features of alcohol dependence. However, 
it is relatively insensitive to harmful/hazardous drinking and does not 
distinguish between current and prior alcohol problems (Adams et 
al, 1996).  
The Alcohol Use Disorders Identification Test (Table 3) is the most 
commonly used screening tool for alcohol misuse (Saunders et al, 
1993). It comprises 10 questions that explore alcohol use over the 
past year. The total score indicates a drinking risk category – lower, 
increasing, higher or possible dependence. The AUDIT also serves as 
clinical decision tool as the score provides an indication of appropriate 
interventions. It can also be used as an outcome measure.
Several adaptations of the Alcohol Use Disorders Identification Test 
(AUDIT) tool have been validated in older populations (Roberts et al, 
2005). These adaptations include the AUDIT-5, a five-item version 
of the full AUDIT (Piccinelli et al, 1997) and the AUDIT-C, which asks 
only the three questions of the full AUDIT that assess drinking pattern 
(Bush et al, 1998). Suggested cut-off points for the AUDIT-5 (Philpot 
et al, 2003) and AUDIT-C (Aalto et al, 2011) are for both instruments, 
as well as for the full AUDIT.
The use of computers for screening in primary care for rapid 
identification of substance abuse in primary care settings is also 
suitable for psychiatrists. The DAPA-PC (Drug Abuse Problem 
Assessment for Primary Care) has been pioneered in the USA (Holtz 
et al 2011; Haskins et al 2017).  
The Fagerstrom Test for assessment of nicotine dependence is also 
a rapid tool (Fagerstrom et al 1990).
Table 3   Alcohol Use Disorders Identification Test
AUDIT Score Drinking category
0-7 Lower risk (0−4 for 65+ age group)
8-15 Hazardous/increasing risk
16-19 Harmful/higher risk
20+ Possible dependence
The most widely used age-specific screening tool, the Short Michigan Alcoholism Screening 
Test – Geriatric version (SMAST-G; Blow et al, 1998a), has been validated for use in older 
hospital in-patients. It addresses problems more commonly seen in older people, such as 
‘drinking after a significant loss’ or ‘drinking to take your mind off your problems’.
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Case study 1
Mrs AB is a 75-year-old retired teacher who was referred to a community 
mental health team for older adults. She had no previous contact with 
mental health services but had presented to her GP with several different 
problems over the past few years, such as tiredness, sleep disturbance 
and poor food intake. Mrs AB had not attended her annual health check 
for five years and any suggestion of blood tests has been refused. She 
had no family and no social contacts.
At assessment on a home visit, the flat was cluttered, and Mrs AB was 
dressed in clothes that did not appear clean. Her refrigerator was empty, 
as she said that she had been ‘living off take-aways’. 
On mental state examination, there was no evidence of cognitive 
impairment, but Mrs AB had a depressive disorder that was treated with 
antidepressants and she was allocated a care coordinator with whom 
she did not engage. She did not take her antidepressants and refused 
input from psychology, occupational therapy and social services. She 
was therefore discharged from mental health services, as she had 
mental capacity to refuse input.
Mrs AB was re-referred 12 months later, following the onset of memory 
problems, detected by her GP, having locked herself out of her flat at 
night. She said that she had “gone to buy something to drink” when the 
incident happened.
At interview, she was screened using the AUDIT and found to be in the 
higher risk category of alcohol misuse. Following a full assessment 
of her substance misuse, she reported drinking a quarter of a bottle 
of spirits a day since her retirement six years previously. She did not 
consider reporting her alcohol consumption when first seen, as she 
‘did not consider it to be a problem’. This case study highlights the 
importance of assessing substance misuse routinely – if Mrs AB had 
been asked about it initially, her alcohol misuse may have been detected 
at first presentation.
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Assessment of substance 
misuse  
The framework in Table 4 outlines a structured and systematic 
approach to assessment. Each substance of relevance should be 
covered separately. By assessing quantity, frequency and chronology 
of use and misuse, a clearer picture can be built of how mental health 
and health, as well as genetic, personality, early life, psychosexual and 
occupational factors have influenced substance misuse. This will also 
undoubtedly be precipitated, perpetuated and maintained by ongoing 
mental and physical health, social isolation, independence in activities 
of daily living, housing, finances and concerns over safeguarding and 
mental capacity.
The protocol will also need to be supplemented with information 
from collateral sources. This includes information from relatives, 
friends and informal carers (taking account of information sharing 
and confidentiality, GP consultations (including current prescribed 
medication), hospital discharge summaries, home carer reports, 
day centre reports, reports from housing officers/wardens of 
supported housing, criminal justice agencies and results from previous 
investigations such as psychometry and neuroimaging (The Royal 
College of Psychiatrists, 2015).
Far greater prominence needs to be given to social functioning and 
social networks in older people than in younger adults. In older 
people, there is comparatively less emphasis on forensic history and 
occupational history than in younger people.  Social pressures such 
as debt, or even substance-using ‘carers’ or open drug dealing may 
impact on the older person’s welfare.  Vigilance about safeguarding 
is essential.
Functional ability also has greater relevance when assessing older 
people. This can be assessed using the Barthel Index which rates the 
ability to perform Activities of Daily Living (ADLs) (Wade & Collin 1988). 
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Fig. A1.1 A five-phase framework for assessing substance misuse in older patients (after Crome & Bloor 2006).
Recent onset or 
early onset?
Abstinence 
or harm 
reduction?
Anxieties and 
concerns dealt 
with?
Set a quit 
date?
Is specialist 
input needed?
V?
Phase 2 - Assess
 Assess degree of dependence and educate patients about the effects of 
substances
 Assess the level of motivation or ‘stage of change’ at which the patient is 
and suggest staged goals, e.g. abstinence or harm reduction
 Discuss and negotiate treatment choices, e.g. pharmacological 
interventions, admission to specialist services
 Be aware that clinical manifestations of the condition and age-related effects 
such as neurocognitive dysfunction may impair history-taking
Phase 3 – Advise
 Use a brief 5–10 minute motivational interviewing framework
 Give the patient the opportunity to ventilate anxieties and concerns
 Offer feedback about clinical findings, including physical examination and 
biochemical and haematological tests
 Outline and discuss the benefits and risks of continued substance use; 
outline safe levels of drinking
 Provide self-help materials, e.g. manuals
Phase 4 – Assist
 Be supportive and encouraging, and instil positive expectations of success
 Acknowledge that previous failed attempts to cut down or give up may have 
engendered loss of confidence and self-esteem
 If the goal is abstinence, suggest that a quit date is set, so that the patient 
can plan accordingly (e.g. get rid of any alcohol in the house) and safely 
(e.g. is it safe abruptly to stop drinking?)
 Work through a range of alternative coping strategies, including the 
identification of cues that might help distract the patient
Phase 5 – Arrange
 Be prepared to refer or organise admission to a specialist or appropriate 
unit if the patient:
□ is in severe withdrawal, including delirium tremens
□ is experiencing unstable social circumstances
□ is likely to develop serious withdrawal symptoms owing to a severe 
dependence or previous severe withdrawal, including delirium tremens
□ is severely dependent
□ has a serious comorbid physical illness
□ has comorbid mental illness, including suicidal ideation
□ is using multiple substances
□ has a history of frequent relapse
Phase 1 – Ask
 Ask all patients about alcohol, drug, nicotine and other substance misuse, 
including prescribed and over-the-counter medications
 Differentiate between use, harmful use and dependence
 Consider using appropriate screening instruments
 Be aware of, and sensitive to, the ambivalence that patients may feel about 
their substance misuse
 Be non-judgemental and non-confrontational
V?
V?
V?
V?
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Fig. A1.2 Suggested outline for schedule of issues to be covered in assessment (after Crome & Bloor, 2006).
Each substance should be 
discussed separately
 Alcohol
 Amphetamines
 Benzodiazepines
 Cannabis
 Cocaine
 Ecstasy
 γ-hydroxybutyrate (GBH)
 Heroin and other opiates
 Methadone
 Nicotine
Episodes of treatment for  
substance problems
Medical history
Family history
Psychiatric history
 Age at which substance first tried
 Age at onset of weekend, weekly and daily use
 Pattern of use during each day
 Route of use (if applicable), e.g. oral, smoking, 
snorting, intramuscular, intravenous
 Age at onset of specific withdrawal symptoms and 
features of dependence syndrome
 Current use over previous day, week, month and 
maximum use ever
 Current cost of use
 How is use being funded?
 Periods of abstinence
 Relapse triggers
 Preferred substance(s) and reasons
 Dates, service, practitioner details, treatment/
interventions, success or otherwise, relapse 
triggers
 Episodes of acute or chronic illness: respiratory, 
infective, HIV, hepatitis, injury (including 
accidents), surgery
 Admission to hospital, dates, problems, treatment 
and outcome
 History of substance misuse and related problems
 History of psychiatric problems, e.g. suicide, self-
harm, depression, anxiety, psychotic illness
 Assessment by general practitioner for ‘minor’ 
complaints, e.g. anxiety, depression
 Treatment by general practitioner with any 
psychoactive drugs
 Referral to specialist psychiatric services: dates, 
diagnosis, treatment and outcome
 Mental Health Act assessments
 Is there any debt to finance substance problems?
 Biochemical, haematological, urinary, salivary, 
sweat, hair, alcohol levels
 Family, friends and colleagues
 Social Services
 Criminal justice agencies
 Health services 
 Voluntary agencies
V
V
V
V
V
Financial situation
V
Investigations V
Collateral information V
X
X
X
X
X
X
X
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Table 4: Framework for assessment of substance use and misuse in older people 
Area of questioning Questions to ask
Cover each of the following 
substances individually
• Alcohol
• Amphetamines
• Benzodiazepines
• Cannabis
• Cocaine
• Ecstasy
• Heroin and other opiates
• Novel psychoactive 
substances
• Methadone
• Nicotine
• Over the counter 
medication
• Substances bought over 
the Internet
• Prescribed medication
• Solvents
• Age of initiation: first tried each substance
• Age of onset of weekend use
• Age of onset of weekly use
•  Age of onset of daily use
•  Pattern of use during each day, i.e. quantity/weight, frequency
•  Route of use, e.g. oral, smoking, snorting, intramuscular, intravenous, 
subcutaneous (“skin popping”)
•  Age of onset of specific withdrawal symptoms and dependence syndrome 
features 
•  Current use over previous day, week, month
•  Number of days of abstinence (reasons for this)
•  Current cost of use
•  Maximum use ever
•  How substance use is funded
•  Source of substances 
•  Periods of abstinence
•  Triggers to relapse
•  Preferred substance(s) and reasons
•  If injecting, current injection sites, previous injection sites, any problems 
with these
Treatment episodes for 
substance misuse
•  Dates, length of contact with service
•  Type of services, and what was provided/types of interventions
•  The outcome of each contact, what was achieved, did patient view it as 
successful or otherwise
•  Reason for discontinuing contact with the service
•  Triggers for relapse, reasons for contact with the service again
Psychiatric history •  Current signs and symptoms
•  Current diagnosis, medication
•  Assessment by GP for anxiety, depression, memory problems
•  Previous diagnosis of dementia
•  Treatment by GP with psychotropic drugs
•  Referral to specialist psychiatric services for assessment and treatment, 
dates, reasons, diagnosis, outcome (including in-patient admissions)
Family history •  Parents, siblings, grandparents, aunts, uncles, wife, husband, partner, 
children, grandchildren
•  History of substance misuse within the family members mentioned, and 
any related problems
Personal History •  Educational attainment
•  Separation, divorce, death
•  Family relationships, conflict, support
•  Occupational history
•  Whether childhood spent with biological parents or others
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Table 4: Framework for assessment of substance use and misuse in older people 
Area of questioning Questions to ask
Social History •  Current living arrangements, e.g. home, hostel, care home and with whom
•  Cared for/carer
•  Permanent, temporary
•  Social network
•  Activities of daily living
•  Housing support needs
•  Benefits
•  Any areas of vulnerability
•  Typical day
Lifestyle issues • General physical state
• Sleep
• Diet 
• Injecting practices including risk to others
• Wound management
• Oral health
• Vaccination history
• History of breast, cervical cancer, prostate screening
• Sexual health issues
Medical history • Current diagnosis, medications, treatment
• Acute or ongoing disorders: respiratory, infective, HIV, tuberculosis, 
cardiovascular, hepatitis, injury, accidents, surgery, overdose
• Any screening for blood-borne viruses (hepatitis B, C and HIV), dates and 
outcomes
• Falls, pain, constipation, sensory impairment
• Admission to hospital, dates, problems, treatment, length of admission and 
outcome
• Current GP, care, condition(s), treatments
Psychiatric history • Current diagnosis, medication
• Anxiety, depression, memory problems
• Previous diagnosis of dementia
• Treatment by GP with psychotropic drugs
• Referral to psychiatric services for assessment and treatment, dates, 
reasons, diagnosis, outcome (including in-patient admissions)
• Any mental health act assessments
Criminal history • Involvement in criminal activities, both related and non-related with 
substance use
• Age at first contact with the criminal justice system and reasons
• Cautions, charges, convictions
• Types of activity, shoplifting, theft, prostitution
• Imprisonment at any time
• Any current issues
Social background/Personality • Ethnicity and cultural background
• Religious and spiritual beliefs
• Coping styles/resilience
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Table 4: Framework for assessment of substance use and misuse in older people 
Area of questioning Questions to ask
Financial status • Mental capacity over finances
• Debt
• Arrangements for budgeting and expenses
Biological measures • Biochemistry: alcohol levels, drug screens, liver function tests
• Haematology 
• Virology
Psychological measures •  Brain MRI, liver ultrasound, endoscopy
Contact with other services 
(current and previous)
• Vulnerable adult
• Safeguarding risk to children (as grandparent)
Risk factors • Social/cultural isolation
• Self-neglect
• Recent losses
• Carer stress
• History of harm to self and others
• Elder abuse
Further information • Carers, family, friends, colleagues
• Other service providers
Perspective of patient • Perception of problems
• Mental capacity of health care decisions
• Motivation for change – strengths, barriers, support
(Adapted from: Crome and Ghodse, 2007 and Society for Study of Addiction website 2015)
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Box 1: ICD–10 diagnostic guidelines for the dependence syndrome (WHO, 1992)
(a) a strong desire or sense of compulsion to take the substance
(b) difficulties in controlling substance-taking behaviour in terms of its onset,termination, or levels of use
(c) a physiological withdrawal state when substance use has ceased or been reduced, as evidenced by: the      
        characteristic withdrawal syndrome for the substance; or use of the same (or a closely related) substance 
        with the intention of relieving or avoiding withdrawal symptoms
(d) evidence of tolerance, such that increased doses of the psychoactive substances are required in order              
        to achieve effects originally produced by lower doses (clear examples of this are found in alcohol- and    
        opiate-dependent individuals who may take daily doses sufficient to incapacitate or kill non-tolerant       
        users)
(e) progressive neglect of alternative pleasures or interests because of psychoactive
(f) substance use, increased amount of time necessary to obtain or take the substance or to recover from its 
        effects 
(g) persisting with substance use despite clear evidence of overtly harmful consequences,such as harm to    
        the liver through excessive drinking, depressive mood states consequent to periods of heavy substance   
        use, or drug-related impairment of cognitive functioning; efforts should be made to determine that the      
        user was actually, or could be expected to be, aware of the nature and extent of the harm.
 
Narrowing of the personal repertoire of patterns of psychoactive substance use has also been described as 
a characteristic feature (for example, a tendency to drink alcoholic drinks in the same way on weekdays and 
weekends, regardless of social constraints that determine appropriate drinking behaviour).
It is an essential characteristic of the dependence syndrome that either psychoactive
substance taking or a desire to take a particular substance should be present; the subjective awareness of 
compulsion to use drugs is most commonly seen during tempts to stop or control substance use.
A definite diagnosis of dependence should usually be made only if three or more of the following have been 
present together at some time during the previous year:
Diagnosis
Two diagnostic systems are used to make a diagnosis of Substance 
Use Disorder, with either Harmful or Dependent Substance Use:
 z DSM5: Diagnostic and Statistical Manual of the American 
Psychiatric Association (American Psychiatric Association, 2013). 
In DSM5, “dependence” and “abuse” diagnoses are combined 
into “substance use disorder. 
 z ICD 10: International Classification of Diseases (WHO, 1992) 
classifies misuse as harmful use or dependence. 
The above criteria were developed in a younger adult population and 
may not apply to older people. The limitations of DSM5 diagnostic 
criteria for Substance Use Disorder listed in Table 5.
It is important to attempt to establish a diagnosis of dependence 
or severe substance use disorder to understand the severity of the 
condition and as to whether to use pharmacological agents for 
withdrawal, substitution or maintenance. However, depending on 
circumstances, this judgement may have to made with astute caution, 
and ideally by a team comprising an addiction specialist, a geriatrician 
and a specialist in old age psychiatry.   
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Table 5 
DSM5 diagnostic criteria for Substance Use Disorder (SUD)   
The presence of at least 2 symptoms indicates a Substance Use Disorder (SUD). The severity of SUD 
is defined by Mild (the presence of 2−3 symptoms); Moderate (4−5 symptoms) or Severe (6 or more 
symptoms)  
Criterion Limitations in older people
1 Substance taken in larger 
amounts or over a longer period 
that was intended
Cognitive impairment may interfere with self- monitoring
2 There is a persistent desire or 
unsuccessful efforts to cut down 
or control substance use
There may be reduced incentive to decrease harmful use, which 
includes fewer social pressures and fewer personal and family 
pressures secondary to ageism
3 A great of time is spent in 
activities necessary to obtain 
substances, or recover from 
effects
Negative effects may occur at relatively low levels of use
4  (New 
criterion 
in DSM5)
Craving or a strong desire or urge 
to use substances
Older people may not recognise the urges as cravings, or may 
attribute it to something else such as anxiety, depression or 
boredom
5 Recurrent substance use resulting 
in failure to fulfil major role 
obligations of work, school or 
home
The roles and expectations of older people and their families 
might have changed so that this is not acknowledged as a 
problem
6 Continued use despite having 
persistent or recurrent social or 
interpersonal problems caused or 
exacerbated by substance use
Older people deny or may not realise that the problems are 
associated with substance use
7 Important social occupational or 
recreational activities are given up 
or reduced due to substance use
Older people may have decreased activities due to physical and 
psychiatric comorbidities or ‘slowing down’ 
Social isolation and disabilities may make detection more difficult
8 Recurrent use in situations in 
which it is physically hazardous
Older people may deny or not realise that a situation that was 
once safe, has become physically hazardous
9 Substance use is continued 
despite knowledge of having a 
persistent or recurrent physical 
or psychological problem that 
is likely to have been caused or 
exacerbated by substances
Older people may deny or not realise that these symptoms are 
substance related
Practitioners may not attribute some or all problems as 
substance related
10 Tolerance Older people may not develop dependence
11 Withdrawal Even low intake may cause problems
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Clinical examination 
There are well-documented associations between the substance use, 
mental disorder and physical conditions. As a detailed description 
of the physical and mental disorders is beyond the scope of this 
report, a summary is provided below (Crome et al 2015; the Royal 
College of Psychiatrists 2015). Both mental state and physical 
examination support the diagnostic process and will influence further 
investigations and treatment (Royal College of Psychiatrists, 2015). 
Mental state examination
There are key features of the mental state examination which are of 
great relevance to substance misuse include:
 z Delirium associated with intoxication or withdrawal. Delirium 
tremens has a high morbidity and mortality and is treatable. It 
represents a medical emergency.
 z Wernicke’s encephalopathy may also present with, or be 
confused with, signs of delirium or intoxication and opportunities 
for treatment may be missed.  The ‘classic triad’ of oculomotor 
abnormalities, cerebellar dysfunction and altered mental state 
only occur in 20%. However, 80% of patients present with an 
altered mental state of mental sluggishness, apathy, impaired 
awareness of an immediate situation, disorientation, poor 
attention, agitation and hallucinations.
 z Low mood and anxiety may accompany the misuse of a range 
of substances, particularly depressant drugs such as alcohol, 
sedatives and hypnotics. It is not uncommon to find an atypical 
presentation of symptoms suggestive of a mood disorder. These 
include being ‘masked’ by cognitive impairment or ‘somatised’ 
by presenting as physical symptoms such as lack of energy.
 z Suicidal ideation: Older people with depression are known to 
be at high risk of suicide when accompanied by alcohol misuse.
 z Psychotic symptoms are associated with a variety of substances 
such as cannabinoids, stimulants and hallucinogens; withdrawal 
states accompanying alcohol and/or sedative/hypnotics are also 
associated with transient psychotic symptoms. Chronic use of 
stimulant and depressant drugs (e.g. alcohol) can manifest as 
psychosis.
 z Cognitive impairment may arise from alcohol brain injury, 
alcohol-related traumatic brain injury, benzodiazepine use, stroke 
or chronic subdural haematoma. Cognitive impairment may be 
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assessed using the mini-mental state examination (MMSE) 
(Folstein et al 1975) and Addenbrookes Cognitive Examination 
(ACE) (Mioshi et al 2006).
Physical examination
The following list highlights some of the problems which should be 
considered on physical examination:
 z Weight loss
 z Self-care 
 z Gait and balance, e.g. tremor and festination, spastic hemiplegia, 
and use of walking aids
 z Skin integrity: evidence of injury, e.g. ulceration, pressure damage
 z Tar staining of the fingers and hair 
 z Stigmata of chronic liver disease: macronodular liver, liver tumour 
or ascites
 z Psoriasis, skin carcinoma and porphyria cutanea tarda 
 z Superficial and deep vein thrombosis, ulceration and sinus 
formation. 
 z Subacute bacterial endocarditis can arise from injecting drugs. 
 z Nail fold infarcts, splinter haemorrhages, Osler’s nodes, Janeway 
lesions 
 z Macular rash, psoriasis and sebhorrheic dermatitis 
 z Gum disease and dental caries 
 z Chronic obstructive pulmonary disease (COPD)
 z Hypertension and stroke 
 z Neurological manifestations of traumatic intracerebral bleeding, 
and Wernicke’s encephalopathy
 z Bony injury in acute intoxication
 z Cerebellar syndrome and peripheral neuropathy
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Further investigations are almost always appropriate if patients are 
presenting with associated symptomatology.  These may include 
urine or breath tests, blood alcohol levels, full blood count, mean 
corpuscular volume, urea and electrolytes, liver function tests, 
vitamin B12 and folate levels. More specialised investigations such 
as neuroimaging studies or screening for blood borne viruses may 
have to be undertaken.
Conclusion
As assessment constitutes the first stage of treatment, it is vitally 
important that the opportunity for further engagement, retention and 
intervention is secured through an empathic and non-confrontational 
tone and style at the first interview. The quality of the collaboration 
or coordination between the medical and social care teams, the 
patient and their families and carers at this point can be instrumental 
in determining the outcome by setting the scene for what might be 
a long-term therapeutic relationship. Appropriate utilisation of a 
structured framework, diagnostic criteria, and a systematic procedure 
for intervention, will aid interpretation of clinical presentations in 
substance-using older people and point practitioners in the right 
direction. 
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Key Messages
 z Current services are poorly equipped in the assessment, 
treatment and care of older people with alcohol-related brain 
damage (ARBD).
 z ARBD has a wide range of mechanisms involved in its 
development, with Wernicke-Korsakoff Syndrome and alcohol-
related dementia being the most common clinical presentations
 z Rising rates of hospital admissions for ARBD has implications 
for clinical service provision.
 z Assessment, diagnosis, harm reduction and recovery require 
specialist skills and involves a joint approach between health 
and social care professionals, as well as families, carers and 
third sector providers.
 z Reduction of, or abstinence from, harmful drinking may be 
associated with partial reversibility in cognitive function
 z Long term care is not a substitute for appropriate rehabilitation 
 z Substance misuse is associated with a wide range of physical 
complications that require appropriate assessment, treatment 
and aftercare. 
Alcohol-related brain 
damage and physical 
complications of 
substance misuse
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Introduction
Alcohol misuse is associated with over 200 mental and physical 
disorders (Stewart et al, 2017). As well as the health impact of acute 
and chronic liver disease, it is also associated with brain damage 
(including dementia); cancers of the mouth, throat and breast; and 
hypertension, heart disease and stroke (NHS Choices, 2016). Ageing 
is associated with a reduction in total body water and a resulting 
increase fat to water ratio. As alcohol is water-soluble and not fat-
soluble, these changes mean that, for a given alcohol intake, the 
concentration of alcohol in the blood is higher in an older than in a 
younger people. It is therefore likely that physical complications can 
occur at lower levels of alcohol consumption in older people. However, 
abstinence from harmful drinking may be associated with partial 
reversibility in cognitive function.                                             
Older people are also likely to experience both acute and chronic 
physical complications associated with other substance misuse, 
compounded by polypharmacy and age-related physical disorders. 
The route of administration is also central to the physical complications 
of substance misuse (e.g. smoking and lung cancer; intravenous 
drugs and blood borne viruses).
Alcohol-related brain damage
Alcohol is known to be associated with brain damage through a variety 
of mechanisms (Box 2). In older people with ARBD, there is also likely 
to be accompanying cerebrovascular disease with or without a history 
of stroke, cerebellar damage; as well as a history of traumatic head 
injury with or without a history of chronic subdural haematoma (The 
Royal College of Psychiatrists, 2014).
Box 2: Mechanisms of alcohol neurotoxicity (Kim et al, 2012)
Direct toxicity (frontal and hippocampal damage)
Malnutrition (Wernicke’s encephalopathy/Korsakoff’s syndrome)
Metabolite toxicity
Electrolyte imbalance
Hepatic encephalopathy/infection
Inflammatory (e.g. Tumour Necrosis Factor Alpha)
Modifying factors (e.g. Apo E allele/elevated homocysteine)
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Definition
The most common clinical presentations of ARBD are cognitive 
impairment in Wernicke-Korsakoff’s Syndrome (WKS) and Alcohol-
Related Dementia (ARD). The chronic effects from repeated episodes 
of Wernicke’s encephalopathy (see under ‘Mental state examination’ 
in the Assessment of substance misuse chapter) result in Korsakoff’s 
Syndrome (KS). KS presents with lasting impairment of recent 
memory, while short-term memory is preserved. In ARD, there is 
both impaired short-term memory and impairment in other areas of 
cognitive function. 
Cognitive impairment should be distinguished from alcohol-related 
“blackouts” (Lee at al, 2009). The latter are acute episodes of memory 
loss for the events around any part of a drinking episode. They 
are associated with acute alcohol intoxication but without loss of 
consciousness. Although associated with poor transfer (encoding) 
of information from short to long-term memory and with alcohol 
dependence, blackouts are not known to be associated with long-
term brain damage.                                                                                              
A diagnosis of probable ARD is made using the three diagnostic 
criteria shown in Box 3. 
Box 3: Diagnosis of alcohol-related dementia (Oslin et al, 1998)
Evidence of cognitive impairment
Significant alcohol use defined by minimum average of 35 standard US 
drinks (>52 UK units) per week for men and 28 standard US drinks (>42 
UK units) for women, for a period of greater than 5 years 
The period of significant alcohol use must occur within three years of 
clinical onset of cognitive impairment
In ICD 10 (WHO, 1992), ARD is classified under “Residual and 
late-onset psychotic disorder” where alcohol has chronic effects 
on cognition, affect, personality, or behaviour. In DSM5 (American 
Psychiatric Association, 2013), there is no separate category of ARD, 
which is defined within “alcohol-induced neurocognitive disorder”. 
ICD10 and DSM 5 have categories defining WKS as “amnestic 
syndrome” and “alcohol-induced major neurocognitive disorder, 
amnestic confabulatory type” respectively. 
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Epidemiology and demography
In England, hospital admissions for WKS have increased by 26% in 
the 18−65 age group, but by 87% in the 65 and over age group over 
the past 3 years (NHS Digital, 2017). 
Western Scotland has the highest prevalence of KS in Western Europe. 
ARBD discharges have been increasing in Lanarkshire at a significant 
rate (more than three times the Scottish average), with increases 
among males 40–60 years of age and among individuals from more 
affluent areas (McColl et al, 2010).      
 
ARBD is commonly associated with homelessness, with a study 
from Glasgow finding that 82% of homeless people had cognitive 
impairment and 78% were drinking hazardously. Most of these 
people were over 50 years of age (Gilchrist & Morrison, 2005). 
 
Rates of ARBD can depend on the setting, with facilities specialising 
in early identification and treatment of memory disorders reporting 
rates of 3% (McMurtray et al. 2006) and nursing homes reporting 
rates as high as 10% (Oslin and Cary 2003).
A tertiary referral service in the Wirral region of the UK receives an 
average of three referrals per month from general hospital in-patient 
units in the Liverpool area (Emmerson & Smith, 2015). 
Neuro-imaging  
Brain Magnetic Resonance Imaging (MRI) has shown significant 
shrinkage of the volume of mammillary bodies in patients with KS 
compared with healthy controls. MR Spectroscopy also supports this 
view, but also finding that ARD has the potential for some aspects 
of brain regeneration though white matter remyelination (Zahr and 
Pfefferbaum, 2017).
Cognitive impairment
ARD shows better performance on language tasks but poorer 
performance on visuospatial tasks compared with Alzheimer’s disease 
(Ridley et al, 2012). Frontal lobe damage is particularly common in 
ARBD, which may explain the high rate of behavioural problems seen 
in ARD (Rao, 2016). Unlike other forms of dementia, there is partial 
reversibility of some people with ARD such as in white frontal white 
matter integrity, particularly for late onset alcohol misuse (Gazdzinski 
et al, 2005). Alcohol use disorders also frequently complicate primary 
dementia, increasing cognitive decline (Rao and Draper, 2015).
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Prognosis
The prognosis of ARD is determined by the nature and extent of brain 
damage. There is scope for recovery in mild or moderate alcohol-
related cognitive impairment, where abstinence can be associated 
with some reversibility of cognitive function. However, it is common 
for older people with a long history of alcohol misuse to have ARD 
superimposed on pre-existing WKS, together with other co-existing 
disorders such as stroke and traumatic brain injury.
Management
In management of ARBD, there is a limited role for drug treatment 
(Sachdeva et al, 2016) except in cases of severe mood and 
behavioural disturbances. An opportunity to remain abstinent and 
to receive supportive rehabilitation (Table 6) in the community or in 
an appropriate multidisciplinary team set up is known to be the most 
suitable model for rehabilitation. 
Table 6 Clinical Phases of rehabilitation programme                
(Wilson et al, 2012)
Phase 1 Physical stabilisation (variable time):
Acute hospital management of encephalopathy, delirium 
tremens and withdrawal in the context of physical 
stabilisation and appropriate thiamine therapy (NICE 
2010). 
Phase 2 Psycho-social assessment (usually 2–3 months): 
• Calm environment 
• Early initiation of rehabilitation programme
• Regularisation of sleep, appropriate nutritional 
maintenance and mood stabilisation
• Development of therapeutic relationships 
• Early engagement with family and carers
Phase 3 Therapeutic rehabilitation (lasts up to 2–3 years): 
• Ecologically relevant  
Milieu-based approach 
• Adaptable environment 
• Diary-keeping 
• Activity scheduling 
• Graded task assignment 
• Memory and orientation cuing
Phase 4 Adaptive rehabilitation (variable):
Adapting the environment to compensate for residual 
cognitive and functional deficits
Phase 5 Social integration and relapse prevention (ongoing)
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Case study 2
Stephen is a 69-year-old male who was drinking alcohol for more than 
30 years, mainly at weekends. He retired four years ago and since then 
he has been drinking 2-litre bottles of whiskey per day which is 280 
units of alcohol every week. He has had over 10 hospital admissions 
for detoxification and to improve his nutrition. Following this, he is 
judged by the medical ward to have capacity in making an informed 
decision about the risks associated with drinking and expresses a wish 
to go back home. He usually remains sober only for a few hours after 
discharge, when he goes out and starts drinking again. No cognitive 
testing is done during in-patient admission, but Stephen is known to 
have liver cirrhosis and alcohol-related hypertension.
When he drinks heavily, he is in bed almost all the time (except when he 
manages to go out to buy alcohol). He does not look after his personal 
hygiene and becomes incontinent. He has also had four seizures related 
to alcohol withdrawal. He does not take his medication for high blood 
pressure regularly. His wife left him in a year ago, although, he believes 
she still lived with him. At a home assessment, he has significant short-
term memory impairment and scores 57/100 on the Addenbrookes 
Cognitive Examination (ACE III), with severe frontal impairment and 
moderate impairment of memory and visuospatial function. He was 
referred to the community old age psychiatry service following his last 
hospital admission, as he has not engaged with addiction services. 
Although he was vulnerable in the community, no referral had been 
made to the safeguarding team. Stephen has poor insight into his 
situation, denies any heavy alcohol intake and lacks capacity over harm 
from alcohol. 
Eventually he was admitted to an old age psychiatry in-patient ward. 
Currently steps are being taken to providing rehabilitation. He was 
incapacitous to make an informed decision about his care, which was 
done in his best interests after discussion with his family. 
Physical complications
Physical complications from substance misuse are often evident from 
physical examination (see Assessment chapter). A detailed account 
of physical complications is beyond the scope of this report, but the 
most common acute and chronic physical complications are detailed 
in Table 7 below. Older people are more likely to experience adverse 
physical complications of substance misuse owing to accompanying 
age-related changes in cardiac, cerebrovascular, respiratory and renal 
function; as well as changes in mobility and an increased likelihood 
of falls.
Hepatitis C virus (HCV) is becoming a major public health problem in 
older people. In England, 160,000 people have chronic HCV infection 
(Public Health England, 2014). Chronic HCV infection is associated 
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with end-stage liver disease and hepatocellular carcinoma but is 
also treatable with antiviral therapies. Given the association of HCV 
with intravenous drug misuse, there is a likelihood of increased rates 
of intravenous opioid misuse being associated with future rises in 
rates of HCV infection among baby boomers in the UK. This has 
already happened in the United States, where baby boomers make 
up a quarter of the population but account for three quarters of all 
people with HCV (Yehia et al, 2014). Baby boomers also have a poor 
awareness of the need for HCV screening (Allison et al, 2016).
Table 7: Acute and Chronic Effects of Substance Misuse
Acute Effects Chronic Effects
Intoxication: head and other bony 
injury
Neurological: Peripheral 
neuropathy, cerebellar damage, 
repeated head injury with chronic 
subdural haematoma
Overdose: respiratory depression 
and coma, myocardial infarction, 
arrhythmia, stroke
Liver and pancreatic: jaundice, fatty 
liver, cirrhosis, chronic pancreatitis
Complications from alcohol 
withdrawal (e.g. dehydration, 
arrhythmia, seizures)
Respiratory: Bronchitis, 
emphysema, pneumonia, 
tuberculosis, chronic obstructive 
pulmonary disease, lung cancer, 
“crack lung”.
Chronic rhinitis, anosmia, 
nosebleeds and perforation from 
cocaine misuse
Gastro-intestinal: acute 
haemorrhage, pancreatitis, 
alcoholic hepatitis
Gastro-intestinal: Upper and lower 
respiratory tract and breast cancer, 
hepatitis C
Cardiovascular and 
cerebrovascular: myocardial 
infarction, arrhythmia, heart failure, 
venous and systemic complications 
of intravenous drug misuse, stroke
Falls: multiple factors increase 
likelihood (e.g. loss of balance, 
poor coordination, impaired 
judgement, risk-taking, autonomic 
neuropathy, peripheral neuropathy, 
cardiac disease, osteoporosis and 
myopathy)
Adapted from Substance Misuse in Older People: An Information Guide  
(Royal College of Psychiatrists, 2015).
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Treatment 
 
 
 
Key messages
 z There is a paucity of UK-based research and evidence for 
treatment interventions and services relating to the management 
of substance use disorders in older people. 
 z The evidence to date indicates that many older people with 
substance misuse want to abstain and have the capacity to 
change.
 z Older people benefit from treatment, and in some cases, can 
have better outcomes than younger people. 
 z Older people respond well to brief advice and motivational 
enhancement therapy.
 z Pharmacological treatment should always be provided as part of 
a management plan which includes psychosocial interventions. 
 z Pharmacological treatments should be used judiciously and 
monitored frequently.
 z Treatment of co-existing psychological and physical conditions 
is critical to achieving optimal effectiveness of treatment for 
substance misuse.
 z Age-specific programmes demonstrate positive outcomes for 
older adults. 
 z Intensive treatments tend to focus on abstinence as an outcome, 
and overall success rates at 6-12 months compare favourably 
with younger populations. 
 z Generally the more treatment delivered, the better the outcome.
 z Key components of treatment are to be supportive, non-
judgmental and non-confrontational, flexible, sensitive to gender 
and cultural differences, focused on client functioning, on coping 
and social skills, and holistic. 
 z Close liaison between practitioners and agencies, as well as 
family and carers, who are involved in the care of the patient 
is vital. 
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 z Future research requires standardisation of age range, diagnostic 
tools and assessment instruments, treatment options and style 
of delivery in order to enhance comparability.
 z The inclusion of older adults in all treatment intervention studies 
in substance misuse should be the norm.
 z Older people should not be excluded from treatment because 
of age: treatment should be available, attainable and accessible.
Introduction
ge amount of literature on pharmacological and psychological 
treatments for adult substance misusers, which has been used 
to develop evidence-based guidance and numerous consensus 
statements (Lingford-Hughes et al., 2012; National Collaborating 
Centre for Mental Health, 2007, 2008, 2011). A detailed discussion of 
these is beyond the scope of this report, but the list of online resources 
in the Appendix and the reference list should direct readers to relevant 
documents and organisations.
The National Institute for Health and Clinical Excellence (NICE) has 
issued guidance on the treatment of alcohol and drug misuse in 
general, but not specifically in older people (Lingford-Hughes et al, 
2012; National Collaborating Centre for Mental Health, 2007, 2008, 
2011). The studies on which its recommendations are based usually 
exclude those aged over 65 (sometimes even those over 50), as well 
as those with physical and psychiatric comorbidity. However, the latest 
version of the Department of Health’s guideline on the treatment of 
drug misuse and dependence includes an expanded section on older 
addicts, and acknowledges that the population receiving treatment 
for drug dependence is ageing. 
Three recent reviews of the literature have assessed the evidence to 
support the treatment of substance misuse in older people and to 
identify which treatments, if any, are appropriate for this population. A 
systematic review by Moy et al (2011) defined older people as those 
aged 50 and above (Moy, Crome, Crome, & Fisher). Sixteen studies 
were found to fit the inclusion criteria and were categorized according 
to the British Association for Psychopharmacology consensus 
statement (Lingford-Hughes et al., 2012). Bhatia et al (2015) updated 
and extended this review, highlighting a further 13 papers (Bhatia, 
Nadkarni, Murthy, Rao, & Crome, 2015). Moy et al (2011) concluded 
that the evidence indicated that older people do not have worse 
outcomes than their younger counterparts when treated, and in some 
cases even do slightly better. Bhatia and colleagues have extended 
these findings, highlighting evidence that shows that interventions 
for at-risk drinking, cigarette smoking and prescription drug misuse 
were associated with positive outcomes.
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A third review (Kuerbis & Sacco, 2013) with broader inclusion criteria 
reported studies in which mixed age or non-age specific treatments 
were applied to older adults, those using age-specific treatments, and 
studies comparing mixed and age-specific treatments. The included 
studies spanned the full spectrum of intensity of care from brief advice 
to inpatient care, and the majority focused on alcohol only. 
Although there were limitations to many of the studies, the overall 
trend of the results pointed to a greater response to treatment 
(particularly with a longer duration and intensity of interventions) and 
greater treatment adherence in an older population. Although there 
are potential benefits of age-specific treatment programmes, it does 
appear that older people can respond to treatments that have been 
developed and tested in younger populations. 
Alcohol
Pharmacological Interventions
Pharmacological treatments are usually reserved for patients who 
have alcohol dependence, and they are available to treat withdrawal 
syndromes, to maintain abstinence, or to prevent complications 
(including vitamin replacement). Most pharmacological agents should 
be used with caution, as pharmacokinetic and pharmacodynamic 
considerations mean an inevitable dosage reduction and careful 
monitoring in older people. There is no specific guidance on the use 
of acamprosate, naltrexone, or disulfiram in older people. Addiction 
psychiatrists initiating treatment in older people should therefore work 
jointly – and cautiously – with old age psychiatrists and/or geriatricians 
and their teams, and frequently monitor treatment.
The treatment of substance misuse in older people also needs to take 
account of comorbid physical problems such as neuropsychiatric 
disorders and hepatic complications (e.g. alcoholic liver disease and 
hepatitis C), as well as respiratory complications such as chronic 
obstructive pulmonary disease (COPD). Comorbidity can be a key 
factor, with increased risk with age of suffering from chronic pain, 
insomnia, bereavement, loneliness and mood disorders. In addition, 
impaired memory, immobility, incontinence, sensory impairment and 
iatrogenic problems can develop. These physiological and other health 
changes mean that older people, especially some over 65, can be 
at greater risk of harm when using even small amounts of alcohol, 
medications or other substances. Falls, in particular, can have serious 
consequences in later life. When prescribing any psychotropic drugs 
for this age group it is usually prudent to ‘start low and go slow’. 
Prescriptions in the over-65s often include multiple medications, with 
plenty of scope for interactions and adverse effects. Over-65s are 
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particularly vulnerable to the effects of drugs and alcohol due to a fall 
in their ratio of body fat to water, a reduced capacity to metabolise 
drugs, the potential presence of coexisting medical disorders and 
greater likelihood of drug-drug interactions.
Management of alcohol withdrawal and detoxification
Although the basic mechanisms of alcohol withdrawal are not age 
dependent, there is evidence that alcohol withdrawal may be more 
severe and more prolonged in older patients in general hospital 
settings, compared with a younger age group (Brower, Mudd, Blow, 
Young, & Hill, 1994). This finding was not replicated in a study of 
older patients admitted to a detoxification unit, but the presence of 
a comorbid physical illness was an exclusion criterion in the study 
(Wetterling, Driessen, Kanitz, & Junghanns, 2001b). The effect of 
comorbid physical illness in modifying the course of alcohol withdrawal 
syndrome in older patients does not affect the severity of the 
syndrome, but associated physical illness and age-related infirmities 
are a significant modifying factor (Wojnar, Wasilewski, Żmigrodzka, & 
Grobel, 2001). Alcohol withdrawal can be a life-threatening condition 
and prompt medical intervention is essential if there are major signs 
of withdrawal syndrome.
From the evidence, it is clear that older people respond to interventions 
with the same degree of success as younger patients, and a review 
of the treatment of alcohol problems in older patients emphasised the 
importance of providing adequate pharmacological and psychosocial 
interventions for this population (Whelan, 2003).   
There is evidence that different benzodiazepines are equally efficacious 
in managing alcohol withdrawal and detoxification (Whelan, 2003). 
For uncomplicated withdrawal, 20 mg of chlordiazepoxide four times 
a day for 7 days, supplemented by additional treatment for symptom 
suppression, is ‘typical’ in a younger adult, although age, degree of 
severity of dependence, and the need for seizure prevention should be 
taken into account. There is some evidence that alcohol withdrawal in 
older patients may be more severe and prolonged in general hospitals, 
but this may not always be the case (Crome & Bloor, 2006; Wetterling, 
Driessen, Kanitz, & Junghanns, 2001a). In older patients, a lower 
starting dose of chlordiazepoxide is advised, with an increase in 
dose if withdrawal symptoms are not controlled. This is a clinical 
judgement, and the dose should be sufficient to be effective, but 
also should take account of the patient’s overall clinical condition. A 
longer-acting drug may prevent seizures and delirium, but could lead 
to accumulation. Other methods of administering benzodiazepines 
are by ‘front-loading’ (i.e. until light sedation is achieved, at which 
point no further medication is given), or when ‘symptom-triggered’ 
(as opposed to a fixed regime). All these regimes require skilled staff. 
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Given the wide age range and heterogeneity of the patient population, 
each patient should be assessed, treated and monitored regularly. 
Older people respond very differently to younger people and the 
withdrawal process and reduction regime may take longer. As a rule 
of thumb, older people should have a lower starting dose, i.e. about 
quarter to half of that given to a younger person, but it is suggested 
that approved guidelines should be followed and monitored. 
The CIWA (Clinical Institute Alcohol Withdrawal Scale (Sullivan, Sykora, 
Schniderman, Naranjo, & Sellers, 1989) should be used, while bearing 
in mind that this was devised for use with working-age adults.
Best practice guidance for the use of benzodiazepines in older patients 
indicates that shorter-acting preparations are preferable (National 
Institute for Health and Clinical Excellence, 2010a). The evidence for 
the use of lorazepam in the treatment of alcohol withdrawal syndrome 
in older people has been reviewed (Peppers, 1996). The usual 
lorazepam regime for a younger adult would be a slow tapering dose 
starting at 2 mg four times a day. As with all detoxification regimes it 
is safest to titrate the dose against symptoms which results in better 
control and a lower total dose. In older patients, particularly those 
with severe liver disorder, the risk of accumulation is reduced with 
shorter-acting preparations such as oxazepam. Chlormethiazole is not 
recommended for older patients because of its effect on respiration, 
cardiovascular complications and the unpredictability of the serum 
levels achieved (Broadhurst, Wilson, Kinirons, Wagg, & Dhesi, 2003). 
Likewise, carbamazepine has not been evaluated in older populations 
and is therefore not recommended.
Thiamine and Wernicke’s encephalopathy
Despite the commonness of vitamin deficiency in alcohol dependence, 
the quality of evidence for the prevention and treatment of Wernicke’s 
encephalopathy is weak. A Cochrane review of the evidence for the 
efficiency of thiamine (vitamin B1) in treating Wernicke’s encephalopathy 
concluded that, although there is good empirical evidence to support 
current best practice guidelines, there is insufficient evidence from 
randomised controlled trials to guide the clinician on the correct dose, 
frequency of administration or duration of treatment (Day, Bentham, 
Callaghan, Kuruvilla, & George, 2013).
The use of oral thiamine is not recommended in the treatment 
of Wernicke’s encephalopathy, as the levels reached from oral 
administration are not sufficient to address the deficiency. All patients 
at risk of developing Wernicke’s encephalopathy, particularly those 
with poor diet or malnutrition (Sgouros et al., 2004), should be 
given 250 mg thiamine intramuscularly or intravenously once daily 
for 3–5 days. For suspected or actual Wernicke’s encephalopathy, 
the recommendation is a minimum of 500 mg intramuscularly or 
intravenously three times a day for at least 2 days for as long as there 
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is some improvement, followed by 250 mg once daily for 3–5 days, 
depending on the response. Thiamine for parenteral administration 
is also available in formulations combining vitamins B and C. One 
such formulation (now withdrawn in the UK) was associated with a 
very small risk of anaphylaxis, mostly on intravenous administration. 
Consequently, intravenous administration should ideally be given in 
facilities where anaphylactic shock can be treated, so this should 
take place in an in-patient setting. 
If delivery in the community is necessary, procedures should be 
followed to ensure safe administration (Lingford-Hughes et al., 2012).
Relapse prevention
Acamprosate, disulfiram and naltrexone are all licensed for the 
prevention of relapse in abstinent alcohol dependent adults (Lingford-
Hughes et al., 2012; National Collaborating Centre for Mental Health, 
2011). However, less evidence is available for their use in older adults. 
A trial comparing naltrexone as a relapse prevention medication with 
placebo found that the group aged 55 and over had longer drinking 
careers and greater physical disability. However their greater rates of 
treatment engagement and medication adherence were associated 
with a greater likelihood of abstinence (Oslin, Pettinati, & Volpicelli, 
2002).
Psychosocial interventions
All pharmacological interventions should be undertaken as part of 
a management plan that incorporates psychosocial treatments. 
Psychosocial interventions are the mainstay of most addiction 
treatment, although outcomes may be enhanced where they are 
combined with appropriate pharmacological treatments. Psychosocial 
interventions have been evaluated in older people in various 
combinations and intensity and in a variety of settings. Reviews of the 
research evidence are available (Bhatia et al., 2015; Kuerbis & Sacco, 
2013; Moy et al., 2011).  The following section gives a description of 
the main studies and their outcomes.  
Brief interventions
Alcohol problems exist across a wide spectrum of both quantity and 
frequency of use, and most people with risky patterns of drinking are 
not dependent on alcohol. The process of systematically identifying 
drinkers at increased risk of harm and delivering advice about 
moderating alcohol consumption has been shown to be an effective 
strategy in various settings. NICE recommends that professionals in 
the National Health Service carry out alcohol screening as part of 
routine practice (National Institute for Health and Clinical Excellence, 
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2010b), and the process of identification and brief advice should be 
offered as a first step in treatment (Day, Copello, & Hull, 2015). Older 
people receiving brief intervention had lower alcohol consumption 
than the control group after follow-up of one year or longer (Kaner et 
al., 2007). This benefit was greater in men than women.
Mixed-age treatments implemented with older adults
Studies testing non-age-specific brief interventions in primary care for 
older adults who were hazardous drinkers (e.g. (Gordon et al., 2003) 
have shown that hazardous alcohol consumption in older people is 
common and that brief interventions reduce alcohol consumption in 
older people similar to younger populations. 
Age-specific treatment
Several studies from the USA have evaluated whether alcohol-related 
risks and problems are reduced by providing older patients and the 
primary care physicians treating them with personalised reports of 
drinking risks and education about the benefits of cutting down.
 z Fink and colleagues used the Computerised Alcohol-Related 
Problems Survey (CARPS) at baseline and 12 months to classify 
the drinking status of patients over 65 years as either non-
hazardous (no known risks), hazardous (risks for problems), or 
harmful (presence of problems). At baseline, 21% were harmful 
drinkers, and 26% were hazardous drinkers. All participants 
received education, but when their physician was also informed 
of their classification, there was a significantly greater average 
decrease in quantity and frequency of alcohol consumption (Fink, 
Elliott, Tsai, & Beck, 2005).
 z A telephone disease management program for depression and/or 
at-risk drinking engaged 97 patients in a Veterans Administration 
primary care setting (Oslin et al., 2003). Patients were identified 
by systematic screening and assessment, and the mean age of 
participants was 61.6 years. Participants were assigned to either 
a Telephone Disease Management (TDM) program (consisting of 
seven regular contacts by a behavioral health specialist to assist 
in assessment, education, support, and treatment planning) or 
usual care. At a 4-month follow-up, response rates were better in 
those assigned to TDM (39%) compared with usual care (18%).
 z A controlled clinical trial (Project GOAL: Guiding Older Adult 
Lifestyles) tested the efficacy of brief physician advice in reducing 
the alcohol use and use of healthcare services of problem drinkers 
aged 65 or over (Fleming, Manwell, Barry, Adams, & Stauffacher, 
1999). Twenty-four community-based primary care practices in 
Wisconsin screened over 6000 patients, and 105 men and 53 
women met the inclusion criteria and were randomised to receive 
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either two 10- to 15-minute physician-delivered counselling 
sessions that included advice, education, and contracting using a 
scripted workbook, or a control intervention. The older adults who 
received the physician intervention demonstrated a significant 
reduction in 7-day alcohol use, episodes of binge drinking, and 
frequency of excessive drinking.
 z The Primary Care Research in Substance Abuse and Mental 
Health for the Elderly (PRISM-E) multi-site RCT compared 
integrated treatment in primary care with enhanced specialty 
referral for older adult at-risk drinkers (Bartels et al., 2004; Oslin 
et al., 2006). The brief intervention package incorporated a 
workbook and motivational enhancement techniques in three 
30-minute sessions. Both arms produced an overall reduction 
in drinking or binge drinking, but no difference was detected 
between the two. However, the integrated approach was 
associated with greater treatment engagement, especially for 
those with greater problem severity.
 z The Healthy Living as You Age (HLAYA) study in California was an 
RCT of 631 at-risk drinkers aged 55 or over in primary care (Lin 
et al., 2010; Moore et al., 2011). Participants were randomized to 
receive either an active intervention consisting of a personalised 
report, booklet on alcohol and ageing, drinking diary, advice 
from the primary care provider and telephone counselling from 
a health educator at 2, 4 and 8 weeks, or a booklet on healthy 
behaviours. At 3 months, intervention group participants reported 
drinking fewer drinks in the past 7 days, less heavy drinking, and 
had lower risk scores. At 12 months, only the difference in the 
number of drinks remained statistically significant.  
 z A naturalistic retrospective study in London, UK, followed up 
108 people aged 65 and over with alcohol misuse who were 
referred to an old age liaison psychiatry service over a 5-year 
period. Of the 50 people who were managed by community 
mental health teams, 19 (38%) had achieved abstinence from 
alcohol or controlled drinking at 6-month follow-up. Treatment 
comprised assessment and brief intervention, accompanied by 
psychosocial interventions to improve social function (Rao, 2013).
Specialist outpatient treatment
A national survey of substance abuse treatment programmes in the 
USA found that only 18% were specifically designed for older adults 
(Schultz, Arndt, & Liesveld, 2003). Several potential barriers to older 
people accessing services were highlighted, including stigma, shame, 
geographic isolation, inability to pay, and transport problems. There 
may be a perception that older adults either don’t abuse substances, 
or that they don’t respond to treatment due to long addiction histories. 
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Older people have been systematically excluded from major research 
studies, and research has been limited to ‘real world’ contexts, i.e. 
mainly pilot programs and brief interventions in primary care.
Mixed-age treatments implemented with older adults
Attempts have been made to test the differential impact of 
pharmacological and psychosocial interventions in older versus 
younger adults. In a trial of Cognitive Behavioural Therapy (CBT) 
compared with relationship enhancement or vocational enhancement 
therapy, a post hoc analysis found that the older adult group reported 
higher rates of abstinence with the CBT intervention, suggesting that 
vocational enhancement therapy was sensitive to the life stage (Rice, 
Longabaugh, Beattie, & Noel, 1993). Satre and colleagues tested two 
types of outpatient treatment (day hospital and traditional outpatient) 
over an 8-week period, following the participants up after 6 months 
and 5 years (D. D. Satre, Mertens, Arean, & Weisner, 2003; Derek D. 
Satre, Mertens, & Weisner, 2004). 
In comparison to two younger age groups, the groups aged 55 and 
over were significantly more likely to report abstinence from alcohol 
and drugs in the past year at the 5-year point, but were less likely to 
have been a member of a Twelve Step group. However, age was not 
an independent predictor of abstinence when controlling for gender, 
treatment retention and having friends supportive of reduced use.
Age-specific treatment
Attempts at developing age-specific treatment have resulted in 
the evaluation of three generations of one therapy protocol. The 
Gerontology Alcohol Project (GAP) was a pilot day-treatment 
programme for late onset problem drinkers aged 55 or over. It 
involved 50 or more 45-minute group sessions incorporating CBT, 
education and self-management techniques. T  he first 48 admissions 
were evaluated by Dupree and colleagues (Dupree, Broskowski, & 
Schonfeld, 1984), and although only half completed the treatment 
program, 75% had maintained their self-selected goal of abstinence 
or controlled drinking at 12-month follow-up. GAP was later adapted 
to create GET SMART (Geriatric Evaluation Team: Substance Misuse/
Abuse Recognition and Treatment) by the same research group 
(Schonfeld et al., 2000) and delivered as a weekly support group for 
people aged 60 or more. An evaluation of this second iteration again 
highlighted high levels of drop-out, but the 45%  who completed the 
programme were more likely to be abstinent from alcohol at 6-month 
follow-up than those that didn’t.
Eventually the learning from this process was incorporated in the 
manual ‘Substance Abuse Relapse Prevention for Older Adults: A 
Group Treatment Approach’ (Center for Substance Abuse Treatment, 
2005), and was evaluated by Outlaw et al (Outlaw et al., 2012). 
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The 18-session group therapy programme was supplemented by 
individual therapy, case management and medication management 
at a community behavioural health centre. Of nearly 200 participants 
aged 50 or over a three-year period, 42% completed at least 75% 
of the sessions. All drinking outcomes improved over time, but there 
was no difference between the completers and non-completers.
In-patient treatment
Mixed-age treatments implemented with OA
Two studies have compared the outcomes of US Veterans Association 
residential treatment in older adults with younger cohorts (Lemke & 
Moos, 2002, 2003a, 2003b). The older adult population had fewer 
problems at intake and lower psychological distress despite an 
equivalent level of dependence, and better outcomes at 1, 4 and 
5 years (longer length of stay, more counselling, more involvement 
in supportive relationships with other residents and aftercare post-
discharge, lower drinking rates and fewer drinking problems). 
 
Age-specific treatment
Although both middle-age and older-age groups admitted to two 
residential rehabilitation programmes with a Twelve-Step Facilitation 
philosophy (Oslin, Slaymaker, Blow, Owen, & Colleran, 2005) achieved 
equivalent outcomes, the older adults were less likely to report Twelve-
Step Group involvement or involvement in aftercare. The authors 
suggested that the lower rates of engagement suggested the need 
for age-appropriate treatment options. Therefore a series of studies in 
the USA have evaluated residential programs designed specifically for 
older adults. One programme aimed to address perceived problems 
that led to older adults being more likely to drop out of traditional 
treatment by providing a slower-paced, non-confrontational approach 
that emphasised the building of therapeutic alliances (Blow, Walton, 
Chermack, Mudd, & Brower, 2000). The mean length of stay was 
20 days, and of 90 admissions evaluated at a 6-month follow-up, 
56% were abstainers, 13% non-binge drinkers, and 27% binge 
drinkers. A second residential program in Florida included individual 
and group activities incorporating CBT, motivational enhancement 
therapy, Twelve Step Facilitation and groups adapted for older adults 
focusing on grief, loss, continuing care, leisure, recreation, and life 
stage transitions. Treatment lasted between 4 and 42 days, and 
71% were continuously abstinent at 6-month follow-up and 60% at 
12-months (Slaymaker & Owen, 2008).
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Comparing mixed-age and age-specific treatments
An RCT comparing an age-specific residential treatment program 
(OAR) with a mixed-age, confrontation-based inpatient and outpatient 
treatment utilised a special inpatient unit which emphasized peer 
support, promotion of self-esteem and time-limited goal setting 
(Kashner, Rodell, Ogden, Guggenheim, & Karson, 1992). Greater 
rates of abstinence were noted at 6 months and 12 months in the 
group receiving the age-specific treatment.
Summary
Although there were limitations to many of the studies, the overall trend 
of the results points to a greater response to treatment (particularly 
with a longer duration and intensity of interventions) and greater 
treatment adherence in an older population. Brief interventions for 
older adults in primary care have produced mixed results. However, in 
general, providing advice about the potential hazards of heavy drinking 
is beneficial. Matching the patient to the treatment may be important. 
Older adults presenting to specialist treatment are heterogeneous, 
and have lower severity of alcohol problems even at similar rates of 
alcohol dependence to younger people. Treatment generally works, 
with similar rates of abstinence to younger groups. Age-specific 
treatment may potentiate treatment, possibly due to greater levels 
of engagement or retention in treatment, but it does appear that 
older people can respond to treatments that have been developed 
and tested in younger populations. Standardisation of age range, 
diagnostic tools and assessment instruments, treatment options and 
style of delivery would enhance comparability of research studies.
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Drugs
Analgesic misuse
The misuse of prescribed analgesics may present in many ways, and 
several factors attributable to the patient or the prescriber may lead 
to this pattern of use. It may involve patients taking higher doses of 
prescription analgesics or ‘borrowing’ from a friend or relative. It may 
also occur when prescribed analgesics are taken for a longer duration 
than desired, resulting in physical and psychological dependence, or 
taken for cases other than the approved indication.  
The prescription of stronger opioid drugs for non-cancer pain has 
increased over the past 25 years. For example, back pain is a very 
common cause of disability and often leads people to seek healthcare 
(Deyo, Von Korff, & Duhrkoop, 2015). Rates of prescription of opioids 
for back pain are increasing, and although there is some evidence for 
opioids reducing pain levels in acute back pain, there is little evidence 
for improvement of functional outcomes. For chronic back pain, 
systematic reviews find even less evidence of efficacy, with a 30% 
reduction in pain across chronic non-cancer pain conditions (Kalso, 
Edwards, Moore, & McQuay, 2004). There are no RCTs that extend 
beyond 4 months of treatment, and so, the long-term effectiveness 
and safety of opioids are unknown. Loss of long-term efficacy could 
result from drug tolerance and emergence of hyperalgesia. 
Common short-term side effects are constipation, nausea, sedation, 
and increased risk of falls and fractures, and these are worse in older 
people. A nested case-control study in a cohort aged 18-80 without 
cancer from the UK General Practice Research Database found that 
current use of one or more opioid medications was associated with a 
strong risk of fracture of the hip, humerus or wrist (adjusted odds ratio 
= 2.70, 95% confidence interval: 2.34, 3.13) (Li, Setoguchi, Cabral, & 
Jick, 2013). The findings suggested that acute central nervous system 
effects of opioids, rather than chronic opioid-induced hypogonadism, 
played a key role in fracture risk. 
Longer-term side effects may include depression and sexual 
dysfunction. Addiction and overdose-related mortality have risen in 
parallel with prescription rates. Prescribed analgesics are implicated 
in intentional deaths of older people, often when taken with an 
antidepressant. Use of analgesic combinations, like codeine-ibuprofen, 
not only increases the risk of dependence but also of gastro-intestinal 
haemorrhage (Frei, Nielsen, Dobbin, & Tobin, 2010). Clinical dilemmas 
are common. Clinicians treating pain in older patients may prefer 
to use lower doses of analgesics to reduce the risk of abuse and 
dependence, but in doing so may under-treat pain. Higher levels of 
pain severity, symptoms of depression and lower levels of physical 
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disability are associated with opioid analgesic misuse (Park & Lavin, 
2010), making these patients challenging to treat (Jamison, Link, & 
Marceau, 2009). 
Inconsistencies in definition of aberrant analgesic use, in objective 
measurement of medication consumption, and in description of clinical 
outcomes, can make identification of those overusing analgesics 
difficult (Chou et al., 2009).
Screening for high-risk patients, treatment agreements, and urine 
testing have not reduced overall rates of opioid prescribing, misuse, 
or overdose. A better strategy may be to respect the risks of the 
medication by more selective prescription of opioids and lower doses; 
use of prescription monitoring programs; avoidance of co-prescription 
with sedative hypnotics; and reformulations that make drugs more 
difficult to snort, smoke, or inject (Deyo et al., 2015).
Benzodiazepine misuse
Although not recommended for long-term use of more than four 
weeks, repeat prescribing of benzodiazepines is a common problem 
encountered in general practice. This can lead to tolerance, misuse 
and dependence. Misuse of long-acting benzodiazepines is 
associated with multiple risks, including falls, drowsiness and ataxia, 
confusion, impaired psychomotor function, deficits in visuospatial 
and verbal learning, processing speed, road traffic accidents and risk 
of dependence. Dependence can lead to anxiety, depression and 
cognitive impairment causing further medical and neuropsychiatric 
morbidity in this vulnerable population.
Substance misuse for older women appears to be a complex, dynamic 
phenomenon shaped by social and personal experiences including 
violence, mental health disorders and social obligations (like caring 
for others) (Koenig & Crisp, 2008), and is often unintentional (Blow 
& Barry, 2012).  Symptoms of benzodiazepine misuse, including 
cognitive impairment and falls, can be easily confused with other 
conditions of ageing. As primary care consultations become 
more rushed and services become more fragmented, misuse of 
psychoactive prescription medication may become more difficult 
to detect. To offset this risk, practitioners can frame the problem of 
substance misuse in older people in terms of patterns that can be 
recognised. For example, one definition of psychoactive prescription 
medicine misuse is ‘any maladaptive and persistent use of medication 
that leads to functional impairment (like worsening gait or cognitive 
impairment), or to psychological distress including social isolation’ 
(Payne, Gething, Moore, & Reid, 2011). 
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Another recognisable pattern is deliberately taking prescribed or 
over-the-counter medicines at higher than recommended doses for 
extended periods, with hoarding of drugs and combination use with 
alcohol (Gossop & Moos, 2008). These working definitions place 
substance misuse within familiar clinical frameworks of age-related 
functional loss, prescription medicine management and observed 
behaviour (hoarding, alcohol use). However, it may be difficult to 
distinguish drug-seeking behaviour due to poorly controlled pain 
from true abuse of prescription medications. 
It is possible that ensuring pain is adequately controlled will reduce 
the need for inappropriate use of benzodiazepine drugs and potential 
for abuse (Chatterjee et al., 2017).
Other over-the-counter drugs 
Medications bought over the counter can lead to dependence, and 
although community pharmacists are acutely aware of this they are 
not always certain about how to respond to apparent misuse. A review 
of the research literature identified five key groups of medication: 
codeine-based (especially compound analgesic) medicines, cough 
products (particularly dextromethorphan), sedative antihistamines, 
decongestants and laxatives (Cooper, 2013b). A UK survey of the 
general population found that being older was associated with a 
greater risk of abuse of or dependence on OTC medication (Fingleton, 
Watson, Duncan, & Matheson, 2016).
Individuals misusing these types of OTC medication often consider 
themselves ‘addicted’, but are also socially and economically active 
and therefore different from many illicit drug misusers. They blame 
themselves for losing control over their medicine use (which usually 
begins for genuine medical reasons), consider specialist drug 
treatment services to be inappropriate for treating their problems, 
and are often concerned that this ‘hidden addiction’ will be recorded 
in their GP medical notes (Cooper, 2013a). Laxative misuse in older 
people is a good example of this. It is mainly attributed to prolonged 
use after an episode of constipation, with the belief that daily bowel 
movements are necessary for good health (Roerig, Steffen, Mitchell, 
& Zunker, 2010). Treatment requires substitution of bulk laxatives for 
stimulant ones, and education about normal bowel function.
A lack of information about customers and poor communication 
between community pharmacies are barriers to pharmacists providing 
more support for older people with these forms of medication misuse. 
Customer expectations, medicine advertising and easy access to 
different community pharmacies compound the problem. There is 
tension between consumer freedom and the needs of pharmacists 
to understand more about consumers as patients (Cooper, 2013c).
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The older heroin addict
The importance of preventing and treating drug use problems in older 
people is becoming more pressing as the UK population ages. Drug 
treatment services now have increasing numbers of patients who are 
being maintained on opioid substitution treatment into their 50s and 
beyond. The majority (90%) of heroin users initiate use before the 
age of 30 years, with only 3% initiating after 50 years of age (Wu & 
Blazer, 2011). It was once believed that illicit drug users ‘matured’ out 
of their drug use, but there is evidence that older heroin users do not 
reduce their use as they age (Rosen, Hunsaker, Albert, Cornelius, & 
Reynolds, 2011). In the USA, the proportion of older adults seeking 
treatment for substance misuse is increasing relative to younger adults, 
and the pattern of drug use is changing, with increasing consumption 
of heroin (Arndt, Clayton, & Schultz, 2011). 
Patients maintained on opioid substitution treatment into their 50s 
and beyond have complex comorbidities and are often prescribed 
multiple medicines. Seamless and supportive care for these patients 
is helped by a named clinician developing good relationships and 
communications with the patient’s pharmacist and primary care team, 
and with mental health or other specialist health and social care 
services as appropriate. Primary care practitioners and community 
geriatricians may face rising demand for medical care from this 
population, because the ageing process appears to be accelerated by 
long-term opiate use, with rapid physiological ageing promoting multi-
system disease (Reece, 2012). Older people with a history of heroin 
dependence have poorer physical health and social functioning than 
their non-dependent peers (Grella & Lovinger, 2012), and show high 
levels of major depression, posttraumatic stress disorder, generalised 
anxiety disorder, arthritis and hypertension (Rosen, Smith, & Reynolds, 
2008). 
Liver disease (through hepatitis C infection) was reported as the most 
common cause of mortality among ageing opioid-dependent people 
in an ageing Australian cohort (Gibson, Randall, & Degenhardt, 2011). 
There is evidence of damage to the structural integrity of the prefrontal 
cortex even in abstinent heroin users, with limitations in executive 
functioning, memory and attention control (Cheng et al., 2013), 
making awareness of drug-related cognitive impairment important 
for general practitioners, memory clinic staff and community mental 
health services. 
Treatment of opiate misuse
There is considerable evidence for the use of methadone, 
buprenorphine and Ż2-agonists (clonidine and lofexidine) in the 
management of withdrawal states, but it has been gathered in 
populations of younger adults. The choice of medication will depend 
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on factors such as preferred duration of treatment, adverse effects 
(bradycardia and hypotension due to Ż2-adrenergic agonists) and 
the severity of withdrawal symptoms. A combination of the patient’s 
clinical condition, degree of dependence and preference, together 
with the practitioner’s experience, will determine which drug to use. 
Similarly, there is an established evidence base from younger people 
for methadone or buprenorphine maintenance treatment. There is 
inadequate evidence for treatment with naltrexone and injectable 
opioids, and for using coercive methods, with older users. 
UK National Guidance recommends a range of strategies to facilitate 
the management of substance misuse in older people (Clinical 
Guidelines on Drug Misuse and Dependence Update 2017 Independent 
Expert Working Group, 2017). Specialist services should provide 
additional time for comprehensive assessment (including collateral 
history wherever possible), physical examination and investigations, 
and easy-to-read and prominently-displayed information leaflets. 
The option of delivering assessment and treatment sessions within 
the patient’s home should be available if required, and the needs 
of family members or carers should be recognised and addressed. 
Drug treatment services should have a lower threshold for arranging 
inpatient detoxification for older people.
An integrated model of service delivery involving substance misuse, 
mental health, primary care and social care services, coordinated 
by a named individual, is likely to deliver the best outcomes for the 
complex healthcare and social needs of older people who use drugs. 
Older people receiving long-term opiate substitution treatment (OST) 
should be regularly reviewed by their GP, as the physical and mental 
health problems associated with prescribed opioids (see above) are 
equally applicable to this population. However, mobility or accessibility 
problems are a concern for older patients expected to attend frequent 
appointments. Services need to find suitable solutions when pain, 
mobility or anxiety is a problem, particularly in the context of damaged 
or absent relationships with other healthcare providers. Developing 
good relationships with the patient’s pharmacist and primary care 
practice team are crucial to ensure seamless and supportive care, 
especially as comorbid health problems and polypharmacy become 
more prevalent.
It is important that older patients established on long-term prescribing 
for drug dependence are not faced with arbitrary withdrawal of such 
treatments simply due to a change of service provider, particularly if 
there is no evidence of instability or deterioration in problems. 
Decisions about such prescribing should be based on careful, 
individualised assessment and should take account of all relevant 
factors including historical assessments of need and responses to 
treatment.
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The majority of drug users in treatment do not die from a drug-related 
death (i.e. due to acute toxicity or mental and behavioural disorders due 
to drug use). Beynon and colleagues have shown that the likelihood 
of dying from a drug-related death diminishes with age, and the odds 
of a drug user aged 40 and over dying from a non-drug related death 
are three times the odds of a person aged less than 40 dying from 
a non-drug related death (Beynon, McVeigh, Hurst, & Marr, 2010). 
However, drug-induced deaths only represent a small proportion 
of all deaths related to drug use; deaths from conditions known to 
be associated with drug use, for example, hepatitis C, aspiration 
pneumonia, deep vein thrombosis and endocarditis, are excluded 
from official figures on drug-related deaths (Beynon, McVeigh, & Roe, 
2007). The current focus upon drug-related deaths detracts attention 
from other causes of premature death and in particular, the types of 
death which disproportionately affect older people who use drugs.
Hser and colleagues followed heroin-dependent subjects for 33 
years, investigating their health status and medical conditions by 
blood or physical examination (Hser, Hoffman, Grella, & Anglin, 
2001). They found high rates of tobacco smoking ,use of alcohol and 
multiple illicit drugs among these opiate addicts. The study provided 
objective evidence demonstrating high rates of morbidity among 
these surviving long-term drug users, most notably abnormal lung 
and liver functions and infectious diseases, and to a lesser extent, 
abnormal blood glucose levels. The self-rated health status reported 
by this sample was generally worse than that reported by men of 
similar ages in the general population, with particularly low scores 
for perceived energy level and greater perceived limitations due to 
physical or health problems.
A study in Scotland reported that older drug users feel that there 
is more stigma towards them compared to younger drug users, 
as professionals were perceived to dismiss them as a ‘lost cause’ 
(Matheson & Liddle 2017).  This age difference could inhibit help-
seeking as they felt marginalised, and there was an expressed 
desire to separate older and younger drug users in services. Many 
participants wanted specific services for older substance misusers, 
particularly peer support groups. 
Tobacco use cessation in older adults
Tobacco smoking is less prevalent in older adults when compared 
to younger groups, but it remains common (Pilowsky & Wu, 2015). 
Statistics on smoking in England 2016 show that 11% of people 
aged 60 years and over were smokers, compared to nearly a quarter 
of those aged 16−34 year old (Office for National Statistics, 2017). 
Research suggests that older adults are less likely to attempt to 
stop smoking, and less likely to stop, compared to younger adults. 
However, as health status deteriorates with age, tobacco use among 
College report CR211 85
older adults is associated with increased health risks (heart disease 
and stroke) and mortality. Past-year smoking in people over 50 years 
old has also been associated with increased odds of binge drinking 
alcohol, illicit drug use and nonmedical use of prescription drugs 
(Blazer & Wu, 2012).
Smoking cessation interventions
There is evidence that older smokers are interested in stopping, with 
one study showing a 4% increase in likelihood of enrolling in a smoking 
cessation trial for every year increase in age (Dahm et al., 2009). 
However, few studies have examined smoking cessation interventions 
among older adults. A review found 13 RCTs that provided findings 
about the effectiveness of smoking cessation interventions among 
adults 50 years or over (10 of which were from North America) 
(Zbikowski, Magnusson, Pockey, Tindle, & Weaver, 2012). Nine of 13 
studies found a significant intervention effect at one or more follow-up 
assessments, suggesting successful interventions with older adults 
are available and feasible. The best results come from interventions of 
longer duration. Most studies included counselling of varying intensity 
and eight provided medication for smoking cessation (bupropion, 
nicotine patches, nicotine gum or varenicline).
Relatively little is known about which types of intervention or aspects 
of intervention design older adults may find preferable and convenient. 
Heavy-smoking older adults may require extended pharmacotherapy 
and psychosocial intervention. As newly diagnosed health problems 
can be a trigger for smoking cessation, healthcare providers can 
motivate and help older adults quit (or reduce) smoking as an integral 
part of their practices (Choi & DiNitto, 2015). In older smokers, 
depression appears to act as an important barrier to quitting, although 
quitting has no long-term impact on depression (Shahab et al., 2015).
The use of e-cigarettes in the older population
E-cigarettes (and the practice of ‘vaping’) has been marketed as a 
healthier alternative to smoking tobacco. However, there is a debate 
about whether e-cigarettes will renormalize smoking and become 
a gateway to tobacco use by introducing non-smokers to nicotine. 
The long-term health effects of using e-cigarettes have yet to be 
established, although a report for Public Health England in 2015 
concluded that ‘e-cigarettes are 95% less harmful to your health 
than normal cigarettes, and when supported by a smoking cessation 
service, help most smokers to quit tobacco altogether.’ Older adults 
are using e-cigarettes in increasing numbers as a way to stop smoking, 
but also to circumvent no-smoking policies (Cataldo, Petersen, Hunter, 
Wang, & Sheon, 2015)
College report CR211 86
Family and Carers
There is a significant body of research that shows both the impact that 
substance misuse can have on families (Copello & Templeton, 2012), 
and the positive contribution that social networks can have on treating 
substance use disorders (Copello, Velleman, & Templeton, 2005). 
Although there is little literature concerning carers of older people 
with substance misuse, they are likely to be central to the detection of 
alcohol misuse.  However, their apparent lack of awareness of alcohol 
as a causative or contributing factor may result from their reluctance 
to judge the role of alcohol in the life of the person for whom they 
care. Second, the risk to older people from other older and younger 
people with alcohol misuse has potentially serious consequences 
for safeguarding older drinkers, who are already vulnerable to abuse 
(Homer & Gilleard, 1990; Reay & Browne, 2001). 
Many years of illicit drug or alcohol use may leave older people with 
poor physical health, reduced mobility and limited social support, and 
it may be difficult to place them in mainstream residential or nursing 
homes. Some countries (e.g. Denmark, Germany, Netherlands) have 
developed specialised nursing homes and accommodation services 
for this group, but there are concerns that this process may introduce 
stigmatisation and increase social exclusion (European Monitoring 
Centre for Drugs and Drug Addiction, 2010). 
‘Age-sensitive treatment’ 
To summarise, it is perhaps helpful to encapsulate the key components 
of treatment for older people.   An expert panel in the USA has 
detailed the characteristics of age-sensitive psychosocial treatment for 
substance abuse in older adults (Schutte, Lemke, Moos, & Brennan, 
2015). The ideal approach is supportive and non-confrontational, and 
flexible regarding treatment goals, approach, location, mode and 
duration. Physiological differences in the metabolism of alcohol and 
other drugs between men and women, as well as differences in the 
course of problems and barriers to treatment, mean that treatment 
must be sensitive to gender. Cultural differences must also be taken 
into consideration, and there should be a focus on client functioning, 
coping and social skills. A holistic approach considers the roles of 
physical and mental health conditions, disabilities and functional 
impairments, psychological, social, vocational and legal factors in 
developing a treatment plan (Schutte et al., 2015).
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Case study 3
Mrs E is an 81-year-old widow living in sheltered accommodation. She 
was referred to the specialist community alcohol team by the older 
adults team, to whom she had originally been referred by her GP. She 
suffered from recurrent depressive disorder and her GP had prescribed 
an antidepressant as well as sedatives. Mrs E’s relationship with her 
daughter was strained and there were concerns about her safety after 
she was found walking the streets in her nightdress in the early hours 
of the morning. She had previously sustained injuries following falls 
and, 6 years earlier, had consulted a neurologist for ‘resting tremor and 
cogwheel rigidity’.
Mrs E reported a 5-year history of alcohol dependence following her 
husband’s death. After admission for in-patient alcohol detoxification, 
she was referred to the older adults psychiatric team, but the referral 
was not accepted. She was therefore supported in the community 
by the community alcohol team before discharge to her GP. The GP 
re-referred Mrs E after a matter of weeks, following concerns regarding 
her safety secondary to falls and cognitive impairment. There was 
deterioration in the relationship with her daughter, who had distanced 
herself from her mother’s care. A re-referral to the older adults team 
was declined. Social Services’ input was sought and care put in place. 
This included attendance at a day centre and input from a home care 
service, following which Mrs E was again discharged to her GP.
Case study 3 key points:
 z Changes in social circumstances such as bereavement may be powerful 
precipitants of alcohol misuse.
 z There may be problems in joint working between specialist teams, 
particularly where patients ‘fall through the gaps’ in service provision.
 z The inclusion of social (including family) support in the treatment 
package is an essential factor in reducing harm and improving health and 
social function.
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Case study 4
Mrs F is a 66-year-old living with her partner (aged 52). They  have 
been on stable methadone maintenance for over 10 years (Mrs F was 
prescribed a daily dose of 80 mg). Both were being managed through 
a shared-care arrangement between their GP and the local drug and 
alcohol service. Mrs F was referred to old age psychiatry services 
because of concerns regarding her cognitive state. On assessment she 
was found to have significant impairment (MMSE score of 16 out of 30). 
Her partner indicated that he felt ‘unable’ to look after her any longer 
and said he intended to leave the relationship. She was admitted to a 
dementia assessment ward, where her 80 mg dose of methadone was 
continued, but she very rapidly became over-sedated and the dose 
was reduced. It was suspected that her partner had either been using 
or selling part of her daily prescription. Following discussions with 
the local drug and alcohol service, the consultant old age psychiatrist 
decided that the methadone should gradually be withdrawn in order to 
assess its effect on Mrs F’s cognitive function. 
Following this withdrawal, she showed a marked improvement 
in cognition and self-care (MMSE increased to 24 out of 30). She 
underwent full investigations (including for blood-borne virus infections) 
and was diagnosed as having a late-onset dementia secondary to 
Alzheimer’s disease. Her partner had ‘disappeared’ at this stage, and 
Mrs F was discharged into sheltered accommodation with Social 
Services’ support.
Case study 4 key points:
 z This case illustrates several points regarding the assessment and 
management of opiate use in people with cognitive impairment: such 
patients are very vulnerable and readily exploited
 z Opiates at high doses can have a significant deleterious effect on 
cognitive function, particularly in patients with underlying cognitive 
impairment
 z Close, joint working between the different teams involved in the care of 
these patients is essential
Current implementation 
 
Despite a significant evidence base for the efficacy of treatment 
for substance use disorders, this has not always been matched 
by funding for service provision in the UK and other countries. 
Therefore it is perhaps not surprising that services that attend to 
the special needs of older substance users are often lacking. For 
example, despite the evidence for both residential and age-specific 
services for older adults, three out of four residential alcohol 
treatment facilities (rehabs) in England excluded older adults on the 
basis of arbitrary age limits (Wadd & Dutton, 2017). The majority 
have limited or no disabled access, further limiting access to older 
adults with disabilities or limited mobility, and residential units tend 
to treat all residents in a similar way with the result that the needs 
of older adults are not fully met.
College report CR211 89
Cost effectiveness
There is a range of public health initiatives targeting substance use 
disorders that are effective and cost effective, summarised by Public 
Health England (2016). Treating people with alcohol use disorders 
is cost-effective: for every £1 spent on treatment, the public sector 
saves £5. Providing alcohol treatment to the 10% of the population 
with dependent drinking in the UK could reduce costs by between 
£109 million and £156 million each year (South West Public Health 
Observatory, 2008). Treatment for illicit drug use disorders is also 
cost effective (Connock et al., 2006). Data is starting to emerge 
for populations of older people (Barnett et al., 2014), but the cost-
effectiveness of treatment for substance use disorders in this 
population remains to be fully evaluated.
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Service delivery and 
implementation
Key Messages 
 z Ensure that all services are user-friendly and non-judgemental, 
flexible and consider the individual needs of older people at all 
points of the treatment journey.
 z Improve access to and the availability of services – age should 
not be a bar to receiving high quality care for substance misuse.
 z Improve collaboration, communication and cooperation between 
health and social care professional teams, families and carers 
at all stages of treatment and recovery.
 z Develop care pathways for substance misuse within mental health 
services for older people and mental health treatment for older 
people within substance misuse services.
 z Specify operational definition(s) of integrated care and models 
of care.
 z Review addiction psychiatry and old age psychiatry services to 
formulate a plan for change.
 z Ensure ‘mainstreaming’ of skills in the management of substance 
misuse within mental health services for older people.
 z Encourage the development of innovative models of service 
delivery for older substance misusers.
 z Improve public and professional education about the need 
for, and role of, the specialist through education, training and 
workforce development.
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Introduction 
Defining the Older Population 
Substance misuse is an issue for older people as well as for younger 
people. The profiles of substances used may differ from the younger 
population, but the impact of substance misuse will still influence 
mental health, physical health and social domains.
The definition of an older person varies. The EMCDDA defines an 
older person as those aged 40 or over whose recurrent drug use is 
causing them harm or is placing them at a high risk of such harm 
(EMCDDA, 2017, Responding to the needs of the ageing drug user), 
Dr Tony Rao in his submission to the All Party Parliamentary Group for 
Complex Needs and Dual Diagnosis (31 July 2017) states that typically 
a drinker’s body will age 10 years faster that the average non-drinker.
The UK guidelines on Clinical Management (2017) also makes the 
point that the older age group suffer from stressful life events or 
lifestyle changes involving loss such as retirement, marital breakdown, 
social isolation, increasing morbidity or bereavement. 
Psychiatric comorbidity 
Most opioid users seeking treatment in community-based substance 
misuse treatment programmes have at least one co-occurring 
psychiatric disorder. The presence of psychiatric comorbidity in this 
population is associated with increased psychological distress, poorer 
quality of life, and reduced response to substance misuse treatment . 
The presence of mental and physical needs and polypharmacy 
combined with social problems such as unsuitable housing and social 
isolation, will mean that the older person will be in contact with a 
range of services. This includes primary and secondary care, mental 
health and substance misuse services, social services and voluntary 
agencies and possibly even the criminal justice system.
Treatment pathways for comorbidity 
The structure of clinical services for substance misuse often results 
in either:
 z Sequential treatment − meaning that patients receive treatment 
from one service, so that treatment for a co-existing problem is 
delayed until involvement with first service has finished.
 z Parallel treatment − which involves different providers from 
different services treating the same problem simultaneously 
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(Crome et al 2015). Research has identified that the referral 
of patients with co-occurring psychiatric disorders receiving 
methadone maintenance to a community psychiatry programme 
on its own is often ineffective, even after reducing common 
barriers to care (King et al, 2014).
An integrated care model could therefore apply to addressing physical 
health needs, mental health needs and substance misuse needs 
both within and across different services (Institute of Medicine, , 
2012). At present, there are elements of service models that cater 
for a co-occurring disease model. No comprehensive integrated 
care model has been identified, but “mainstreaming” should be the 
preferred model rather than designated services.
An identified evidence gap
Generally speaking, policy and guidance has not acknowledged 
co-occurring substance misuse and mental health disorders in the 
older population and therefore services are not well prepared or 
equipped for working with them. In 2016, the All Party Parliamentary 
Group on Complex Needs and Dual Diagnosis (APPG, 2016) 
highlighted the challenges to providing care for older people with 
‘dual diagnosis’. The group noted that:
 z barriers to assessment and treatment needed to be removed 
 z improved outcomes with service provision for alcohol-related 
brain damage, prescribed medication misuse, polysubstance 
misuse, as well as specialist rehabilitation and long-term care 
are required   
 z the most common barriers to treatment are ageism, stigma, 
misdiagnosis, complexity and an inadequate number of specialist 
services. 
Consequently, the group concluded that health outcomes were better 
with community care compared with hospital care and that ‘things 
cannot change and improve for older people with complex needs 
unless services are commissioned differently’.
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The service delivery landscape 
in the UK
 
 
General Practitioners
The UK service provision landscape has been rapidly changing. In 
general practice, the trend has been for smaller GP surgeries to merge 
and form larger partnerships. Some of these larger partnerships 
are now being run by commercial companies and by charitable 
organisations. These GP services are generally commissioned by 
local Clinical Care Groups with support from Public Health England. 
Substance misuse services 
Substance misuse services are now largely run across England by 
large charitable organisations. Substance misuse services are now the 
responsibility of Local Authorities whose role it is to put these contracts 
for service provision out to tender. These tenders are competitively-run 
processes with Public Health England input. The specific issues for 
substance misuse services are frequent re-tendering, shrinkage of 
overall budgets, and payment by results. The additional impact has 
been in the loss of NHS inpatient detoxification units to the extent that 
there is now no NHS detoxification service within the Greater London 
area. Residential Rehabilitation budgets have also been reduced by 
a quarter across the country. As noted elsewhere in this document, 
there has also been a severe impact on training posts for addiction 
psychiatry in England.
The CQC do not currently rate substance misuse services, however 
this will be introduced in 2018. The CQC has, however, highlighted 
serious concerns from its inspections of detoxification and rehabilitation 
services across the UK (CQC Briefing, 2017).
Older people’s mental health services
Older people’s mental health services, like general psychiatry, have 
also faced a reduction in funding and frequent changes in care delivery 
models. 
Impact of the changing landscape 
The net impact of the changing landscape in practice has meant that 
services are very stretched. There is a lack of skilled staff and staff 
shortages. For patients this means waiting for treatment to start, 
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not being reviewed often enough, not seeing the same keyworker 
and having consistency in the delivery of care. This can also mean 
seeing fewer specialist staff than they would have seen in the past. 
Pressured services with rigid commissioning frameworks can lead to 
silo working practices. Practically, patients will be sicker when seen 
and are likely to take longer to recover.
An ageing population with more complex and multiple needs will need 
seamless, integrated and skilled care which is holistic and integrated.
This is a care model that can deal with all the issues arising from a 
co-occurring disease model. Any solution to managing substance 
misuse, physical and mental health care will need to come from 
within the services. 
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Table 8: Special health needs of older people with substance use problems 
The UK Guidelines on Clinical Management (2017) highlight the following special health needs of the older 
population: (Adapted table)
Special health need Description of need
Biological  
Due to pre-existing 
substance misuse and as 
a general consequence of 
ageing
• Increased sensitivity to alcohol or drugs or prescription medications. 
Previously safe use can become unsafe as age-related metabolic changes 
occur. 
• Age-related disorders common in the older population, including chronic pain, 
hypertension, diabetes, cognitive impairment and chronic airways disease.
• Hepatic damage due to hepatitis B or C infection or excess alcohol use (or a 
combination).
• HIV infection.
• Chronic airways disease from smoking tobacco or from inhaling drugs or TB.
• Increased cardiovascular disease risk due to alcohol, smoking and lifestyle
• Venous damage (IV access can be difficult) and/or arterial damage.
• Past cardiac valve destruction.
• Poor dental health.
• Mobility problems consequent on groin injecting or with old age.
• Traumatic injuries due to falls, accidents or assaults.
• Ongoing risk of overdose.
• Impaired immunity.
• Increased risk of cancer.
• Chronic pain.
• Increased risk of falls, sedation, cognitive impairment and road traffic 
accidents with polypharmacy, when prescribing sedating medicines such as 
benzodiazepines, hypnotics, antipsychotics, 
• Antihistamines, anticholinergics or other opioids (painkillers)
• Risk of drug-drug interactions which may increase or decrease methadone 
levels and to a lesser extent buprenorphine
• Alcohol or drug withdrawal syndromes may be more severe and prolonged
• Risk of QTc prolongation when methadone is co-prescribed with a range of 
medications including antipsychotics, tricyclic antidepressants, citalopram, 
and erythromycin.
Psychological • Impaired mental health (with increased risk of self-harm and suicide).
• Loneliness, boredom and mental health problems for some who become 
isolated with age as well as social and occupational role changes in later life.
• Anxiety and depression.
• Early dementia and alcohol-related brain damage.
• Short term memory issues.
Social • Family breakdown/relationship problems.
• Housing or financial problems can develop with dwindling resources or 
increased care costs.
• Retirement and boredom.
• Ongoing criminal justice involvement.
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What is integrated care?
 
An overview of the approach and evidence base 
There are various definitions of integrated care (Old Age Faculty 
Report, FR/OA/05, Nov 2016).
 z Micro level integration is where there is a coordination of care 
for individual patients and their carers (Ham and Curry, 2010).
 z Meso level integration is when organisations collaborate to 
coordinate care for groups of patients (Ham and Curry, 2010).
 z Macro level integration is when the whole system works together 
to connect medical needs with whole-person needs like long 
term care, education and training (Leutz, 1999).
Integration can be achieved by addressing mental health, physical 
health and substance misuse together either within a care system for 
an individual (e.g. a journey through an assessment, treatment, care 
and recovery) or between providers. The latter would be achieved by 
coordination between the mental healthcare system with primary care, 
geriatric medicine, addiction psychiatry, mental health, accident and 
emergency departments, social services, housing and community 
facilities. There is also a need to use the skills of the multidisciplinary 
team such as nursing, psychology, occupational therapy, pharmacy, 
social workers and support workers. This is endorsed by the Royal 
College of Psychiatrists as addiction services are seen by the Royal 
College of Psychiatrists as an essential component of Older People’s 
Mental Health   Services (Connolly, 2012).
This view is also supported in the UK guidelines for clinical management 
(Department of Health, 2017) which states an integrated model of 
service delivery involving substance misuse, mental health, primary 
care and social care services, coordinated by a named individual, 
is likely to deliver optimal outcomes for the complex healthcare and 
social needs of older people who use drugs. These guidelines also 
identified that older patients can achieve as good an outcome or even 
better than a younger age cohort.
Five tests of integrated care (RCGP, 2012)
The RCGP has developed the following five tests for Primary Care 
which can be used as a framework to assess different models of 
integration and inform policy.
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Proposed models of integrated care should:
 z ensure community-based services are led by community-based 
clinicians with a person-centred perspective.
 z underpin safe patient care by ensuring that GPs can continue 
to act as independent advocates for their patients, with the 
emphasis on the person not the institution.
 z be person-focused, responding to the needs of the individual 
and protecting them from over-medicalisation, with GPs working 
with specialists to contribute to the holistic care of the individual. 
Proposed models of integrated care must not:
 z lead to major top down structural reorganisation, which would 
lead to the setting up of new bureaucratic structures and divert 
millions of pounds away from patient care.
 z lead to the diversion of NHS funding away from general practice 
and primary care given their vital role in delivering person-centred 
care.
 
Features of an integrated older people’s mental health team 
(Wilberforce et al, 2016):
 z A multi-disciplinary core team, including health and social care 
professionals
 z Members directly line-managed within the team
 z A single point of access 
 z All professionals using the same structured assessment 
documentation 
 z All or most patients having a single care coordinator  
 z All or most patients having a single care plan 
 z At least one health professional within the team able to authorise 
services funded by the local authority  
 z The team and local social services having access each other’s 
patient records 
 z All core team members sharing the same office base 
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Implementing change in service 
provision 
There is a pressing need for action at three levels:
Level 1- Change at the national level  
 
National parliament and regional assemblies
The health, societal and financial implications of not meeting the 
needs of older people with substance misuse problems has been 
acknowledged politically in the UK. An all-party parliamentary group 
has identified skills and commissioning gaps but found, most of 
all, that ageism, misdiagnosis and stigma are the major barriers to 
developing effective services (31st All Party Parliamentary Group 
on Complex Needs and Dual Diagnosis, 2016). It is recommended 
that the Academy of Medical Royal Colleges, the Royal College of 
Nursing, Voluntary Agencies and other national stakeholders should 
collaborate to lobby both national and regional political parties to 
address the area of addiction in older people. Initially, this might 
take the form of lobbying the cabinet office for specific funding to 
develop older people’s services under the £30m life chances fund for 
outcome-based interventions in addiction. Other examples of political 
action could include pressing for new health and social policy and 
legislative initiatives such as those aimed at introducing minimum 
pricing for alcohol. 
 
The Department of Health
Research indicates that there are significant barriers to public 
awareness and understanding of the problem of substance misuse 
in older people (DrugScope, 2014) particularly around ageism, stigma 
and lack of knowledge leading to chronic misidentification and under-
reporting. There is good evidence to suggest that the recommended 
daily limits of alcohol consumption in adults may in fact increase risk in 
the older person (Crome et al, 2012). Public health campaigns aimed 
at older people, carers and health professionals are an essential first 
step in driving improved service provision. This could be done under 
the auspices of regional public health bodies and coordinated with 
third sector services (Public Health Agency NI, 2016). There is also 
a gap in service provision for people aged 50−65. These people can 
have problems generally associated with presentations to older age 
services but be unable to access them.
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The Royal College of Psychiatrists
The Royal College of Psychiatrists continues to lead in advocacy, 
quality assurance, service design and development of the evidence 
base in the field of substance misuse in the older person. Within the 
College many faculties share interests in this area including Psychiatry 
of Old Age, Addictions Psychiatry and Neuropsychiatry.  In addition, 
the challenges of dealing with unmet needs are shared to some extent 
by other specialties such as Psychiatry of Intellectual Disability and 
Child and Adolescent Psychiatry (Royal College of Psychiatrists, CR 
175, 2012).  
College strategy should aim at pooling faculty resources in special 
populations with substance misuse, where appropriate, to act as an 
effective beacon of good practice and act as a medical and public 
advocate. 
The Royal College of Psychiatrists has broadly addressed future 
workforce needs in mental health services in England (Royal College 
of Psychiatrists, 2017). The challenge lies in recruiting suitable trained 
psychiatrists to fill the gap left by the 60% reduction in training places 
within addiction psychiatry over since 2006 and to provide them 
knowledge, skills and attitudes appropriate for working with older 
people (Wessely S, 2017; Drummond, 2017). The workforce plan’s 
emphasis on retention and return to practice could be a basis to 
maintain expertise in this area through greater use of flexible working. 
Primary care skills are also to be improved and this would be a partial 
solution to the urgent need to develop services (Health Education 
England, 2017) (The Royal College of Psychiatrists, 2017). The Royal 
College of Psychiatrists Divisions for the devolved nations should 
press for a similar approach to addressing future workforce needs 
and make use of the evidence base being established in mental health 
plans for England (Health Education England, 2017).
The College should further develop the area of substance misuse in 
old age as part of the College centre for quality improvement (CCQI) 
in its role as a coordinator of national audits and accreditation.  In time, 
key areas such as the existence of dedicated ‘dual diagnosis’ services 
or care pathways for older people with substance misuse problems 
should form part of the accreditation process in Older Adults Mental 
Health Services (AIMS-OP), elder-friendly acute wards (CCQI-QM) and 
Psychiatric Liaison Accreditation network (PLAN). In its role supporting 
Commissioning for Quality and innovation (CQUIN), CCQI has been 
instrumental in auditing physical health risks in severe mental illness. 
This role could be expanded to data collection regarding the need for, 
and provision of, services in the field of older people with substance 
misuse to support future CQUINs under the NHS England funding 
framework to encourage commissioning of services (see below).
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Partnerships should be developed in this field with other medical 
stakeholders in the Academy of Medical Royal Colleges such as 
the Royal College of Physicians, British Geriatrics Society and 
Royal College of General Practitioners. These links could be used 
to cultivate expertise and improve research and could be used 
to influence other colleges’ curricula for competencies and that 
of the Foundation Programme. A report defining the roles and 
competencies of doctors working in the field of substance misuse 
(Royal College of Psychiatrists, 2012) will be of benefit in this area. 
The Royal College of General Practitioners
The Royal College of General Practitioners has always championed 
integration of care as crucial to patient-centred practice, seeking 
approaches that improve patient care and experience as well as 
being efficient and effective (general practice and the integration of 
care: an RCGP policy report). 
There are several policy papers from the RCGP outlining the need for 
integrated care and models and principles for integrated care such as:
 z Primary care drug and alcohol treatment: commissioning and 
provision against a backdrop of localism (Harris and Halliday, 
2013) 
 z Responding to the needs of patients with multi morbidity- A vision 
for general practice (Baker and Jeffers, 2016).
 z The policy paper on Integration of Care (Mathers et al, 2012).
Health Regulators 
The presence of services for older people with addictions should 
be incorporated into inspection criteria for the United Kingdom’s 
healthcare regulatory bodies: The Care Quality Commission (England), 
Health Improvement Scotland, Healthcare Inspectorate Wales and 
The Regulation and Quality Improvement Authority (Northern Ireland). 
Initially, providers with specific services for older people with addictions 
could be eligible for good or outstanding ratings with such services 
later becoming compulsory.
The CQC in its Building Bridges, Breaking Barriers report (2016) 
emphasise that older people have more complex needs and receive 
care in multiple settings. They also support the provision of integrated 
care to deliver better and safer care.
The CQC report recommended:
 z Locally, health and social care leaders build on the 
opportunities offered by initiatives such as the NHS Five Year 
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Forward View vanguards and the development of Sustainability 
and Transformation Plans to develop and agree a shared 
understanding and definition of what integrated care means 
for their population in their local area, and then work towards 
delivering this shared aim.
 z NHS England and ADASS lead on developing an agreed 
methodology at a national and local level across health and 
social care for identifying people who are at risk of admission to 
secondary care or deterioration, underpinned by a clear data set.
 z Commissioners and providers meaningfully involve older 
people in making informed decisions about their care needs 
and care planning – in particular about the outcomes that are 
important to them – based on the existing national and local 
guidance.
 z Commissioners and providers in an area ensure that 
information and support for older people and their families or 
carers is available and that this sets out what details of what 
services are available, connections between different services, 
and how the people’s accessibility requirements will be met.
 z The National Quality Board, in partnership with the National 
Information Board, develop and share a set of validated data 
metrics and outcomes measures for integrated care. These 
should have person-centred outcomes at the heart of decision-
making about service provision and be based on a consistent, 
shared view and definition of integration.
Level 2 - Change at the regional level 
Commissioning 
Commissioning strategy in this area is informed by several recent 
policy drivers such as the Five Year Forward View for Mental Health 
(NHS England Independent Mental Health Taskforce, 2016), (NHS 
England, 2016) and the Mental Health Crisis Care Concordat (www.
crisiscareconcordat.org.uk). It is effectively summarised in the Public 
Health England Guide for Commissioners and Service Providers 
(Public Health England, 2017) that addresses addiction services 
across all groups including the older person. 
Collaboration between services is a key principle in the guide, which 
recognises that potential commissioners could include Clinical 
Commissioning Groups (CCG), Local Authorities, Primary Care 
Commissioners (PCC) and Prison Governors. Services must work 
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across several boundaries in keeping with the NHS constitution 
and prevent exclusion. It is suggested that key mechanisms for 
commissioning services include the use of Joint Strategic Needs 
Assessments (JSNA) and Sustainability and Transformation 
Partnerships (STP).
Commissioned services should reduce harm, improve health, enhance 
recovery and respond effectively and flexibly to presenting needs and 
prevention of exclusion. This can be seen to be particularly important 
in the older population where engagement can be difficult, and the 
risk of exclusion is high and should be specifically addressed by 
commissioners.
Public Health England’s commissioning guide (2017) sets out the 
following priorities for commissioners: 
 z An agreed pathway to enable collaborative care delivery by 
multiple agencies in response to individual need.
 z Appointing a named care coordinator for every person presenting 
to services.
 z Joint commissioning across all care settings supported by senior 
and visible leadership.
 z Enabling people to access to care when and where it is most 
beneficial for them.
 z Commissioning a 24/7 response to people experiencing mental 
health crisis including those who are intoxicated on presentation.
 z Commissioning local pathways enabling people to access other 
services such as those for homelessness, domestic abuse or 
physical healthcare.
 z Ensuring access to a range of recovery supports in both the 
short and long term.
It also recommends a framework of care based on:
 z Enabling a strong therapeutic alliance.
 z Collaborative care delivery.
 z Care that reflects the views and needs of the person.
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 z Care that supports and involves carers.
 z Therapeutic optimism.
 z Safe management of intoxication.
 z Routine stop smoking advice and support
Commissioners and providers are expected to collaborate across 
services and develop an integrated ‘offer’ of care to each presenting 
person which addresses specific needs across the domains of 
physical and mental health, social support and housing.  Interventions 
should be comprehensive and NICE-compliant and be provided by 
competent and well-supervised practitioners.
Service access criteria are to be developed in conjunction with experts 
by experience to eliminate the risk of exclusion. Quality governance 
and safeguarding duties should be shared across all involved services. 
Finally, alcohol, drug recovery and community engagement and ‘stop 
smoking’ services should be assertively promoted across all mental 
health services. Recent commissioning frameworks in substance 
misuse tenders have encouraged ‘dual diagnosis’, health screening 
and liaison activity with general hospital teams but the focus has not 
been on the older person age group.
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Clinical commissioning groups commission:
 z NHS England commissions:
 z Local authorities commission:
 z Police and Crime commissioners:
The CQUIN Schemes are designed to deliver clinical quality 
improvements and drive change. The stated goals are reducing 
inequalities in access to healthcare, improving the experience of 
using services and to improve outcomes. The 2016/2017 scheme 
has also been influenced by the ambitions of the Five Year Forward 
View (CQUIN guidance for 2016/2017, NHSE March 2016)
CQUIN Targets can powerfully influence local care delivery systems. 
Any provider of healthcare services commissioned under an NHS 
Diagram of the post 2013 commissioning and delivery landscape
Local authority hosted local safeguarding children, young people, and vulnerable adults’ boards (providers 
and commissioners have a statutory responsibility to inform boards when individuals are believed to be at 
risk)
Health and Wellbeing Boards (leaders from the health and social care system work together to improve 
health and wellbeing of the local population and reduce health inequalities)
People with co-occuring conditions and their carers (including young carers) and family members
Healthcare in 
prescribed places of 
detention (includes 
alcohol, drug and 
mental health 
treatment)
Healthcare services 
in police custody
(Police and crime 
commissioners 
and other criminal 
justice agencies 
may also be co-
commissioners of 
specific services 
for people with 
co-occurring 
conditions in 
contact with the 
criminal justice 
system)
Alcohol and drug 
treatment services
Local stop smoking 
services
Specialised mental 
health services
Liaison and diversion 
schemes in police 
custody suites and 
courts
Social care services 
for adults and young 
people, and approved 
mental health 
practitioners (AMHPs)
Providers of other 
supporting services – 
homelessness, young 
people’s support 
services, domestic 
violence services, family 
support services
Primary care providers School nurses
Street triage
Urgent and emergency care 
(including NHS 111, A&E and 
ambulance services)
Health-based places of safety
Child ad adolescent mental 
health services (CAMHS)
Liasion mental health services 
and alcohol liaison services in 
acute hospital settings
Community and in-patient 
mental health services 
(including IAPT and crisis 
resolution home treatment 
teams (CRHTTs)).
Police and crime 
commissioners:
Local authorities 
commission:
Clinical commissioning 
groups commission:
NHS England 
commissions:
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standard contract (full-length or shorter-form version) is eligible for 
CQUIN. This is inclusive of the independent sector, e.g. care homes, 
and the third sector. Future CQUIN targets encompassing the needs 
of the co-occurring disorder population could have the potential for 
dramatic service improvements.
Current CQUIN targets include:
 z improving physical healthcare to reduce premature mortality in 
people with serious mental illness (PSMI) by assessment and 
early interventions offered on lifestyle factors for people admitted 
with serious mental illness (SMI) (CQUIN guidance for 2017/2019, 
NHSE Nov 2016).
 z improving services for people with mental health needs who 
present to A&E by ensuring that the needs of these people are 
met more effectively through an improved, integrated service, 
reducing their future attendances at A&E (CQUIN guidance for 
2017/2019, NHSE Nov 2016).
 z preventing ill health by risky behaviours – using alcohol and 
tobacco – by supporting people to change their behaviour to 
reduce the risk to their health from alcohol and tobacco. (CQUIN 
guidance for 2017/2019, NHSE Nov 2016).
Level 3 - Change at Trust level and charity sector 
level  
 
Particular reference is made in this section to services in 
Manchester and London (Rakshi, 2011) (Andrews, 2011) (Rao R 
and Shanks. S, 2011) that have developed services in response to 
local unmet need and serve as beacons of current good practice.
4.3.1 Principles in Service Development
Key principles in a local service for older adults with substance misuse 
have been identified at the national level (Public Health England, 
2017).  These include:
 z ‘Everyone’s business’ − All healthcare staff are responsible for 
identifying people at risk and arranging appropriate care.
 z ‘No wrong door’ − Every point of contact with health and social 
services should be capable of identifying a substance misuse 
problem and arranging further assessment and management. 
There can be no exclusion from accessing services on the basis 
of substance misuse.
College report CR211 106
 z ‘Making every contact count’ − The need for flexible services 
that create opportunities for assessment, treatment and 
harm reduction when engaging with older people is of critical 
importance to avoid the well-established risk of ‘slipping through 
the net’. 
Whilst services aim to enhance the quality of life of people misusing 
substances and prevent older people from dying prematurely (Royal 
College of Psychiatrists, 2015), stigma is still an issue for substance 
misusers and can affect presentation to services. 
Older patients can feel quite suspicious of disclosing substance use 
based on previous experiences of disclosing this type of information. 
Thus, patients may present later with more serious problems. 
Determining which services are needed locally 
A provider should first examine what services are currently available. 
Ideally these should include:
 z A service for older adults with ‘dual diagnosis’/ ‘co-occurring 
functional mental health and drug use conditions’ based in the 
community. These services should also be able to build links 
with geriatric medical teams. Local JSNAs are a good starting 
point for assessing need. Also, national guidance is quite clear 
in that ‘dual diagnosis’ services should be providing more of 
a consultancy service role and approach rather than being a 
dedicated service.
 z Clear arrangements for assessing and managing people with 
drug-related brain injury (such as alcohol-related brain disease, 
Wernicke-Korsakoff’s disease and alcoholic dementia).
 z An inpatient service to allow for complex detoxification and 
patients with physical and psychiatric co-morbidity.
 z Liaison services to local general hospitals.
 z Arrangements for seamless transition and working for patients 
who transfer between service areas, for example from the 
Emergency Departments to substance misuse services or OPMH 
services
A service provider should start by compiling data on current service 
use and likely levels of unmet need. This could come from local audit, 
the national evidence base or the fingertips national database of 
public health profiles. Developing the necessary local data streams 
may be supported by a trust as part of audit, quality improvement or 
governance roles. There is also a gap in data in estimating the level 
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of need where co-occurring conditions covering substance misuse, 
mental health and physical health are concerned.
The “Fingertips” database, the national drug treatment monitoring 
system (NDTMS) and audit against national standards are useful 
means of identifying current good practice and where new services 
and roles should be developed. 
Some services or components of a ‘comprehensive service’ may 
already be present locally. However, some may need to be built from 
scratch and it is anticipated that many commissioning requirements 
might be met through better service alignment and co-working 
arrangements. For example, patients with complex needs in 
detoxification could be managed in an appropriate in-patient setting 
whether this is in the NHS or charity sector as long as the appropriate 
expertise and input is available. Patients with alcohol-related brain 
injury might have shared care with local neuropsychiatry or brain injury 
services. Where demands are large or cannot be met by realignment, 
bespoke services may need to be designed and funded.
It is also worth keeping in mind that demand is likely to increase as 
the population ages. Any new service design needs to consider the 
future demands to cope with this. New innovative service provision 
can also draw in previously excluded patients which can increase 
the demand. It is very clear that no one service on its own can cope 
with the demands of mental health, addictions and physical health 
issues. There is also no comprehensive model available to emulate 
at this stage. 
Building a service
For a local provider attempting to develop new addiction services for 
older adults, a number of key steps have been identified (Rao and 
Shanks, 2011):
 z Building on existing good practice.
 z Scoping the need for new services and roles.
 z Creating new service options where possible.
 z Developing clinically effective care pathways
 z Promoting robust partnerships with key stakeholders (including 
patients and carers).
 z Building a skilled workforce
College report CR211 108
 z Establishing robust communication and reporting structures
 z Promoting health education, prevention and early intervention 
for patients. 
Developing best practice 
Although there is an overall lack of such service provision, as noted 
in the Treatment section, there is a body of research which indicates 
that treatment can be effective for the older substance misuser.  These 
interventions can be delivered by trained staff with appropriate facilities 
in a variety of settings. 
Although there is an overall lack of such service provision, the first 
mental health strategy for mental disorders in older people with alcohol 
misuse has been developed in one part of the UK (Rao and Shanks, 
2011). 
In 2009, the initial development of this service was built on strategic 
aims (see Box 3 on the following page) and objectives and continues 
to be developed with a ‘dual diagnosis’ working group. This group 
includes a consultant old age psychiatrist, nurse consultant lead 
for ‘dual diagnosis’ across the trust, senior clinical academic group 
manager for quality, modern matron and nurse borough leads. 
Developing effective working between substance misuse and 
OPMH Services- The SLAM Experience Model 
The Mental Health of Older Adults and Dementia Clinical Academic 
Group (MHOAD) at South London and Maudsley NHS Foundation 
Trust (SLAM) has developed a ‘dual diagnosis’ care pathway aligned 
with the general care pathways for dementia, depression, anxiety, 
psychosis and personality disorder.
The ‘dual diagnosis’ care pathway offers a joint approach to care, 
involving the patient, care coordinator, General Practitioner, multi-
disciplinary team, consultant old age psychiatrists and (where 
relevant), specialist addictions practitioners. Although not part of 
a comprehensive ‘dual diagnosis’ service, it involves screening, 
assessment and brief intervention for alcohol misuse and onward 
referral for more complex substance misuse problems.
Phases of intervention comprise assessment (including screening), 
engagement, assessing and facilitating motivation to change, 
developing an action plan that incorporates harm reduction and 
recovery, as well as relapse prevention. A study from this service 
found that 40% of older people with ‘dual diagnosis’ referred from 
medical in-patient settings achieved either abstinence or controlled 
drinking at 6 months follow-up (Rao, 2013). 
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Consequently, the SLAM MHOAD service has the potential for being 
replicated across other areas of the UK. This would be achieved as 
shown in Box 4 below.
Box 4:  
How the SLAM MHOAD service could be replicated across other     
areas of the UK
 z Building on existing good practice (e.g. referral to and from liaison 
old age psychiatry and addiction psychiatry services)
 z Scoping the need for new services and roles (e.g. delivery 
of in-patient training to meet Commissioning for Quality and 
Innovation-CQUIN outcomes)
 z Creating new service options where possible (predominantly home-
based assessment and treatment of “dual diagnosis” by Community 
Mental Health Teams)
 z Developing clinically effective care pathways (currently alcohol, but 
future plans to include benzodiazepines, tobacco and cannabis)
 z Promoting robust partnerships with key stakeholders (e.g. patients 
and carers group)
 z Building a skilled workforce (acquiring relevant competencies 
through “dual diagnosis” training)
 z Establishing communication and reporting structures (e.g. serious 
incidents, screening and brief intervention)
 z Promoting health education, prevention and early intervention for 
patients 
 z Strategic buy-in and a group to monitor, develop and implement new 
approaches and embed existing approaches which work well
 
Developing care pathways 
A good starting point is to identify current pathways and to work 
with local CCGs and PHE to develop pathways that are needed. 
The development of clinically effective care pathways is at the 
centre of the national commissioning strategy and new evidence-
based treatment pathways (EBTPs) for addiction services are under 
development (Public Health England, 2017) (NHS England, 2016). It 
is important that these include pathways to meet the needs of older 
patient. Current practice in London identifies three key areas for care 
pathway development in ‘dual diagnosis’ (alcohol) services (Rao and 
Shanks, 2011):
 z A functional non-psychosis pathway
 z A functional psychosis pathway
 z An organic (brain injury and dementia) pathway
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In addition to these, a care pathway will be needed for those older 
adults without a co-occurring mental health need:
 z For medical teams and OPMH teams − A substance misuse 
only pathway.
 z For SM teams −  a pathway to physical healthcare and Mental 
Health
 z For MH teams −  a pathway to manage physical healthcare 
When these local pathways are being developed it would be worth 
considering whether services can directly refer to each other without 
the need to work through a GP which would introduce a delay into 
the care delivery system. 
In addition, practically given premises constraints across the health 
services, a useful way of working would be for staff to co-locate or be 
based for part of the week in partner services. As relationships build, 
care pathways will follow. Prudently, this would be worth starting on 
a small scale and building up.
Workforce Planning and Training at the Local Level
A number of approaches are available for workforce development 
and planning. In the first instance, training needs can be identified 
through appropriate tools such as the Leeds Capability Framework 
which is based on the ‘closing the gap’ capability framework.
Existing approaches to workforce training include:
 z Institute of Psychiatry: Online understanding drugs and 
addiction course (https://www.futurelearn.com/courses/
understanding-drugs-and-addiction)
 z British Association for Psychopharmacology Masterclass in 
Addiction (https://www.bap.org.uk/masterclasses)
 z Royal College of Psychiatrists Centre for Advanced Learning and 
Conferences (CALC)
 z MSc/MA/ pgCert. at Kings College London  
(http://www.kcl.ac.uk), University of the West of Scotland 
(http://www.uws.ac.uk), University of West London  
(http://www.uwl.ac.uk/international), Manchester Metropolitan 
University (http://www2.mmu.ac.uk)international) or Middlesex 
University, London (www.mdx.ac.uk)
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Experience suggests that training can be effectively implemented at 
a local level with rapid benefits for both patients and professionals 
(Saxton L, 2011) and it is recommended that training needs be 
incorporated into workforce planning in advance through personal 
development plans and appraisal processes. At a service level, staff 
can be trained and supported to enhance their skills base. Frontline 
keyworkers across medical, psychiatric and substance misuse need 
to be conversant with common conditions across the areas they are 
not working in. This makes for effective triage, brief interventions and 
referrals onwards.
SM and OPMH staff need to have a working understanding of topic 
areas such as smoking, smoking cessation, COPD identification 
and management, obesity, liver conditions such as fatty liver, ALD, 
hepatitis, and end stage liver disease issues. There also needs to be 
a working understanding of Ischemic heart disease and hypertension, 
neurological conditions such as strokes and TIAs, as well as diabetes 
management. 
Finally, a knowledge of BBVs would help. Pain management 
knowledge is also helpful to have SM and geriatric medical staff 
need to have a working understanding of common mental health 
conditions, such as anxiety, and how to identify and manage this, 
depressive illness, memory assessment and management, dementias 
and capacity assessment and identifying psychosis Geriatric medical 
staff and OPMH staff need to have a working understanding of alcohol 
dependence − how to screen, how to provide BI and how to refer. 
Additionally, they need a working awareness of the needs of an ageing 
OST population with all the comorbidities that accompany this. While 
this may seem like a big task, a simple solution may be for staff in 
each of these areas to train each other via joint training days. 
On a final note SM teams ‘get recovery’ and are good at recovery-
oriented activities. These activities span mood management, anxiety 
management, life skills, basic healthcare, healthy living, social activities, 
employment and education in addition to substance misuse specific 
groups. This can be used across the older population to enhance 
recovery in the medical and psychiatric care settings.
College report CR211 112
An aspirational practical way of enhancing treatment delivery:
Example 1
What OPMH services could do 
with regards to physical health
Entry into substance misuse 
services 
What OPMH services could 
do with regards to substance 
misuse 
Full physical screening:
• At start
• At least annually
Physical examination to include:
• Blood pressure and pulse rate
• ECG
• Blood sugar level
• BBV testing
• COPD status
• Blood tests − U&E, FBC, 
GGT
• Pain assessment
• MMSE
Co-working and co-location 
with:
• GP Surgeries 
• Diabetic Clinics 
• COPD Clinic 
• Cardiology 
• Gastroenterology 
• Sexual Health Clinics
• Dentistry 
Substance misuse triage 
covering:
• Illicit drug use 
• Alcohol use 
• GP summary 
• Past drug and alcohol history 
• Current and past mental 
health 
• Current and past physical 
health 
• Social situation issues 
Screen for:
• Anxiety 
• Mood
• Previous psychiatric input 
• Current psychiatric input 
• Mental health needs 
Collaborate with:
• OPMH service to optimise 
treatment within SM services 
• And co-work with OPMH for 
patients with more serious 
MH needs
One to one and group work to 
cover:
• Substance misuse issues 
• Substance specific groups 
• Relapse prevention 
• Healthy lifestyle 
• Weight management 
• Smoking 
• Life skills 
• Community reintegration 
• Education and skills 
• Exercise groups 
• Sleep hygiene 
• Coping skills 
Regular reviews 
to cover the above areas and work 
with other local services 
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An aspirational practical way of enhancing treatment delivery:
 
Aftercare provision
Within secondary medical care and mental health services, the 
common scenario is a discharge back to the patient’s own GP once 
an episode of care has ended. The patient can then be referred 
back to secondary services should a problem arise again. This is a 
very different model from community substance misuse services. 
Community substance misuse services explicitly track discharges 
and re-presentations to services, and frequently this is linked to PbR 
targets. 
Substance misuse services now offer a range of aftercare support 
ranging from one-to-one support, groupwork, post discharge 
programmes, volunteering and mentoring programmes as well as 
ETE programmes to support patients post clinical discharge and to 
prevent a relapse. This is a model that could be adapted within older 
people’s mental health services.
What OPMH services could do 
with regards to physical health
Entry into substance misuse 
services 
What OPMH services could 
do with regards to substance 
misuse 
Full physical screening:
• At start
• Annually
Physical examination to include:
• Blood pressure and pulse rate
• ECG
• Blood sugar level
• BBV testing
• COPD status
• Blood tests- UDE, FBC, GG7, 
LF7
• Pain assessment 
• Oral health checks
Co-working and co-location 
with:
• GP Surgeries 
• Diabetic Clinics 
• COPD Clinic 
• Cardiology 
• Gastroenterology 
• Sexual Health Clinics
• Dentistry 
Initial Appointments covering:
• Reasons for referral 
• Mental health symptomology 
• Substance misuse 
• Physical health 
• Social situation needs  
Verbally screen for:
• Illicit drug use 
• NPS
• Alcohol issues 
• Benzodiazepine use 
• AUDIT/CAGE screens 
• BBV testing 
• Breathalyse /UDS/Saliva Test
• Blood tests – FBC, U&E, 
GGT, LFT  
Brief advice work and 
collaboration
• To collaborate with SM 
services to optimise services 
for clients 
• Collaborate with SM services 
for more complex patients 
Regular reviews 
to cover the above areas and work 
with other local services 
Example 2
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Conclusion
To date, older people with substance misuse problems have been 
extremely poorly served, except in a small number of centres. The 
risks and problems engaging people with addictions issues are 
magnified and in crucial ways very different in older people. There is an 
increasing recognition of this problem and with this an increasing will 
to address it through health policy. The Royal College of Psychiatrists 
has a role in advocating for this group and shaping effective, efficient 
evidence-based services from the national to the local level. There 
is an increasing evidence base, and beacons of good practice have 
been established nationally. All psychiatry of old age and addictions 
services should immediately survey their current service provision 
and begin to develop along the lines suggested above.  
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Education and training
Key Messages
 z Education and training at all levels are central to addressing the 
challenges posed.
 z Key skills for managing addiction and substance misuse in older 
people can be readily incorporated into new models of medical 
training, and training of other health professionals.
 z An expansion in healthcare staff with skills in addictions will be 
needed to improve education and training across health and 
social services, the public and third and private sectors.
 z The Royal College of Psychiatrists has a major role as a source 
of expertise and to aid the medical, allied health professionals 
and others who can be expected to do the majority of work in 
primary and secondary care. An expansion of the numbers of 
psychiatrists skilled in working with older people with addictions 
is required in order to deliver the necessary wider services.
Introduction 
The overall picture for older people with substance abuse problems 
is of an unmet need, constantly growing in both scale and complexity 
with significant levels of physical and psychiatric morbidity, as well 
as and rising rates of mortality. The Department of Health currently 
focuses on the treatment of drug users (Department of Health, 2010). 
Outside of alcohol and tobacco use and the physical complications 
of illicit substance use, the management of addiction has mostly 
remained with mental health services. To date, much work has been 
done developing the care of those with mental illness and co-morbid 
substance misuse but this has largely focused on people of working 
age such as the Capability Framework for working with people with 
dual diagnosis. The Society for the Study of Addiction (https://www.
addiction-ssa.org) remains a leading source of expertise and advocacy 
in the general field of addictions. Substance misuse in older people 
is recognised as a growing area requiring specific research and 
development and specialist skills.
Addiction services are seen by the Royal College of Psychiatrists 
as an essential component of older people’s mental health services 
(Connolly, 2012). Although the emphasis of this document will be on 
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the role of psychiatry, it is acknowledged that much of the work in 
this area is, and will continue to be, done in primary care. 
The greater part of expertise cannot remain solely within a relatively 
small number of mental health professionals. There is a pressing need 
to equip a wider spectrum of health professionals with the skills to 
assess and manage addiction problems in older people before we 
can have effective services (see Service Delivery chapter).
This will require action at several levels.
Public education
Research indicates that there are significant barriers to public 
awareness and understanding of the problem of substance abuse in 
older people (DrugScope, 2014) particularly around ageism, stigma and 
lack of knowledge, ultimately leading to chronic misidentification and 
under-reporting. There is evidence to suggest that the recommended 
daily limits of alcohol consumption in adults may in fact increase 
risk in the older people  (Crome I. , 2012) (Crome & Crome 2018); a 
powerful argument for specific education targeted at older people.
Public health campaigns aimed at older people, carers and health 
professionals are an essential first step in driving improved service 
provision. This could be done under the auspices of regional public 
health bodies and coordinated with third sector services (Public Health 
Agency NI, 2016).
The Royal College of Psychiatrists has identified four main strategic 
areas for development in the field of older people’s mental health, 
including promoting engagement and awareness. It already has high-
quality resources to aid in public and professional education in this 
field (The Royal College of Psychiatrists, 2015) and should position 
itself as the leading ‘go-to’ source for information and educational 
resources.
At the divisional level, the College can encourage interest in this 
field through their public engagement, addictions and psychiatry of 
old age faculties.  Key stakeholders should be identified locally and 
include a balance of healthcare and third sector representatives and 
experts by experience. Engagement and awareness is probably best 
approached at this local level to identify and co-ordinate with existing 
local services to identify key areas for improving public education.
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Undergraduate medical training
Undergraduate medical training in the United Kingdom was 
comprehensively reformed following the recommendations of 
Tomorrow’s Doctors (General Medical Council, 2003) and the 
subsequent Outcomes for Graduates (General Medical Council, 2015). 
Promoting excellence: standards for medical education and training 
(General Medical Council, 2015) sets out the standards educational 
bodies are currently required to meet and the General Medical 
Council’s processes for the governance of medical education. 
The Royal College of Psychiatrists has previously developed an 
undergraduate core curriculum for psychiatry (The Royal College 
of Psychiatrists, 2011) although this deliberately delegates individual 
points of the curriculum to the medical schools to implement.  
General Medical Council policy could reflect the need for development 
in substance abuse by older people. This could take the form of 
establishing it as a distinct area of undergraduate teaching in medical 
schools’ physical or mental health programmes.  
Medical Schools in the United Kingdom
The medical school curriculum is set and quality assured by the school 
management committee and school teaching board or equivalent 
bodies within the university.
Research into undergraduate curricula in the UK up to 2004 found 
on average, a relatively small amount of teaching allocated to 
substance misuse which tended to be included as part of psychiatry 
or pharmacology courses (Glass,1989; Crome, 1999; Crome, 2004) 
From 2008 there has been a concerted effort to improve education 
in substance misuse throughout medical training in accordance with 
international guidelines for curriculum development by the International 
Centre for Drug Policy (ICDP).  (International Centre for Drug Policy, 
2012).  
This has focused on:
1 An agreed high-level curriculum in addiction across UK medical 
schools.
2 Focusing support for implementation of the curriculum at the 
local level.
3 Curriculum alignment with Tomorrow’s Doctors
4 High quality validated teaching materials to aid delivery of the 
addictions curriculum.
College report CR211 118
By 2014 some 47,000 future doctors had benefitted from the 
improvements to substance misuse training in the UK (Goodair, 2014). 
The next challenge lies in capitalising on this good start and improving 
expertise specifically in the area of old age substance misuse for these 
doctors and those who graduated before them.
Substance misuse in older people must be developed further as 
an important part of the larger undergraduate curriculum. It can be 
incorporated in formal teaching in psychiatry, care of the elderly, 
internal medicine and general practice. Informally it should form an 
increasing part of the ‘hidden curriculum’ (Goodair, 2014) learned 
through experience in everyday clinical practice in all parts of 
medical training. It could be developed as part of a student selected 
component (SSC) and form part of teaching in medical ethics where 
realistic management of addiction would be a useful topic for problem-
based learning (PBL) (Vernon & Blake, 1993).
At a national level, the Royal College of Psychiatrists could consider 
a written submission to the General Medical Council about the 
importance of addictions in older people as a field for development 
in the medical schools’ undergraduate curricula.
The Royal College of Psychiatrists at the divisional level can engage 
with medical undergraduates through facilitating opportunities 
for gaining experience in addictions locally and by encouraging 
participation in undergraduate prizes such as the medical student 
essay prize in old age psychiatry (RCPsych Prizes and Bursaries for 
Trainees, 2016). Bursaries could be established for undergraduate 
attendance at relevant conferences and training in line with the faculty 
of old age psychiatry’s strategic aims of improving recruitment.  
The addictions and old age faculties may wish to consider setting 
up an undergraduate prize in the near future that could be open to 
entries dealing with addiction in older people.
Postgraduate medical training
The General Medical Council
The independent Shape of Training review of Postgraduate Medical 
Education (Greenaway D. , 2013) recommends the introduction 
of a generic capabilities framework for developing curricula for 
postgraduate training. It is proposed to focus specialist training on 
common areas between specialties, adding flexibility to training and to 
replace the certificate of completion of training (CCT) with a certificate 
of specialty training (CST).
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Case study 5: Developing core skills at the undergraduate level
Developing core skills in the treatment of addictions, particularly 
in the areas of smoking and alcohol abuse is an important for all 
health professionals. Core competencies can be developed early in 
the undergraduate curriculum of medical schools and allied health 
professionals with immediate benefit to patients. 
Medical Student intervention to promote effective nicotine dependence and 
tobacco healthcare (MIND-THE-GAP) (Kumar A., 2017). 
An Irish study group identified that medical students were a potential 
untapped resource for delivering the smoking cessation education and 
counselling to inpatient wards.
In a small, randomised trial, students who had received standardised 
cessation training had better outcomes working with patients than 
standard hospital interventions. There was positive feedback from both 
patients and students and the method is being further investigated.
Undergraduates can develop the necessary skills quickly and 
incorporate them into patient care at an early stage. Although medical 
students are used in this example it represents an ideal opportunity to 
share experience with other healthcare professionals training in nursing 
and allied health professions.
The new Generic Professional Capabilities Framework is based on 
Good Medical Practice (General Medical Council, 2013) and covers 
areas such as communication, leadership, quality improvement and 
safety. It is to be used as the basis for developing new postgraduate 
medical curricula (General Medical Council/ Academy of Medical 
Royal Colleges, 2017).
Adapting for the future (General Medical Council, 2017) sets out a 
future where postgraduate medical training will be increasingly flexible 
and consist of related curricula sharing outcomes across medical 
specialties. 
As noted, the field of substance misuse (and especially substance 
misuse in older people) is an example of a topic with professional 
values, skills and knowledge that are important across multiple medical 
specialties. Generic professional capabilities in health promotion and 
safeguarding the vulnerable are also widely applicable. 
Within the Royal College of Psychiatrists, the faculty of psychiatry 
of old age and faculty of addictions must develop and advocate 
for the explicit inclusion of substance misuse in the elderly in new 
postgraduate curricula. They should identify key commonalities in 
the field of old age substance misuse with faculties of other medical 
royal colleges to design common curricular details in line with new 
guidance in the documents Excellence by Design (General Medical 
Council, 2017) and Standards for Curricula and Assessment Systems 
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(General Medical Council, 2017).  The following new simplified process 
for curricular improvement will allow quicker design, implementation 
and review of future curricula.
Administrative 
change 
process
Resubmission
College 
curriculum 
development
Submission
Four-nation 
support 
(strategic 
workforce)
Feasibility
(post 
graduate 
deans)
Advisory 
meeting
AR decision
Review
GMC quality 
assurance 
framework
New processes in developing and approving postgraduate medical curricula (General Medical Council 2017)
From 2012, the General Medical Council (GMC) has been working 
to introduce credentialing, which aims to provide a framework of 
standards and accreditation in areas where regulation is limited 
or absent (General Medical Council, 2015).  It is expected that the 
credentialing process will roll out in different medical specialties 
simultaneously, on the basis of providing added value to patients 
and the public. It is suggested that the field of substance misuse 
and addictions in older people wouldbe a good topic to pilot for the 
proposed credentialing process.
In addition, the GMC is well placed to emphasise the importance 
of competency in this area as part of medical revalidation within 
relevant specialties.
The Royal College of Psychiatrists
The competencies to deal with substance abuse in older people 
can be developed at all levels. It should be part of developing old 
age and addictions competencies in core training and a topic for 
examination at MRCPsych papers 1 and 2 and CASC. It is suggested 
the topic can be easily integrated into existing areas rather than 
standing alone and that a database of examination resources could 
be quickly established and resources incorporated into the trainees 
online (TrOn) educational modules. 
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At the post-membership level, substance abuse in the older people 
should be further developed as a specific topic in higher specialist 
training for an old age psychiatry certificate of completion of training 
(CCT) and in addictions and liaison endorsements. It must be viewed 
as a key area of competency with distinct, important differences in 
assessment and management as compared to substance misuse 
in working adults.   
The responsibility for implementation of the specialist training curricula 
in old age psychiatry and in addictions will lie with the local deanery, 
Training programme directors (TPD) and educational and clinical 
supervisors. They will need to map the area of addictions in older 
people to the intended learning outcomes described in current 
and future College curricula for specialist training (Royal College 
of Psychiatrists, 2015) (Royal College of Psychiatrists, 2015) (Royal 
College of Psychiatrists, 2016) to the local training programme. 
The old age faculty of the Royal College of Psychiatrists would be well 
placed to advise TPD what form training should take and what would 
be considered appropriate evidence of competency at the annual 
review of competence progression (ARCP) (Fitch, 2008).
At present, there is an additional role for the Royal College in 
ensuring that substance misuse in the older people forms part of the 
assessment criteria in determining eligibility for a certificate of eligibility 
for specialist registration (CESR) in the field of psychiatry of old age.
The existing continuing professional development in this area, 
online and through College courses organised through the centre 
for advanced learning and conferences (CALC), such as the annual 
update on providing care for older substance misusers should be 
developed and expanded.
The College should promote and advertise opportunities for research 
and policy development nationally and lead in the identification of best 
practice, evidence-based treatment pathways (EBTPs), audit tools 
and outcome measures, either specifically in the fields of addiction 
and old age psychiatry or as part of other areas such as the national 
audit of dementia (Royal College of Psychiatrists).
The Academy of Medical Royal Colleges
Partnerships should continue to be developed in the field of substance 
abuse in older people with other medical stakeholders in the Academy 
of Medical Royal Colleges such as the Royal Colleges of Physicians 
(possibly through the British Geriatrics Society) and Royal College 
of General Practitioners.  
The core medical competencies for working in the field of substance 
abuse generally have already been outlined by a working group 
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representing 13 Medical Colleges and working extensively with 
patients to promote effective compassionate care (see Notes and 
thoughts from a patient chapter). 
Knowledge
 z Effects, common 
presentations and potential 
for harm.
 z Addictive potential 
of prescribed and 
non-prescribed drugs.
 z Interventions, treatments 
and prognosis.
 z Effects of drugs on children 
and families.
 z Lower risk limits on 
alcohol use.
Behaviour and attitudes
 z Effects, common 
presentations and potential 
for harm.
 z Addictive potential 
of prescribed and 
non-prescribed drugs.
 z Interventions, treatments 
and prognosis.
 z Effects of drugs on children 
and families.
 z Lower risk limits on 
alcohol use.
Skills
 z Competency in assessment
 z Recognition of acute and 
long-term presentations
 z Providing brief advice
Key Recommendations for core competencies in substance misuse 
(Alcohol and other drugs: core medical competencies, Academy of Medical Royal Colleges, 2012) 
(Sinclair et al, 2012)
These links cultivate and share expertise and allow further coordinated 
incorporation of key knowledge, skills and attributes across medical 
training.
The majority of work in the area of substance abuse in older people 
will naturally take place in primary care. The Royal College of General 
Practitioners (RCGP) also plays a lead role in advocacy, quality 
assurance, setting a vision, training, service development, improving 
evidence base and supporting integrated care provision in this field. 
The existing RCGP substance misuse training modules have enjoyed 
a wide support base. These could be expanded to cover the needs 
of the older population.
The Royal College of Psychiatrists already has well-developed 
partnerships operating with the Royal College of Psychiatrists, the 
British Geriatrics Society and the Royal College of Physicians in a 
number of areas and these must expand to embrace substance 
misuse in older people.
Local Education and Training Boards (LETB) and Postgraduate 
Deaneries
Local education and training boards and postgraduate deaneries 
have responsibility for curriculum delivery. Their quality assurance and 
governance processes will need to ensure that curriculum appropriate 
training in substance misuse in older people is effectively delivered 
by the local educational providers (LEP). 
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It is important that the Royal College of Psychiatrists, regional 
governments and the postgraduate deaneries do not lose sight 
of topics such as addictions in older people, as new training 
arrangements are introduced. Although the area is common to many 
specialities, care must not be taken to let it be lost in the gaps between 
curricula. It is also important that the Royal College of Psychiatrists 
leads in curricular development and implementation, and the future 
development of post-CST credentials in substance misuse in older 
adults.  (British Medical Association, 2017). 
Cultural Aspects of Training
Providing healthcare for an increasing population of older people may, 
in itself, prove to be a cultural challenge to successive generations of 
medical practitioners. There may be different attitudes to the stigma 
of substance misuse and also to the risks it poses to the individual. 
Communication and public education strategies will need to include 
those not routinely using electronic and social media and be geared 
to reaching socially-isolated individuals.
Our ageing population is also increasingly culturally diverse with the 
attendant social and linguistic challenges for healthcare providers. 
Stigma, in particular, may be higher in ethnic minority communities 
and act as a barrier to both substance misusers and their carers 
seeking help.
In the field of addictions, which involves the ability to develop a 
therapeutic relationship, build trust and employ tools such as 
motivational interviewing, success will increasingly require practitioners 
to develop cultural skills.
The importance of cultural competency in medical education has been 
recognised for some time (Betancourt & Alexander, 2010) (Betancourt 
J., 2006) (Rao, 2006). Both educators and practitioners must be 
appropriately trained in delivering healthcare across cultural and 
linguistic barriers (Betancourt & Alexander, 2010). 
Culturally competent in medical education (C2ME) is a consortium of 14 
partner institutions across 11 countries, with the University of Leicester 
representing England. It has developed policies, strategies and tools 
to integrate cultural competence-based learning objectives across 
the undergraduate medical curriculum and to develop competencies 
in medical educators (Ikram & Suurmond, 2015). It is proposed that 
the Royal College of Psychiatrists and Medical Schools can make 
increasing use of this resource in the future when developing training.
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Allied health professionals
Undergraduate healthcare training
The substantial healthcare challenge posed by addiction in the 
ageing population will impact beyond psychiatry and medicine. In 
keeping with the principles of ‘everyone’s business’, ‘no wrong door’ 
and ‘making every contact count’ (Public Health England, 2017) all 
healthcare staff will need to be skilled in identifying and engaging older 
people with substance misuse issues. It is recommended that the 
Royal College of Psychiatrists’ faculties of addictions and psychiatry 
of old age should develop closer links in this field with other bodies 
governing and quality assuring undergraduate education such as 
the Nursing and Midwifery Council (Nursing and Midwifery Council, 
2010), The Health and Care Professions Council and The College 
of Social Work (Narey, 2014). The field of substance misuse in older 
people should also be an on-going part of the curriculum for pharmacy 
undergraduate and pre-registration training as regulated by the Royal 
Pharmaceutical Society of Great Britain (Sosabowski, 2008).
Postgraduate healthcare training
Allied healthcare professionals working in the fields of mental health, 
elderly care and addictions should all have the requisite training in 
addiction and substance misuse in older people as part of their 
induction and training by their employer with appropriate quality 
assurance and appraisal.  
Similarly, there should be an expansion in accredited postgraduate 
training and continuing professional development (CPD) through the 
Nursing and Midwifery Council and the Health and Care Professions 
Council (especially in the fields of clinical psychology, counselling, 
social work, dietitians and occupational therapy).
Physician assistants are likely to form an increasing part of the 
healthcare workforce and the field of addictions and substance misuse 
in the older people should also form a part of both the postgraduate 
diploma curriculum in universities and in recertification (Ostler, 2012).
The healthcare provider
Health and social care providers
The development of clinically effective care pathways is at the 
centre of the national commissioning strategy and new evidence-
based treatment pathways (EBTPs) for addiction services are under 
development (Public Health England, 2017) (NHS England, 2015). It 
is important that these include pathways to meet the needs of older 
patients.  
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It is important that healthcare trusts provide opportunities for training of 
staff at all levels to allow treatment pathways to work effectively. There 
is experience to date in developing training within a small number of 
trusts using local resources (Saxton L, 2011). These serve as useful 
evidence-based templates for developing local and regional training. 
Given the anticipated demographic challenges in substance misuse 
in older adults and the national scope of the problem, knowledge 
of best practice will have to be made widely available. With respect 
to individual expert practitioners in the field, formal training will be 
required. In training a wider range of staff, use could be made of 
national resources such as the development of specific modules as 
part of e learning for healthcare or by commissioning training through 
private providers.
To ensure the development of a skilled workforce trust governance 
processes will have to include appraisal of competencies in staff 
working in areas such as psychiatry of old age and care of the elderly. 
 
Other providers of healthcare
The nature of addictions in older people is such that the opportunity 
to engage the patient effectively may arise at many different points. 
As discussed above, public education will be key to producing the 
societal changes necessary to improve awareness and help seeking. 
To that end, education and training will need to be provided to other 
services likely to come into contact with older people with addictions.
Much day-to-day contact with potential patients is likely to come 
through those providing care in nursing and residential homes, 
sheltered and assisted housing and through those providing care 
packages. The need to provide specialist training for staff looking after 
older people in areas like dementia care and capacity assessment 
is well-recognised and it is proposed that this should also apply to 
substance misuse and other addictions (Carter, 2015). From 2015, in 
England and Wales, the common induction standards and national 
minimum training standards for healthcare assistants and social 
care workers have been replaced by a care certificate based on 
15 standards that must be completed within 12 weeks of starting 
employment. Addiction issues in older people falls into several of 
these standard areas and could be expanded upon in the future by 
the care quality commission (CQC).
Other services likely to come into contact with older people with 
addiction issues include community pharmacists who may become 
aware of abnormal patterns of prescribing, or purchasing in patients 
or who may be approached for advice by carers. Training in substance 
misuse in the older people would be an important part of continuing 
professional development (CPD) in this area.
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Professionals in the criminal justice system can also increasingly be 
expected to be a first point of contact for older people with addiction 
and substance misuse issues. The specific needs of older people 
should form part of substance misuse education in programmes 
such as prison officer entry level training (POELT), initial training 
programmes and continuing professional development (CPD) as 
regulated by the College of Policing and the Professional Qualification 
in Probation (PQIP).
As previously noted, the Royal College of Psychiatrists has an 
important role in advocating for increased training but also in 
helping to develop training programmes and expertise. Indeed, it 
has already developed a two-day course on substance misuse in 
older people. This is also likely to be required by third sector partners 
and the College can help design training and signpost good practice. 
Conclusion
Substance misuse in older adults constitutes a significant challenge 
to both public health and existing services. Addressing the problem 
will require raising public, professional and political awareness in a 
relatively short space of time. We need health professionals that:
 z are aware of substance misuse as an issue in older people and 
capable of identifying complex presentations.
 z are capable of effectively and compassionately working with 
this group of people
 z have the skills to assess and manage substance misuse in older 
people and effectively refer them to effective care.
Educating current and new generations of healthcare practitioners will 
require a carefully prepared curriculum and educational tools that must 
be integrated in the new era of medical training. The central role of 
allied health professionals, professionals working in the criminal justice 
system and other areas must be recognised and the development of 
effective training facilitated. The Royal College of Psychiatrists has a 
role as both an expert and an advocate for better services.
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Key Points
 z Older people with substance misuse should not be assumed 
to lack capacity even if they make what may be perceived as 
unwise decision(s).
 z Consider ‘substance misuse’ as a possible cause in any older 
person with fluctuating mental capacity or elder abuse.
 z All practicable steps including timely and planned review should 
be undertaken to optimise the ability to demonstrate capacity in 
older adults which is time and task specific.
 z Apart from mental health interventions covered by statute, all 
adults can refuse medical procedures contemporaneously or in 
advance when they are competent.
 z If a healthcare professional suspects substance misuse in an 
older person, joint working with other teams and social care 
involvement should be undertaken to assess capacity and 
proactively identify any associated safeguarding concerns.
Introduction
Older people with substance misuse present particular complexities 
when it comes to ethical issues, especially with consideration to 
capacity, consent and the principles used to determine the best 
interests of a patient. This can make it difficult for those involved 
with the care of these patients to weigh the extent of a person’s 
individual rights (their autonomy) and their responsibilities to act in the 
best interest of that patient. The laws concerning adult safeguarding, 
confidentiality and societal protection, as well as wishes of the 
Ethical and legal 
considerations in older 
people with substance 
misuse
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families, could further add to these complexities. Some of these 
ethical and legal considerations are discussed here as the issue 
of increasing prevalence of substance misuse in older adults is an 
emerging challenge for clinicians. This chapter summarises the ethical 
and legal issues which many healthcare professionals may find an 
informative read.
Mental Capacity
In England and Wales, the Mental Capacity Act (MCA) 2005 (BMA 
2016) is used as the legal framework for guidance on issues around 
mental capacity; whereas for Scotland, the Adults with Incapacity 
(Scotland) Act 2000 is applied (Adults with Incapacity Act 2000).
The complex nature of problems associated with substance misuse 
in older people means that there are particular issues around mental 
capacity, especially when there is a conflict between capacity and 
the role of the practitioner in encouraging the older person to give 
up substance misuse (Hazelton et al, 2003). 
This is especially relevant given that one of the core features of 
dependence syndromes is the persistence of substance misuse, 
despite the user being aware of the harm from the substance being 
taken. Using the core feature of harm awareness, an assessment of 
mental capacity in substance misuse can help distinguish an unwise 
decision from a lack of mental capacity on its own.
‘The Mental Capacity Act 2005 (BMA 2016) contains a two-stage 
test of capacity: 
 z Is there an impairment of, or disturbance in the functioning of, 
the person’s mind or brain? 
If so:
 z Is the impairment or disturbance sufficient that the person is 
unable to make that particular decision?’
Under the Mental Capacity Act, a four-stage assessment of decision-
making ability is required to prove that an individual is able to make 
a specific decision at that specific time:
 z Possessing a general understanding of the decision and why 
they need to make it
 z Possessing a general understanding of the likely consequences 
of making/not making this decision
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 z Possessing an ability to understand, retain, use, and weigh up 
the information relevant to this decision
 z Possessing an ability to communicate their decision (by talking, 
using sign language or any other means)
 z A central principle of the MCA is the presumption that all adults 
have the capacity to make decisions for them, unless proven 
otherwise. Provisions for surrogate decision-making should only 
be resorted to after it has been proved that an individual is unable 
to make a particular decision because of an impairment of, or 
disturbance in, the functioning of the mind or brain.
 z The other four central principles of the Act are as follows: 
 z A person must be given all practicable help before anyone 
regards them as not being able to make their own decisions. 
(For example, consider: Would the services of a professional 
such as a Speech and Language therapist be helpful?)
 z A person is not to be regarded as unable to make a decision 
merely because they make an unwise decision. 
 z Anything done or any decision made under this Act for, or on 
behalf of, a person who lacks capacity must be done, or made, 
in their best interests. 
 z Anything done or decided for, or on behalf of, a person who 
lacks capacity should be the least restrictive of their basic rights 
and freedoms. 
Capacity can vary over time and change for different decisions; hence 
assessment of capacity is ‘task-specific’. For substance misusers, 
this becomes an even more crucial issue, as their states of incapacity 
may fluctuate according to their level of intoxication or delirium, or 
according to the time of the day. Ideally, any decisions should be put 
off until the person regains capacity, if practically possible. If a person 
is deemed to be ‘lacking capacity’, it means that they lack capacity to 
make a particular decision or take a particular action for themselves 
at the time the decision or action needs to be taken.
The MCA applies to anyone who has ‘an impairment of or disturbance 
in the functioning of the mind or brain’, which may or may not be 
appropriate to all older people with substance misuse problems.
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Assessing mental capacity of an older adult with 
substance misuse
The Mental Capacity Act is accompanied by a statutory Code of 
Practice (Mental Capacity Act Code of Practice 2007) and healthcare 
professionals have a legal duty to be aware of this. 
The other aim of code of practice is to provide guidance to people 
on what they must do when they work with people who can’t make 
decisions for themselves or care for people who can’t make decisions 
for themselves. 
‘According to The Mental Capacity Act 2005 (MCA) certain people 
must think about the code of practice when they act or make decisions 
on the other person’s behalf. This would include:
 z an attorney appointed under a lasting power of attorney
 z a deputy appointed by the Court of Protection
 z an independent mental capacity advocate
 z a person doing research approved in accordance with the MCA
 z a person who acts in a professional capacity for, or in relation 
to, people who can’t make decisions for themselves
 z a person who is paid to act for or in relation to people who can’t 
make decisions for themselves.’
For England and Wales, the British Medical Association and the Law 
Society have produced detailed (Keene 2015) guidance for doctors 
and lawyers on assessing mental capacity. Scotland and Northern 
Ireland have similar assessments for testing mental capacity of 
patients. Many other European countries have similar guidance in 
place.
As per the BMA guidance and document (BMA 2016), capacity and 
competence are similar terms, are task-specific and to start with all 
adults are assumed to have capacity (ability to make a decision).
Mentally competent older adults with substance 
misuse
Healthcare professionals should be trained to assess the mental 
capacity in this challenging group of older patients before offering 
any medical treatment. 
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Any older patient who is mentally competent can make their own 
decisions and this principle would apply to anyone with history of 
substance misuse. Some of these older adults may have their capacity 
affected by medications or at particular time of day and with support 
they may be able to make their own decisions at least for some tasks. 
Competent adults can decide for themselves whether or not they 
accept medical treatments or any other interventions offered to them 
by the clinicians. If they have capacity, they can also set up advanced 
directives. Unless unconscious, most of these adults would be able 
to make some valid decisions or be able to express their views and 
preferences. If there is doubt about mental capacity, unless it is an 
emergency, formal psychological assessments should be requested 
by specialists (BMA 2016).
If that individual is deemed as having the capacity to make a decision 
for themselves and if that individual is shown as being able to weigh 
up the consequences of their decision and still choosing to use a 
particular substance − the MCA safeguards that individual’s decision-
making capacity by suggesting that decisions otherwise deemed 
‘unwise’ are legally acceptable.
Case study 6
An 82-year lady is referred by her GP to the care of the geriatric 
medicine service with concerns over poor mobility and a pre-occupation 
with pain in her hands.
There is no evidence of bony injury or joint damage. After speaking 
to the GP, it becomes evident that she has been prescribed steadily 
increasing doses of opiate-containing analgesics, as well as having 
recently started on temazepam for insomnia and small doses of 
diazepam for anxiety.
At assessment, she describes pain in hands as ‘unbearable’ and says 
‘noone is taking me seriously’. The onset of this pain coincides with the 
death of her neighbour, her only source of social support. There are also 
ongoing financial worries. Her only child lives nearby, but they became 
estranged following an argument ‘over money’ a year ago. There is no 
other evidence of chronic physical health problems but she reports 
her mood to be worse over the past 6 months. Apart from prescribed 
benzodiazepines and opiate containing analgesics, she also buys 
opiate-containing analgesics (e.g. codeine) over the counter.
On mental state examination, she is agitated, her hair is uncombed and 
her affect is anxious. There is evidence of depression, anxiety, panic 
attacks and agoraphobia, but no cognitive impairment and she is able 
to make informed decisions about her treatment and care.
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Case study 6 key points:
 z This case illustrates the issue around opiates and drug dependency which 
was masked by the focus on physical symptoms whereas drug misuse 
was the hidden issue in this case.
 z Such patients may be suffering from depression or anxiety due to various 
reasons and need to be given more time to judge their mental capacity.
Mental incapacity in older adults with substance 
misuse
If a healthcare professional has undertaken an assessment and found 
that an older adult with substance misuse has lost the capacity to 
make their own decisions for a particular intervention offered to them, 
they should then find out if the patient has any advanced directives or 
a proxy decision maker. Those views and prior wishes expressed by 
patients should be taken into consideration, before any health team 
decides on the ‘best interest’ option for the ‘incapacitated adult’ 
(BMA 2016). 
Case study 7
A 62-year-old man is referred to a Community Mental Health Team 
(CMHT) by a local housing officer after neighbours witnessed a series of 
falls on returning to his flat in the evenings.
He has been reported by neighbours to leave the house early in the 
morning and return at night, often losing his balance and falling while 
making his way back to his ground floor flat. He has not paid his rent 
for the past 6 months and his housing officer has only managed a 
‘doorstep’ visit, at which it was noted that he was dishevelled, unshaven 
but did not look thin and was dressed appropriately. At the same visit, 
he was irritable and abusive but not intoxicated and denied any financial 
problems. He had last been seen by his GP the year before and the GP 
had noted problems in keeping appointments. There was a suspicion 
of alcohol misuse from self-report and blood investigations, but he was 
unwilling to seek further help.
Case study 7 key points:
 z The case shows the importance of close working and good 
communication between various teams looking after an older person with 
suspected alcohol dependency.
 z These patients are vulnerable and prone to physical and mental 
issues if alcohol and drug dependency issues are not dealt with in a 
proactive manner. 
If a patient has capacity and refuses to engage with other services 
for help, it would be considered an ‘unwise decision’ – something 
legally any competent adult can make as long as it is not putting 
others at risk of harm.
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Law relating to mental capacity
All legal jurisdictions in the United Kingdom have moved to using 
capacity-based legislation. Case law is building and it is reasonable to 
expect that the issue of an individual’s capacity to choose to engage 
in harmful substance misuse will arise. In England, people with mental 
incapacity over finances, health and welfare are overseen by the Court 
of Protection. There will also be an important role for the Medical Royal 
Colleges, Medical Protection Bodies and the Regional Departments of 
Health in monitoring and disseminating legal guidance to practitioners.
Deprivation of Liberty Safeguards
Deprivations of Liberty Safeguards (DoLS) may involve those with 
substance misuse or those under the influence of drugs or alcohol. 
If an older person is resisting treatment and it is clear that they are 
lacking capacity, health professionals sometimes consider the use 
of restraint, or impose restrictions on a person’s liberty to provide a 
treatment which is in their best interests. 
‘To be lawful, deprivation of liberty needs to be authorised in 
accordance with procedures set out in the Deprivation of Liberty 
Safeguards which were added to the Mental Capacity Act by 
amendments introduced by the Mental Health Act (MHA) 2007. In 
an emergency, treatment must not be delayed for the purposes of 
identifying whether a deprivation of liberty has taken place, or seeking 
its subsequent authorisation. An authorisation for a deprivation of 
liberty does not provide legal authority for treatment. Treatment for 
adults unable to consent must be given on the basis of an assessment 
of their best interests by health professionals’ (BMA 2016). 
The Mental Capacity Act Deprivation of Liberty code of practice states 
that depriving a patient of liberty may be justifiable if: 
 z t is in their best interests to protect them from harm 
 z it is a proportional response when compared with the harm 
faced by the person 
 z there is no less-restrictive alternative.
There are two types of DoLS authorisation: standard and urgent. 
Standard authorisations
After receiving an application for a standard authorisation, the 
supervisory body has to decide within 21 days whether the person can 
be deprived of their liberty. If the conditions are met, the supervisory 
body must authorise the deprivation of liberty and inform the person 
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and managing authority in writing. It can be authorised for up to 
one year. The person does not have to be deprived of liberty for the 
period of authorisation. The restrictions should stop as soon as they 
are no longer necessary. 
Urgent authorisations
There will be times when a person may need to be deprived of their 
liberty before a standard authorisation can be provided. In these 
situations, the managing authority can itself issue urgent authorisation 
which can last up to seven days, with an option to extend it for a 
further seven days if the supervisory body is in agreement. When 
issuing an urgent authorisation, the managing authority must also 
request a standard authorisation (BMA 2016).
Advance directives
The level of capacity required to request or refuse treatment in advance 
is the same level that would be required for making the decision 
contemporaneously. It may be demonstrated by patients who lack 
insight into other aspects of their life, as long as they understand the 
nature, purpose and likely effects of particular treatments (BMA 2016).
Across the UK a number of laws exist which delineate the assessment 
of capacity and protect the rights of those who lack capacity (Adults 
with Incapacity (Scotland) Act 2000, Mental Capacity Act 2005 
(England & Wales), and the Mental Capacity Act (Northern Ireland 
2016). All these pieces of legislation must comply with the European 
Convention on Human Rights, and ensuring that any intervention for 
any person lacking capacity is in their best interests.
Relevance of advance instructions by older adults 
with substance misuse  
Advance directive/living will/advance refusal are clear instructions (by 
a competent and informed adult at the time of making these decisions) 
for the healthcare teams. Patients can refuse a medical procedure 
or intervention such as participation in research (BMA 2016). These 
refusals may become invalid if, for example, the treatment options 
which the patients refused materially change after they lost their 
mental capacity (which could be due to substance misuse). Any 
refusal which could potentially be serious obliges health professionals 
to take account of the patient’s past and present wishes, however 
communicated. This would also apply where there is a risk of harm 
to others.
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On the other hand, an advance authorisation or request reflects a 
competent individual’s preferences for certain positive interventions 
after competence is lost. These are not binding as are advance 
refusals. 
The BMA states that ‘Whenever a person is making a decision on 
behalf of an adult who lacks capacity, they must consider if it is 
possible to make the decision in a way that is less restrictive of that 
individual’s fundamental rights or freedoms. There are often several 
ways to achieve a desired outcome, and where possible the choice 
must be the one that interferes least with the individual’s freedoms 
while still achieving the necessary goal. The option chosen must, 
however, be in the person’s best interests, which may not in fact be 
the least restrictive’ (BMA 2016). 
What to do when one is not sure of capacity in 
emergency situations?
As a general principle, the law expects doctors to act reasonably in 
the circumstances in which they find themselves. In an emergency 
situation, where it is unclear whether or not an unconscious or 
otherwise mentally impaired patient (which could be due to substance 
misuse in older people) has refused treatment in advance, it is 
reasonable not to delay treatment if that would result in a serious 
risk to the person’s life or health (Keene 2015). 
If it is unclear whether the individual intended an advance decision to 
apply in all circumstances (in this case, under the influence of drugs) 
of impaired capacity, including an apparently unforeseen situation, 
the advice about ‘assessing validity’ should be followed and more 
guidance is available from BMA document (Keene, 2015). 
Surgical procedures and ethics in substance misuse 
Surgeons should use the least restrictive option and ensure all 
surrogate decisions are in individual’s best interest and any treatments 
must be governed by Mental Capacity Act. When competence is 
lost, a fundamental consideration is the ‘known past wishes and 
values’ (advanced decision or statement) of the incapacitated person. 
Patients’ relatives can also often provide a view about what the 
individual would have wanted as people vary in the value they place 
on surgical treatments. If the surgical treatment is innovative and 
involves unknown or significant risk, expert opinion and legal advice 
should be sought before proceeding (BMA 2016).
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Lasting powers of attorney (LPA) 
Competent adults can nominate another person to make healthcare 
decisions on their behalf in advance of situations in which they 
themselves lose capacity. If they do so, they are officially known as 
‘donors’ since they are giving decision-making power to someone 
else. Healthcare professionals should carefully read the wordings of 
LPA. They need to be aware of the powers that have been granted to 
the attorney as there are two types of LPA, one to deal with financial 
affairs and one to deal with personal welfare and medical treatment 
decisions (BMA 2016).
It is important to note that when the donor has capacity, health 
and welfare attorneys cannot make treatment decisions on behalf 
of the donor. Although enduring power of attorney relating to the 
management of property, financial and general affairs have existed 
since 1985, they were not applicable to medical decisions. Enduring 
power of attorney (EPA) was replaced by LPAs in October 2007. 
Under the LPA, powers of attorney are legal documents which cover 
decisions related to financial affairs and also include health and welfare 
decisions. As well as consenting to or refusing medical treatment, 
personal welfare decisions can include questions about where the 
incapacitated person lives, their daily care, their social activities, 
personal correspondence and arrangements for community care 
services. They come into effect if the person concerned loses mental 
capacity or does not want to make decisions about themselves (BMA, 
2016).
Role of health professionals regarding attorneys 
When healthcare professionals are preparing care plans for patients 
who have appointed a personal welfare attorney, they must first assess 
whether the patient has the capacity to agree to the plan. If the patient 
lacks that capacity, agreement must be sought from the attorney, 
who should also be consulted about what is in the patient’s best 
interests. The LPA allows attorneys to make decisions to accept or 
refuse medical treatment on the patient’s behalf once the patient is 
incapable of making the decision, unless the LPA has specified that 
the attorney should not make those decisions. An attorney cannot 
consent to treatment if the patient made a valid advance refusal of it, 
unless the LPA was made after the advance decision and transferred 
that decision to the attorney. Also, if the patient wanted the attorney 
to have powers to accept or refuse life-prolonging treatment, the LPA 
must specifically state that. 
If the health team has a significant concern relating to medical 
treatment decisions taken under the authority of an LPA, the case 
can be referred for adjudication to the Court of Protection (BMA 2016).
College report CR211 137
Court approval 
Some cases around decisions of mental capacity need to go before 
the court under the MCA. In older adults with substance misuse, the 
following may need court approval (BMA 2016):
 z When healthcare professionals need to decide on withdrawal or 
withholding artificial nutrition and hydration from a patient in a 
persistent vegetative state or a minimally-conscious state  
 z Cases where there is a doubt or dispute that cannot be resolved 
locally about whether a particular treatment will be in a person’s 
best interests 
 z Patients presenting with ethical dilemmas in untested areas.
Independent Mental Capacity Advocates (IMCA) 
Family networks of older people with a history of substance misuse 
may be absent, chaotic, and challenging to engage. A relationship 
between the older person and their family relatives may not be based 
on trust or prior knowledge of preferences of the individual. In such 
situations when individuals who lack capacity and who have no family 
or friends (including where there is no suitable next of kin), an IMCA 
can be appointed (BMA 2016).
An IMCA is independent of the healthcare professional making the 
decision and represents the patient in discussions about whether 
the proposed decision is in the patient’s best interests. An IMCA can 
also raise questions or challenge decisions which appear not to be 
in the patient’s best interests. Responsibility for instructing an IMCA 
lies with the NHS body or local authority providing the treatment or 
accommodation.
It is appropriate to consult an IMCA when:
 z an NHS body is proposing to provide, withhold or stop ‘serious 
medical treatment’, or 
 z an NHS body or local authority is proposing to arrange 
accommodation (or a change in accommodation) in a hospital 
or care home, and the stay in hospital will be more than 28 days, 
or the stay in the care home more than 8 weeks.
An IMCA is required to write a report to the NHS body or local authority 
responsible for the individual’s treatment or care. The IMCA’s report 
must be taken into account before the final decision is made (BMA 
2016).
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Disputes, Court of Protection and court-appointed 
deputies  
The Court of Protection is the final arbiter in England and Wales in 
relation to the legality of decisions made under the Mental Capacity 
Act (2005). The equivalent bodies in Scotland and Northern Ireland 
are the Office of the Public Guardian and the Office of Care and 
Protection respectively.
Special considerations
The BMA Mental Capacity Tool Kit (BMA 2016) and the GMC Mental 
Capacity Decision-Making flowchart (GMC 2008) are useful resources 
for clinicians when dealing with difficult situations including providing 
care for older people with substance misuse lacking capacity. 
‘Communicating and Assessing Capacity: a guide for social work and 
healthcare staff’ is useful for professionals in Scotland.
Consideration needs to be given to aspects of assessment, treatment 
and care that are particular to older people, such as maintaining 
dignity, state of loneliness, mental incapacity, elder abuse and 
safeguarding. Timing of capacity assessment, conflict between 
presence of capacity alongside self-neglect and need for medical 
care and the role of practitioner in encouraging the older person to 
give up addictions that are harmful to them need particular attention. 
Legal position on proxy consent to treatment 
decisions in England
In addition to adjudicating in relation to specific decisions, the Court 
of Protection has the power to appoint deputies to assist with 
continued decision-making. An appointment order sets out the 
specific powers and scope of the deputy’s authority but there are 
some general limitations on their authority. Deputies cannot make 
decisions that they think the person concerned has the capacity to 
make themselves. They cannot refuse life-sustaining treatment on the 
individual’s behalf. They cannot go against a decision made by an 
attorney acting under an LPA granted by the individual before losing 
capacity. Where concerns arise about whether an attorney acting 
under an LPA is making decisions in the best interests of the patient, 
then the Court of Protection can adjudicate (BMA 2016).
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Legal position on proxy consent to treatment 
decisions in Scotland  
The Adults with Incapacity (Scotland) Act 2000 (BMA 2016) gives 
health professionals the authority to do what is reasonable and 
necessary to safeguard the health of an incapacitated adult. It also 
makes provision for the appointment of healthcare proxies who should 
be consulted except if an emergency arises which would make such 
consultation impractical. The Office of the Public Guardian  holds 
a register of valid proxy decision-makers. The BMA has published 
separate detailed advice about the Adults with Incapacity (Scotland) 
Act. Competent people over the age of 16 years can appoint a welfare 
attorney to make medical decisions for them once their mental 
capacity is lost. Alternatively, the sheriff’s court can appoint a welfare 
guardian with similar powers and these must be consulted about any 
proposed medical treatment where it is practical and reasonable to 
do so. Attorneys can consent to treatment on the patient’s behalf or 
refuse it if they do so in accordance with the Act’s principles. The 
Adults with Incapacity (Scotland) Act also obliges health professionals 
to take account of the views of the patient’s nearest relative and 
primary carer.  
Disputes, the Sheriff and the Mental Welfare 
Commission  
In Scotland, if doctors propose a course of treatment for the 
incapacitated person which the welfare attorney refuses on the 
patient’s behalf, the treatment cannot proceed until an opinion has been 
obtained from a doctor appointed by the Mental Welfare Commission 
for Scotland. If the appointed doctor agrees that treatment should 
be given, it can proceed even if the attorney continues to refuse but 
any of the parties – including the attorney or any other person with 
an interest in the patient’s welfare – can apply to the Court of Session 
for a decision. If the welfare attorney asks, on the patient’s behalf, 
for treatment which doctors consider inappropriate, an application 
can be made to the sheriff to declare whether or not the treatment 
would benefit the patient.  
Legal position on proxy consent to treatment 
decisions in Northern Ireland 
Currently in Northern Ireland, nobody can consent to, or refuse, 
medical treatment on behalf of an adult who lacks mental capacity 
and decision-making is governed by the common law. 
Health professionals can, however, provide treatment without consent, 
if it is considered by the clinician in charge of the patient’s care to be 
necessary and in the patient’s best interests.  
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Key points from case study 8:
As is evident from Vignette 3, there are many ethical issues involved. When P 
lacked capacity, although it is clear he wanted to stay at home, his personal 
choice with regard to his social care decisions was not taken into account by 
healthcare professionals in his own best interests. There may be some kind of 
mental health issue like depression in this case which may be contributing to 
his alcohol dependence. 
As mentioned in the example above, for patients, families and health 
professionals, there can be different difficulties in making short-term 
decisions related to medical treatment compared to making long-term 
ones like choosing a long-term care option. 
Substance misuse in relation to dignity, ageism and 
human rights
Dignity means being treated as a worthy individual, that is, as an 
individual whose needs are to be considered equally with the needs 
of the other persons. In the UK, there is a duty on all public authorities 
to uphold the Human Rights Act 1998 and to intervene proportionately 
to protect the rights of individuals. Similar legislation is in place in most 
developed countries. The threats to dignity include ageism, abuse, 
inequality, disadvantage and discrimination.
Stigmatisation of patients with alcohol problems 
This is a common issue seen by professionals and,, to an extent by 
those using health services. More can be done to ease stigma and 
prejudice towards people with alcohol issues to allow them to come 
forward for help more readily and before major damage has been 
caused.
Case study 8
P is a 68-year-old man with a longstanding history of excess alcohol 
use and more recent worsening cognition. He was lacking capacity and 
is placed in residential care in his best interests after increasing self-
neglect at home. Abstinent for the next 6 months, his cognition (and 
self-care) appears to improve and he starts to ask to return home. He 
attends the local hospital for further assessment, and it becomes clear 
that he understands and retains the risks of doing so – including the 
risks of going back to drinking again. He is deemed to have capacity 
and returns home, where he starts drinking again. His cognition 
deteriorates and his self-care worsens. Reassessment shows that he 
now lacks capacity and he is placed in care. 
After three months of abstinence, his cognition has improved again and 
he is asking to return home. Although all involved feel that this is an 
‘unwise’ decision, assessment shows that he has regained capacity and 
he returns home again.
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Healthcare professionals may sometimes be too quick to condemn 
and make the person feel inadequate because they have a drink 
problem making it more difficult for the person to ask for help and 
admit it. When dealing with people with substance misuse, healthcare 
professionals should be careful as certain duties have been placed 
on healthcare professionals. These include acting without prejudice, 
treating all patients fairly and without prejudice irrespective of variations 
in their life style, or other potentially discriminatory factors. 
Substance misuse in Black and Minority Ethnic 
(BME) background and Provision of Culturally 
Appropriate Services
Older people from black and minority ethnic (BME) backgrounds face 
major challenges in accessing substance-misuse services. These may 
include language barriers, social stigma as well as cultural and family 
values. Individuals from some BME backgrounds have higher levels 
of alcohol misuse and resulting health problems than the general 
population, such as older Irish and South Asian (Sikh) male migrants 
to the United Kingdom (Rao 2006). Both alcohol misuse and ethnicity 
can contribute to social disadvantage.
In the United Kingdom, the clustering of first-generation Irish people 
in areas of socioeconomic deprivation may explain, at least in part, 
their higher prevalence of alcohol use (Rao et al, 2008). Diversity also 
applies to older lesbian, gay, and bisexual alcohol misusers.
Each racial/ethnic group is not homogenous, and may include 
many subcultures that may be influenced by cultural values such as 
traditional beliefs, family structure, lifestyle preferences, gender roles, 
degree of assimilation, and religious belief. These need to be borne in 
mind by various health professionals and during service developments.
Wills and testamentary capacity in relation to 
substance misuse
Increasingly, doctors are being asked to determine testamentary 
capacity and this is often requested by solicitors. Solicitors will usually 
follow a ‘golden rule’ – that the making of a will by an older person, 
or one who has suffered a serious illness, ought to be witnessed 
or approved by a medical practitioner who ‘satisfies himself of the 
capacity and understanding of the testator, and records and preserves 
his examination and finding’.
The doctor should be able to explain how they made an assessment 
of the testamentary capacity of the testator and could be challenged 
in writing or in the witness box and asked to explain their experience 
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and expertise in assessing testamentary capacity, as well as explaining 
how they came to their opinion.
The general principles of mental capacity assessment should be 
applied. Specific additional considerations must be borne in mind 
and these are explained in an MDU document (MDU 2017).
The BMA and the Law Society have also published guidance for 
doctors and lawyers on assessment of mental capacity, which includes 
helpful points clarifying the approach to assessing testamentary 
capacity (Keene, 2015).
Responsibility of health professionals in reporting 
substance misuse in colleagues
Various additional responsibilities have been placed on healthcare 
professionals in relation to patient safety from actions of others, for 
example protecting patients if it is thought that a colleague could 
be causing harm, for instance, by means of substance misuse. 
The relatively easier access for healthcare professionals to some of 
substances of misuse may potentially make them prone to substance 
misuse especially in periods of stress. Colleagues are expected to 
identify such situations and act on them to highlight any potential 
harm to the professionals as well as patients. 
Alcohol misuse and dementia
It is important to identify substance misuse issues early and proactively 
in the older adult population. Clinicians may decide on the best 
interests of these patients but more focus should be placed on helping 
this group make their own decisions and enhance their autonomy. 
Awareness of the issues like higher prevalence of dementia in older 
people with alcoholism can help healthcare professionals when doing 
mental capacity assessments. Also, older people with dementia and in 
whom alcohol may be the cause of or contribute to dementia should 
not be denied treatment or support for both conditions (Wadd et al, 
2014).
Mental Capacity Act and research
In England and Wales, the Mental Capacity Act not only covers 
medical treatment decisions but also makes provision for mentally 
incapacitated people to be involved in research. (Research is covered 
separately in this guidance.) In Scotland, the Adults with Incapacity 
(Scotland) Act 2000 also regulate the involvement of incapacitated 
adults in research. In addition, the 2004 Medicines for Human Use 
(Clinical Trials) Regulations address proxy decision-making for 
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participation in medical research as well as advance consent or refusal 
by the individual prior to the onset of incapacity. In Northern Ireland, 
there is no statute on this subject. However, English case law, which 
sets out criteria for advance refusals, is likely to be followed.
Mental Capacity Act and the Mental Health Act 
interface
There may be circumstances in which either legal framework (MCA 
or MHA) may apply and the question as to which act applies will be 
for the judgement of the health professional. 
However, as a rule of thumb, if the patient retains capacity the MCA 
cannot be used. If the treatment is for a physical condition, then the 
MHA is irrelevant (unless there is a direct relationship between the 
mental disorder and physical condition, such as poor nutrition from 
depressive disorder). If the treatment is for a mental disorder and the 
patient retains capacity, the MCA cannot be used. Where detention is 
deemed necessary, the MHA must be used provided that the relevant 
grounds are met (BMA 2016). At the time of writing, there is currently 
an independent review of the MHA (Department of Health and Social 
Care, 2017) being conducted.
Elder abuse vs self-neglect due to substance 
misuse
Direct abuse and self-neglect by older people under the influence 
of any drug or alcohol can be difficult to differentiate but both 
situations produce two separate yet interrelated sets of behaviors 
and interactions. One important difference is that in self-neglect (which 
is the result of the older person refusing care), there is often no other 
evidence of abuse. Neglect which can be intentional or unintentional, 
is a common form of abuse. Failure of caregivers to fulfil their care-
giving responsibilities (neglect through omission) is something of 
which all healthcare professionals should be aware while caring for 
older people.
Self-neglect is a failure to provide for one’s own essential needs and it is 
often associated with risk factors like mental health problems, including 
dementia, and depression. Alcohol use has been documented to be 
associated with elder abuse (World- Health Organization 2006)  and 
some pointers which can help identify this are; if older people are 
financially dependent on relatives, alcohol use by older people can 
make carers neglect them and this in turn can encourage them to 
drink more which makes them prone to financial abuse. Victims of 
abuse or partner violence could sometimes resort to using alcohol as 
a coping mechanism (World Health Organization, 2006) and hence 
awareness of this association may help improve management in this 
alcohol dependent older adults (Sullivan et al, 2011).
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WHO states that ‘at both national and international levels, health 
organisations have a key role in advocating for policies that address 
the relationships between alcohol use and elder abuse and in doing 
so promote prevention initiatives that will improve public health’.
Case study 9
A 72-year-old retired teacher has been living alone in her own house 
since the death of her husband one year ago. She was referred to old 
age psychiatry services because of progressive memory changes over 
approximately two years.
Other concerns included deteriorating self-care, poor appetite, weight 
loss and several falls.
She is assessed at home with his daughter present; the kitchen 
contained several empty gin bottles, as did the dustbin.
Her daughter comments that she has had episodes when she appears 
much more muddled over her finances and that she is still driving, which 
causes her some concern. She remains independent with all domestic 
activities but is in arrears on her rent, and money is often “missing” from 
her purse.
Her daughter reports that both she and her late father drank a bottle 
of wine per day between them for many years, but that her mother 
switched to spirits after her father died.
There is no evidence of any other mental disorder but there is history of 
gout, hypertension and Type II diabetes mellitus.
She smokes 20 filtered medium tar cigarettes a day but has no other 
substance use or misuse.
At assessment, she is found to have a mild to moderate degree of 
cognitive impairment (Mini-Mental State Examination (MMSE) score 
of 20 out of 30) and the clinical picture is felt to be consistent with 
alcohol-related dementia.
There is no evidence of physical dependence, but the assessing 
psychiatrist feels that her drinking was undoubtedly contributing to her 
memory impairment.
Key points from case study 9:
 z History from family and close friends play an important part in 
management as patients with substance misuse may not disclose all the 
relevant information themselves. 
 z Elder abuse could easily be missed by healthcare professionals if the 
diagnosis is not looked for in every older adult.
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Principles of medical ethics
All four principles of medical ethics; autonomy, beneficence, non-
maleficence and justice are relevant to older people, with or without 
substance misuse.
The principle of autonomy means respecting the choices and wishes 
of people who possess decisional capacity, along with protecting 
those who lack this capacity.
End of life care issues in older people with 
substance misuse 
Substance misuse in older people is steadily going to increase 
pressure on palliative care services as chronic and life threatening 
conditions due to drugs and alcohol is on rise (Galvani et al, 2016). 
More work needs to be done to help support clinicians providing 
end of life care to be able to identify this complex group of patients 
early. Development of home-based services to prevent hospital 
admissions is another challenge as identifying ‘dual diagnosis’ and 
treating older people with social, physical and other complex issues 
like safeguarding and mental capacity needs different approach 
(Crome & Rao, 2017) along with lot of resources needed for training 
and planning. Advance care planning models encourage people to 
reflect on their fears and concerns (De Vleminck & Deliens, 2018) 
and may be an ideal opportunity for clinicians to proactively include 
topic of substance misuse related complications on the care plans.
Joint working of palliative care teams and substance use services will 
enable the development of integrated services to provide effective 
care to older people with chronic conditions due to both licit and 
illicit drug use. 
Future challenges
The ethical and legal issues that are relevant to an ageing individual, 
or an ageing society are multifaceted and complex, and require 
consideration of how all people are connected in society and across 
the life span. However, it is likely that the older people of the future 
will have a stronger sense of entitlement, will be better educated, are 
likely to be healthier until later in life and will inevitably occupy differing 
roles in society than previous cohorts. The ethical and legal issues 
that concern older people with substance misuse as a population 
will evolve with them. The need for further research in this area is a 
challenge for the future (Arora et al, 2015) but recruiting older people 
with substance misuse in any research will need further guidance and 
training. Training around ethical principles to all healthcare professions 
should form the basis of patient-centered care ‘Older people deserve 
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no less’ (Crome & Arora, 2018) and this ethos should be promoted 
in society. Professionals should aim to provide optimal care which 
considers the priorities and preferences that older substance misusers 
and their families express. This not only takes account of the medical 
conditions and available technical interventions, but also the meaning 
of the illness to the patient and their perception of the value of the 
potential treatment at a particular point in their lives (Gawande 2014; 
Kalanithi 2017).
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Research and  
development
Key messages
 z For too long research into this subject has been ignored.   
 z Older people need to be included in addiction research as they 
are under-represented in research studies.    
 z Barriers to recruitment and retention of older people in research 
studies include lack of motivation, poor health, sensory impairment, 
cognitive impairment, mood disorders, mobility problems and 
frailty. Evidence for strategies to enhance participation is limited. 
 z Research will inform engagement and retention with treatment 
and service responses.   
 z Greater understanding of the economic impact of alcohol and 
other substances on individuals, families, communities and 
society is needed.
Introduction
The response of the public, media, practitioners and academics, to 
the first report ‘Our Invisible Addicts’, was almost overwhelming and 
unanticipated (RCPsych 2011). Since its publication in 2011, there 
have been several further developments. We have followed this up by 
producing an Information Guide (RCPsych 2015), revising RCPsych 
CPD modules, organising several well attended CPD update courses, 
writing journal articles, invited to conferences, and publishing a book 
which collates the most up-to-date international research (Crome et 
al 2015). All these activities comprised components that considered 
research and development. 
Recent research has mainly been in epidemiology but far more 
needs to be undertaken before practitioners can face substance 
misuse problems in older people with confidence. There is sufficient 
information about what is effective to begin to build detection and 
intervention into treatment models that are already functioning within 
the key specialist teams (e.g. addiction, geriatric medicine and 
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psychiatry) to implement what is known. Brief intervention models 
suitable for primary care are needed. A strategy to secure funding 
for further research is important so as to stimulate questions and 
generate some practical answers.    
Who is this group?  
As has been outlined in previous chapters in this report, older 
substance misusers are a very heterogeneous group. Further 
examination of the evolution of substance use across the lifespan 
and its association with ageing is needed. Research which aims to 
characterise what distinguishes older substance users from younger 
people, will point to how we can adapt, tailor and develop preventive 
and treatment interventions.  Understanding their characteristics 
such as physical and mental health, life circumstances, status and 
personal quality, stigma, socioeconomic status, culture, ethnicity, 
activities of daily living and difficulties in accessing services are still 
subjects for research which will impact on treatment. We need to 
investigate to what extent older people suffer from gambling, internet 
and sex ‘addiction’.
Emphasis should be placed on the baby boomer population aged 50 
and over, from both socio-cultural and ‘biological ageing’ perspectives. 
This will, in turn, pose challenges to all of the areas to be explored 
(not least of which will be the difference between those in and not in 
employment). The economic impact of alcohol and other substances 
needs further examination: what are the costs to individuals, families, 
community and society, and how is this balanced by the revenue 
generated?  
Public health messages 
There needs to be greater recognition of the immensity of the problem 
with detailed research and publication of statistics widely marketed 
and disseminated.
Development of effective strategies to reduce risk involves recognising 
that addiction occurs in older people and that there is considerable 
stigma associated and many misconceptions. Older substance 
misusers feel ‘forgotten’, ‘dismissed’ or a ‘lost cause’ (Corrigan et 
al 2017; Ginn & Clark 2017; Matheson & Liddle 2017). Motivation to 
respond to advice or engage with treatment aimed at preventing the 
onset or course of substance misuse may be diminished.
What guidance do we give older people with regard to appropriate 
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alcohol consumption? What is the best way to deliver health education 
to different age groups? This involves better understanding about the 
physiological, psychological and social differences in ageing over a 
wide range of ages.  This potentially spans from about 40 years old 
to over 90 years old.  
Complexity of need
What are the consequences and future needs of this population? 
Older substance misusers are highly complex so an appreciation 
of the interplay of the co-occurrence of physical and mental health 
issues, and social vulnerabilities such as isolation, is pivotal to effective 
treatment. Complex clinical presentations are not exceptional; they 
may be atypical, subtle, and serious because they are compounded 
by different substances including prescribed medications, mental 
and physical conditions, and social context. These are also worthy 
of exploration.    
Involvement of patients, carers 
and providers
Patients and carers have a unique perspective in lived experience 
of substance misuse.   Understanding the attitudes, views and 
perceptions of patients, carers and providers is essential to attracting 
people into treatment that is adapted to their needs.   
Better understanding of reasons why older people use or misuse 
substances, how they explain their use and the meaning it has in their 
lives, can support modification of their behaviours. Engagement and 
retention of older subjects in research including collaboration in the 
development of projects is central to this process (Neale et al 2017).
Clinical research
The focus needs to be on both dependent use and harmful behaviours. 
For example, we need to consider what constitutes dependence in 
older people and how we can diagnose it.
As has been mentioned earlier in this report, similar methodologies 
in clinical trials would enhance the confidence with which findings 
could be implemented. Standardisation of research protocols, e.g. 
instruments developed for older people, stratification by age range, 
clear definitions of what constitutes harmful, hazardous excessive, 
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binge, and dependence in older people. Attention needs to be paid 
to sample size, sensible length of follow-up, specific age range with 
adaptation to needs.   A reasonable length of follow-up is necessary, 
especially as some people may survive into very old age.    
Interventions require clear descriptions and both researchers and 
practitioners require training with manuals and regular feedback. 
Intensity, duration of treatment and aftercare in the community, as 
well as methods of delivery, need to be explained and considered. 
Effectiveness of medications, whether established in younger people 
or those that are new and promising, are another strand.    
The barriers that lead to low uptake of interventions, maintaining 
abstinence or aftercare monitoring, are important areas for study. 
In addition to some of the recognised reasons for non-participation, 
older substance misusers may be frail and burdened with multiple 
morbidities (e.g. mobility, mood and memory) that severely limit their 
capacity to participate in the demanding nature of research (Cherubini 
& Gasperini 2017).
Service provision
Achieving the provision of appropriate services translates into a 
foundation for clinical research.  Although strides have been made in 
investigating treatment for older substance users, and demonstrating 
that benefit does accrue, this is far from adequate. Hence, the 
development of, and research into, models of service delivery is 
greatly hampered. There are few models of effective age specific 
service provision.
Whether to introduce age-specific or mixed age groups is one 
question. Another is whether and how best to integrate, collaborate or 
coordinate a variety of services: addiction, old age psychiatry, geriatric 
medicine, and primary care. Naturalistic studies from services offer 
a way forward to examine treatments, outcomes and programmes.
Given the state of addiction services nationally, the issue is how to 
realistically develop service models that can be evaluated. Apart from 
collaboration and coordination of relevant professionals in ‘virtual 
teams’, there are also important areas such as pain management and 
end of life care which require very specific expertise. There is very 
limited evidence on cost effectiveness of substance misuse treatment 
in older people (Coulton et al 2017).
The use of new technologies will no doubt impact on these issues in 
the future, so this is a further avenue for research and development.
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Conclusion
Overall, we recommend that there needs to be a shift in strategy so 
that older substance misusers are not discriminated against whether 
it is in the clinical, research or policy domains. This includes the 
following:
 z Enhance and expand the evidence base by encouraging, 
supporting and funding research and research training about 
older people with substance problems.
 z Use an array of strategies to engage and retain older subjects in 
research including collaboration in the development of projects.
 z Include older people in all research projects whether qualitative 
or quantitative, epidemiological, clinical and prevention studies.
 z Place greater emphasis on cannabis (including medical prescribing 
of cannabis), opioid prescription drugs and gabapentinoids while 
not ignoring alcohol, tobacco (including e-cigarettes) and other 
illicit drugs.
 z Use clinically meaningful outcome measures based on quality 
of life and independence, including known associations with 
substance misuse such as mood disorders, cognitive impairment, 
pain, falls and social factors such as retirement and bereavement.
 z Undertake rapid reviews of important research publications to 
comment on relevance to older people in a manner that is useful 
to the wide range of practitioners involved in the care of this 
heterogeneous group.
Given the almost universal limitation of resources, collaboration 
internationally is one way in which seemingly infinite problems that 
need solutions can be collated.
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Key messages
 z The older substance misuser is poorly represented in the range 
of policy initiatives, though this may be changing very gradually. 
 z Greater value needs to be placed on the requirements and wishes 
of older substance misusers.   
 z Diverse approaches are required to minimise the health, social 
and economic consequences for a population of “baby boomers” 
who have the fastest increase in rates of substance misuse in the 
population. These include raising awareness, limiting availability 
of, and access to, substances, and improving access to care.
 z Campaigning is required to reduce the stigma associated 
with alcohol and substance misuse among the public and 
professionals.
 z Promote greater recognition of the scale of the problem by wider 
dissemination of up-to-date research. 
 z Evaluation of the economic impact of substance use in older 
people should be initiated.
 z Given the distinctive features of substance misuse in older people, 
identification of how some of their special health and social needs 
differ from younger adults is reflected in policy.
 z Due to the strong relationship between substance misuse and 
mental and physical health in older people, acknowledgement 
that management of complex comorbidities are the norm needs 
to be recognised in policy development.
 z Approaches to treatment and rehabilitation need to be tailored 
and adapted from those found to be effective in younger people, 
and development of novel approaches need to be prioritised.
 z Provision of more addiction services focussed on the needs of 
older substance misusers is needed. 
 z Enhance training at all levels including training more addiction 
psychiatrists and old age psychiatrists with specialist knowledge 
to manage the specific needs of older substance misuser. 
Conclusion
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 z Due to a dearth of research, there is scarce specific evidence to 
inform policy decisions in older people who misuse substances. 
There is a lack of research on policies that specifically target the 
older person’s substance misuse and associated harms.
 z To meet older substance misusers’ needs, concerted effort is 
required by stakeholders including the National Health Service, 
independent sectors, mental health charities and other relevant 
charitable organisations; older people themselves; and financial 
support and direction by government to develop coherent 
integrated policies.
 z Develop a national strategy focussed on older substance misusers 
which is imaginative, viable, sustainable and evidence based.
It is beyond the scope of this document to outline in detail the policies, 
guidelines and protocols. We use the term policy broadly to include 
national strategy, local plans, clinical guidelines and medical protocols. 
We highlight the contributions of some policies which make (usually 
very limited) reference to older substance misusers, and which give 
a flavour of the issues.    Some have been discussed earlier in the 
document and comprise clinical guidelines, service models, training 
and educational programmes and public health initiatives. Clinical 
guidelines recognise and prioritise screening and assessment, 
forming non-judgemental therapeutic alliances; protocols; information; 
advocacy; patient involvement; general healthcare; evidence-
based practice or good practice for the array of available treatment 
interventions. Service model policies have to consider definition of 
access criteria including age; transfer between services; joint working 
and close liaison between professionals; co-morbidity and dual 
diagnosis; extending community-based services (home support, 
accommodation); and match staff to the needs of the older population. 
For example, the RCPsych has endeavoured to raise awareness 
and educate the public and practitioners, and policymakers. This 
has been done through a variety of methods, e.g. developing a 
competency-based curriculum for training addiction psychiatrists 
and old age (RCPsych CR 173), by suggesting that postgraduate 
doctors in other medical specialties be trained (Morris-Williams Z 
2012), by publishing reports (Invisible Addicts, 2011); by producing 
guidance for practitioners (RCPsych, 2015), providing annual updated 
CPD training courses, online CPD modules and information leaflets. 
Many members of the Royal College of Psychiatrists contribute 
to national policy such as NICE guidelines and Advisory Council 
on the Misuse of Drugs reports, Department of Health and Public 
Health England guidance on, for example, clinical management and 
commissioning, as well as to other policies related to older people 
and substance misuse (DH 2017). Members of the Royal College of 
Psychiatrists have also contributed to other national and international 
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policy initiatives (Babor et al 2010a; Babor et al 2010b; Macgregor 
2015).
There have been some important initiatives over the last few years. It 
is well known that availability, accessibility and affordability are central 
to the public health burden of alcohol misuse. The benefits of MUP 
are well-recognised and have been discussed in the Introduction 
chapter. Recent implementation of minimum unit pricing (MUP) in 
Scotland (Scottish Government, 2012) has now been followed by a 
commitment by the Welsh Government to introduce MUP through 
the Public Health (Minimum Price for Alcohol) (Wales) Bill (Welsh 
Government, 2017). Northern Ireland has looked favourably upon such 
a policy for future implementation. However, there are no clear plans 
from Westminster to re-consider its initial commitment to consider 
such an initiative (Home Office, 2012).  As noted in the chapter on 
Research and development, further detailed understanding of the 
impact of alcohol on the economy is required.
Given that home drinking is more common in older people (Nicholson 
et al, 2017), reducing availability to cheaper and stronger alcohol is 
paramount. Changes to accessibility through reducing the number 
of 24-hour off-licence premises also requires careful consideration. 
An Alcohol Research UK investigation (2011) concluded that there 
are different stressors, risk factors in older people, compared to 
younger adults that initiate and maintain use of alcohol and relapse 
of alcohol abuse. The report also made specific recommendations 
addressing staff working with older people who abuse alcohol and 
other substances, commissioners who approve services for these 
people and for prevention programmes that should address risk 
factors and strengthen protective factors that can help older people.
In 2014, the ‘Rethink Good Health’ funding programme (Big Lottery 
Fund, 2014) led to a UK-wide initiative termed ‘Drink Wise Age Well’. 
This aimed to ‘help inform policy and practice about preventing 
alcohol-related harm in later life, improve health and wellbeing of 
people aged 50 and over who are at risk of developing alcohol 
problems and help build more effective services aimed at alcohol-
related issues’ (Drink Wise Age Well 2016).
However, our summation of the wider contributions nationally and 
internationally to date indicates that the older substance misuser is 
in general poorly represented in policy initiatives and does not have 
high profile, though this may be changing very gradually (MacGregor 
2015; Hingson and Ting-Lai 2015; Givel 2015). This might partly be 
to do with the relative lack of research generated in the UK. It might 
also reflect attitudes and a culture that is negative, stigmatising and 
prejudiced. Of course, some policies which are generic are still likely 
to have relevance to the older population. Crucial to design and 
implementation of a cohesive policy response is the acceptance of 
responsibility, including provision of funding by government.  
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We have not had sight of the working group established by the Advisory 
Council on the Misuse of Drugs (ACMD) to review the evidence that 
exists around problems for ageing drug users (aged over 45 years), 
to map the numbers of older drug users in the UK and draw on UK 
and international evidence to establish the current and future needs 
of this cohort. However, in 2017 the Advisory Council for the Misuse 
of Drugs (2017) made a number of recommendations including:
 z Drug and alcohol misuse services should be mandated within 
local authority budgets and/or the commissioning of drug and 
alcohol treatment placed within NHS commissioning structures.
 z Transparency and clearer financial reporting on local drug 
misuse treatment services should be increased to challenge 
local disinvestment or falls in treatment penetration.
 z Links between local healthcare services and local drug treatment 
systems should be strengthened.
 z Commissioning contracts should be five to ten years in length.
 z Research infrastructure and capacity within the drugs misuse 
field should be addressed.
To these we would add that greater value needs to be placed on 
helping this often highly stigmatised and marginalised population, 
where there is a clear indication from epidemiological and demographic 
trends that older people are the age group at highest rate of rise in 
prevalence of substance misuse. Such data needs to be translated 
in practice. The diverse assortment of available and relevant options 
needs to be examined (Babor et al 2010a; Babor et al 2010b). 
This incorporates accessibility, availability, tax and pricing; improving 
the social environment to achieve better social cohesion, driving, 
marketing, education, and treatment that is relevant to the older 
population. Evidence-informed choices which are selected as part of 
a coherent plan or strategy developed by a group of stakeholders can 
then be made. Concerted effort is needed by stakeholders including 
National Health Service, independent sectors, mental health charities 
and other relevant charitable organisations; a government with strong 
political will to reduce availability, reduce access and raise awareness 
of the health-related catastrophe along with social and economic 
impact by alcohol and substance misuse in older people
Treatment services, though extremely important and central to 
our profession, are just one component of a successful policy. We 
recognise that provision is, of course, influenced by wider social and 
cultural issues. There are very few designated services to cater for the 
needs for older people with substance misuse and serve the specific 
needs of older people. Similarly most dual diagnosis services do not 
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care adequately forolder people. Reviewing the need for improvements 
in addiction services for the older patient has to be considered on the 
backdrop of increasing reductions in funding. Many substance misuse 
services are no longer provided by the National Health Service, and 
are delivered by the independent sector and charities, with varying 
quality (Drummond 2017). A recent review from the Care Quality 
Commission underlined the poor quality of detoxification services 
CQC (2017). Since NHS staff may well shrink in the next few years, 
some thought needs to be given about the relevant professional 
development of already existing workforces that encounter older 
people with complex problems – general practice, community nursing, 
accident and emergency and social work.
Pertinent to this report, is that there is evidence of age discrimination. 
The Drink Wise Age Well project released a report 'Calling Time: 
Addressing ageism and age discrimination in alcohol policy, practice 
and research’ (Wadd et al 2017).  The report highlights evidence of 
age discrimination in alcohol policy, practice and research following 
a literature review and a survey of professionals, interviews and focus 
groups with older adults. It is not an uncommon practice in alcohol 
services to prioritise younger patients and discriminate against older 
people, although such discrimination is illegal under the Equality Act 
2010. 
The report states that ‘this discrimination is likely to be due to 
pervasive misconceptions, attitudes and assumptions based on 
stereotypes, for example older adults are incapable of change or 
alcohol problems predominantly affect young people’. This report 
makes many recommendations for national organisations both in 
mainstream and charity sectors, commissioners and researchers and 
policymakers. It also calls for efforts to address the range of issues 
highlighted and ensure recognition and appropriate responses for 
older people with alcohol problems. 
Changing public attitudes, especially perhaps the views of older 
people themselves, is a key component. Public campaigning to 
reduce the stigma associated with alcohol and other substance 
problems is an essential component. The voice of older people must 
be heard in the development of policy. There are new challenges with 
increasing longevity. How do workplace policies manage drug and 
alcohol problems in the older employee? What kind of distribution 
outlets would protect older people from excessive drinking? Are 
smoking harm reduction measures such as smokeless tobacco and 
e-cigarettes beneficial to older smokers? Where do older people wish 
to be treated – with younger adults or in age-segregated services? 
If risk factors for the development for addiction differ in older people 
differ from young adults, what are the implications for public health 
and treatment policy? To what extent do or should mass media 
campaigns, e.g. anti-tobacco counter-marketing, target on the older 
substance-misusing population? How effective are peer self-help 
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organisations in this population? Would this population benefit from 
restrictions on over-the-counter medication?  
As discussed in the Research and development chapter, there is a 
compelling requirement for more research of multiple types in this 
complex group with chronic conditions (Scottish Drugs Forum 2017). 
Assisting workforce expansion in addition to clinical and management 
supervision and support, and training programmes, is also much 
needed. Health and social care as well as criminal justice agencies 
need to plan together to spell out roles, responsibilities and goals 
through a range of mechanisms, be they strategies, practice briefings 
or guidelines. Implementing rational policies requires astute advocacy 
and mobilisation of a range of resources. Of course, financing these 
goals is what will ultimately make possible the choices to provide a 
higher priority to this group (ACMD 2017).   
In order to further develop evidence-informed policies in the future, 
MacGregor (2015) recommends the following:
‘To adapt policies to both a changing reality and altered perceptions 
of the problem, a series of linked activities would need to be initiated:
 z Recognition of the need or problems, supported by collecting 
evidence
 z Articulation of a justification for the development of policy, citing 
values or pragmatism
 z Identification of policy options
 z Formal adoption of policy recommendations and acceptance 
of responsibility
 z Detailed policy design
 z Implementation and evaluation.’
What is clear it that we are a long way from achieving these goals. 
Older people are given very little primacy in policy development. 
However, it does provide a framework for improvement, What is 
needed is a national strategy that is imaginative and viable.
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Appendix 
 
Some examples of evidence-based guidelines 
 
We have included many of the NICE Guidelines throughout 
the document and here outline some of the more recent NICE 
guidelines that made reference – usually briefly – to the older 
population: 
 
NICE PH 24 (2010) Alcohol use disorders - prevention:  
This guideline included the older population (along with the 
unemployed and individuals with lower levels of education, social 
class and income) as one of the population groups specifically 
affected by price increases and reduction in harms. https://www.
nice.org.uk/guidance/ph24 
 
NICE CG 115 (2011) Alcohol use disorders: diagnosis 
assessment and management of harmful drinking and 
alcohol dependence noted that alcohol misuse is under-
identified, especially in older people, by healthcare professionals, 
leading to missed opportunities to offer appropriate interventions.  
It suggested that when assessing the severity of alcohol 
dependence and determining the need for assisted withdrawal, the 
criteria for older people should be adjusted, and a lower threshold 
for admission to in-patient or residential units. One of the barriers 
to effective intervention relevant to the older population is the risk 
that people who are housebound wait longer to access specialist 
treatment. This is compounded by the fact that only few people 
who are dependent on alcohol received treatment. This is due to 
long period between developing alcohol dependence and seeking 
help and also limited availability of specialist alcohol treatment 
services. https://www.nice.org.uk/guidance/cg115 
 
NICE NG 22 (2015) Older people with social care needs 
and multiple long-term conditions: In this guideline, a person 
with social care needs is defined as someone needing personal 
care and other practical assistance because of their age, illness, 
disability, dependence on alcohol or drugs. Various aspects of 
social care and collaborative working are explained. Services 
for older persons are mentioned but no specific emphasis 
on managing alcohol or substance misuse in older people is 
described. https://www.nice.org.uk/guidance/ng22 
 
NICE NG 58 (2016) Coexisting severe mental illness and 
substance misuse: community health and social care 
services. This stresses that the person’s needs need to be 
reassessed to ensure there is continuity of care when they are 
at a transition point in their life (e.g. retirement). Particular groups 
who may need additional support include people who move from 
adult to older adult mental health or social services. This guideline 
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highlighted the plight of specific populations including older people 
with coexisting severe mental illness and substance misuse that 
are at risk as they may not access or may stop using services. 
https://www.nice.org.uk/guidance/ng58 
 
Department of Health − Drug misuse and dependence: UK 
guidelines on clinical management (‘Orange’ book) 2017: This 
has a specific section dedicated to older people. It recommended 
that health practitioners need awareness of substance use in 
older people to identify and address problems and to understand 
that they may present with physical or mental health problems 
in the first instance. Older patients can achieve equivalent or 
better results than younger adults when they enter treatment for 
substance misuse. It is important that they have access to effective 
healthcare services where they will be catered for with dignity and 
sensitivity. Table 5: (p249) describes special health needs of older 
people with substance use problems like complications with long-
term use of substance, polypharmacy and changes in physiology 
due to ageing process. https://www.gov.uk/government/
publications/drug-misuse-and-dependence-uk-guidelines-on-
clinical-management 
 
PHE (2016). The Public Health Burden of Alcohol and the 
Effectiveness and Cost-Effectiveness of Alcohol Control 
Policies: An evidence review. This report clarifies that not all 
alcohol-related crime and disorder gets reported to the police and 
levels of reporting tend to be higher in older people. ‘Recent further 
analysis has shown that, in the UK, any potential protective effects 
seems mainly relevant to older age groups, particularly to women, 
and the peak of any protective effect is achieved at very low levels 
of consumption, around one unit of alcohol per day’. Further 
studies revealed that even moderate drinking can be harmful to 
older people and should be handled sensibly. https://www.gov.
uk/government/publications/the-public-health-burden-of-alcohol-
evidence-review 
 
PHE (2017) Better care for people with co-occurring 
mental health and alcohol/drug use conditions: A guide for 
commissioners and service providers. This guideline covers all 
ages (children to adults, including older adults). This recommends 
that care pathways should meet the specific needs of older 
people. This guideline highlights the special needs of older people 
with co-occurring conditions. These include being on multiple 
medications, requiring age-sensitive treatment such as support 
with the sensory, cognitive and physical problems, and needing 
interventions at a slower pace, involving repetition and provision of 
written information. In addition, it further recommends that mental 
health services for older adults should provide integrated care with 
support from alcohol and drug services. The provision of skilled 
assessment, treatment and recovery-focused care should take into 
account the need for multiple assessments. https://www.gov.uk/
government/publications/people-with-co-occurring-conditions-
commission-and-provide-services
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ACE   Addenbrookes Cognitive Examination
ACMD   Advisory Council on the Misuse of Drugs
ADLs   Activities of Daily Living
ARBD   Alcohol Related Brain Damage
ARCP   Annual Review of Competence Progression
ARD   Alcohol Related Dementia
AUDIT    Alcohol Use Disorders Identification Test
BMA   British Medical Association
BME   Black and Minority Ethnic
BBVs   Blood-borne viruses
C2ME   Culturally Competent in Medical Education
CAGE   A widely-used screening test for problem drinking and potential alcohol    
   problems. Its name is an acronym of the starting letters of its four questions.
CALC   Centre for Advanced Learning and Conferences
CARPS     Computerised Alcohol-Related Problems Survey 
CASC     Clinical Assessment of Skills and Competencies
CBT          Cognitive Behaviour Therapy
CCG   Clinical Commissioning Groups
CCT    Certificate of Completion of Training
CMHT   Community Mental Health Team
COP   Court of Protection
COPD       Chronic obstructive pulmonary disease
CPD   Continuing Professional Development 
CQC   Care Quality Commission
CQUIN   Commissioning for quality and innovation
CST    Certificate of Specialist Training
DAPA-PC  Drug Abuse Problem Assessment for Primary Care
DoLs   Deprivation of Liberty Safeguards
DSM   Diagnostic and Statistical Manual
DWAW   Drink Wise Age Well
EBTP   Evidence based treatment pathways
EMCDDA  European Monitoring Centre for Drugs and Drug Addiction
GAP          Gerontology Alcohol Project
GET SMART     Geriatric Evaluation Team: Substance Misuse/Abuse Recognition and Treatment
GMC   General Medical Council
HCV   Hepatitis C Virus
HLAYA      Healthy Living as You Age
ICD   International Classification of Diseases
ICDP   International Centre for Drug Policy
IMCA   Independent Mental Capacity Advocate
ISAJE   International Society of Addiction Journal Editors
KS   Korsakoff’s Syndrome
LETB   Local Education and Training Board
Abbreviations
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LPA   Lasting Power of Attorney
MCA   Mental Capacity Act
MDU    Medical Defence Union   
MHA   Mental Health Act
MHOAD   Mental Health of Older Adults and Dementia Clinical Academic Group
MMSE   Mini-Mental State Examination Examination
MRCPsych  Member of the Royal College of Psychiatrists
MRI   Magnetic Resonance Imaging
MUP   Minimum Unit Pricing
NICE        National Institute for Health and Clinical Excellence
NIHR   National Institute of Health Research
OAR   Ages specific residential programme
OASIS   Older Adults Support in Southwark
OCT    Over the counter medication
OPMH   Older People’s Mental Health
OST    Opiate substitution treatment
PBL    Problem-based Learning
PBr   Payment by results
PHE   Public Health England 
POELT    Prison Officer Entry Level Training 
PQIP   Professional Qualification in Probation (PQIP)
PRISM-E   Primary Care Research in Substance Abuse and Mental Health f  
or the Elderly 
Project GOAL     Guiding Older Adult Lifestyles 
RCGP   Royal College of General Practitioners
RCPsych  Royal College of Psychiatrists
RCT       Randomised controlled trial
SLAM   South London and Maudsley NHS Foundation Trust
SSA   Society for the Study of Addiction
SSC   Student Selected Component
SUD   Substance Use Disorder
TDM    Telephone Disease Management
TPD   Training Programme Director
TrOn   Trainees Online
WKS   Wernicke-Korsakoff’s Syndrome
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Glossary 
Addiction
A condition involving use of a substance, such as a drug or alcohol, or engagement in a behaviour, such 
as gambling, in which a person has strong cravings, is unable to stop or limit the activity, continues the 
activity despite harmful consequences, and experiences distress upon cessation. It is associated with 
both harm and a lifestyle that results in loss of control over a person’s everyday functioning and role. 
Analgesic
A drug that treats pain.
Brief intervention 
A technique used to initiate change for an unhealthy or risky behaviour such as smoking, or alcohol 
misuse. As an alcohol intervention it is typically targeted to non-dependent drinkers whose drinking 
may still be harmful.   They are usually short (5-30 minutes) one to one sessions and often consist of 
informal counselling and information on certain types of harms and risks associated with substance 
use and/or risky behaviours.
Commissioning
The process of planning, agreeing and monitoring services.
Deprivations of Liberty Safeguards (DoLS)
An independent and objective process applied to hospitals and care homes to ensure that restriction 
of a person’s movements is done in their best interest.
Demography
The study of size, structure and change in populations (including factors such as age and sex).
E-cigarettes
An electronic device that vaporises a nicotine-containing solution for inhalation.
Endoscopy
The use of a flexible telescope to visualise the inside of the body (usually the gastro-intestinal system)
Epidemiology 
The study of the distribution and determinants of health-related states or disorders.  
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Liver ultrasound 
A form of diagnostic imaging that relies on the sound waves reflected from the surface of a body organ 
to look for abnormalities
Minimum unit pricing
A minimum price applied per unit of alcohol, below which it is illegal to sell an alcoholic drink
MRI
Also called Magnetic Resonance Imaging. A form of diagnostic imaging that relies on the movement 
of water molecules to build up a picture of part or parts of the body to look for abnormalities
Naturalistic study
The study of a behaviour or disorder in its natural environment without any additional intervention (e.g. 
the study of progression of a disorder).
Opioid and Opiates
Opiates are substances derived purely from naturally occurring plants (e.g. heroin, morphine and 
codeine). 
Opioids are substances not derived purely from naturally occurring plants (e.g. buprenorphine, 
fentanyl and oxycodone). 
The term “opioids” is now used increasingly to describe both opiates and opioids.
Patient
A person receiving healthcare.
Pharmacokinetic and pharmacodynamics
Pharmacokinetics is the study of what the body does to drugs (i.e. absorption, distribution, metabolism 
and excretion)
Pharmacodynamics is the study of what drugs do to the body (i.e. the effect of binding to receptors).
Prevalence
The proportion of people with a problem or disorder in a population at risk of developing that problem 
or disorder (e.g. the prevalence of drinking in a population that drinks alcohol).
QTc
The QT interval is a measure of the time between the start of the Q wave and the end of the T wave.  A lengthened 
QT interval is a marker for the potential of ventricular tachyarrythmias and a risk factor for sudden death. 
QTc is the corrected QT interval which estimates the QT interval at a heart rate of 60 beats per minute.
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Quintile
A fifth (20 per cent) of a whole (e.g. highest quintile is the highest 20 per cent).
Randomised Controlled Trial (RCT)
A research method to assess treatment outcomes that avoids bias in study design.
Service user
A person receiving healthcare and an alternative term preferred by some people who are receiving 
care for their mental health problems.
Substance misuse
Substance misuse is the harmful use of substances. (like drugs and alcohol) for non-medical purposes. 
The term “substance misuse” often refers to illegal drugs. However, legal substances can also be 
misused, such as alcohol, prescription medications, caffeine, nicotine and volatile substances (e.g. 
petrol, glue, paint).
Testamentary capacity
Mental Capacity to make a valid will.
Twelve-Step Programme
A group therapy approach to encourage abstinence from alcohol based on a model developed by 
Alcoholics Anonymous.
Unit of alcohol
In the UK, one alcohol unit is measured as 10ml or 8g of pure alcohol. This equals one 25ml single 
measure of whisky (ABV 40%), or a third of a pint of beer (ABV 5-6%) or half a standard (175ml) glass 
of red wine (ABV 12%).
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The current evidence base for assessment and management of 
substance misuse in older adults is growing. A few examples of 
established and evidence-based practice useful in setting up a service 
are suggested below. It must be noted that the examples are of 
elements of treatment services working together which could be 
used to build a comprehensive model of care for co-occurring mental, 
physical and substance misuse disorders. No single comprehensive 
model is operational to inform current practice.
Evidence-based specialist treatment services
Older Adults Support in Southwark (OASIS) was a commissioned 
specialist homecare rehabilitation service that provided flexible and 
intensive support for older mental health patients with complex 
needs. Staff developed key competencies engaging those with ‘’dual 
diagnosis’ and this was associated with a drop in alcohol-related 
admissions with ‘dual diagnosis’ from 50% to 5% between 2005 
and 2009, when funding was withdrawn (Connolly, 2012). The legacy 
of OASIS has been new and effective models for intervention by 
community mental health teams in Southwark that act as a model 
for practical sustainable service development.
Fibroscan Services
North London substance misuse services developed an innovative 
service with gastroenterology services in the local general hospital. 
Patients with alcohol misuse would not engage further with GP services 
to carry out basic blood tests to assess their baseline liver function. 
Motivation to engage in treatment can also be variable in this group. 
The substance misuse service approached the gastroenterology 
service to provide a fibroscan service within the substance misuse 
service. This was facilitated by a nurse from the gastro-enterology 
service visiting the substance misuse service twice per week where 
she would opportunistically offer patients the fibroscan service. 
The benefits of this was that patients became more receptive to 
having a conversation about the effects of alcohol on their livers as 
well as the effect of obesity. They also were more willing to engage 
with their GP services to have their baseline liver functions assessed. 
An additional benefit was being able to have a repeat fibroscan once 
weight had been lost or alcohol consumption had ceased. They also 
engaged with their GPs for conversations about their lifestyle in other 
areas. Early cases of cirrhosis were also picked up and managed by 
the gastro-enterology team.
Models of service delivery
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Capital Card
The Capital Card scheme is run by the WDP which is a charity provider 
of substance misuse services primarily based in the London area. 
The capital card is a contingency management-based reward point 
scheme operating like a supermarket loyalty card.
Patients get points based on attending services, groups and having 
BBV screens. Points can be earned in any number of ways which are 
customisable to the service. These could include stopping smoking, 
losing weight, community service and volunteering. Points can be 
redeemed at local retailers and service providers such as gyms, 
barbers, hair and nail salons, charity clothes shops, online education 
courses etc. 
The whole process is entirely electronic: Like with supermarket loyalty 
cards, the Capital Card is swiped to have points added to it, and 
swiped again at the Point-spend outlet to spend the points. The points 
can be monitored by smartphone, if the patient has one, or can be 
viewed each time the card is swiped.
While this card is mainly used in substance misuse services it 
could easily be used to promote healthy lifestyles and community 
engagement work within GP services, secondary healthcare services 
and in older people’s mental health services. 
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Initial triage is based on information from referrer, client and possibly third-party information. Assess for appropriateness of referral, 
degree of risk (e.g. self-harm, self-neglect), urgency and possibility of accompanying mental health problems accompanying 
alcohol misuse. If problem is solely alcohol use refer to Local Drug and Alcohol Team.
Review of problems reported by patient: try to assess at a time of day when they are not intoxicated.  If not possible, do not 
exclude this high-risk group without making an attempt to assess. 
Full psychiatric history (including alcohol-related brain damage and self-harm)
Alcohol history and use of other substances
Full medical history (including physical effects of alcohol misuse) 
Assessment of risk history (including alcohol related risk e.g. self-harm, intoxication, withdrawal, accidental injury and seizures, 
Wernicke’s)
Examination of mental state
Evaluation of current risk & risk management plan (e.g. degree of alcohol misuse, alcohol dependence, capacity, safeguarding, 
self-neglect, falls, poor food and fluid intake, accommodation condition, ideas/plans of self-harm or suicide) 
Outcome measures
Alcohol Use Disorders Identification Test (AUDIT)
SMMSE
Investigations may include the following: Blood tests e.g. Full Blood Count, Urea and Electrolytes, Liver Function Tests (including 
Gamma GT), Electrocardiogram, Neuropsychological: ACE-III
TR
IA
G
E
A
S
S
ES
S
M
EN
T
TR
E
ATEM
N
T P
LA
N
N
IN
G
 B
A
S
ED
 O
N
 A
U
D
IT S
C
O
R
E
 
Lower risk
0–6
Increasing risk
7–15
Higher risk
16–19
Possible dependence
20+
Seek permission from 
person to discuss 
alcohol use and provide 
information. Document 
person’s response.
If agrees, offer health 
information and promote 
continued drinking within 
‘lower risk’ levels. 
If working towards 
abstinence, encourage 
continued reduction and 
plan with person based 
on what has previously 
worked. Generate ideas 
to manage cravings and 
social situations.
Offer alcohol information 
leaflet on units of alcohol.
Update risk assessment 
and care plan if 
appropriate. Ensure the 
person is included in care 
planning.
Seek permission from person to discuss alcohol 
use and provide information. Document person’s 
response
Care plan sessions to discuss reduction of drinking 
and associated risk-taking behaviour. Aim to 
focus on enhancing motivation to make changes 
to alcohol use. Update and regularly review risk 
assessment. Encourage person to keep a drink 
diary.
Provide information on interactions between 
medication and alcohol and impact on physical 
health 
Ensure care plan and crisis plan reflect alcohol 
use and associated care planning and risk 
management strategies. 
Advice − make small gradual reductions in alcohol 
use. Discuss with team dual diagnosis lead to 
explore tools and techniques to achieve this.
If person is willing to engage in local alcohol 
services provide information.
Provide information about 12-step programmes 
such as Alcoholics  Anonymous (AA) and other 
self-help/mutual aid groups e.g. SMART recovery.
Family and carer support. Discuss accessing 
AA, SMART Family and Friends.  Complete 
engagement and support plan.
Seek permission from person to discuss 
alcohol use and provide information. Document 
person’s response.
Care plan sessions to help discuss reduction of 
drinking and associated risk taking behaviour.
Update and regularly review risk assessment 
Ensure care plan and crisis plan reflect alcohol 
use and associated care planning and risk 
management strategies. Encourage the person 
to keep a drink diary.
Detoxification − Facilitate referral to local 
alcohol service for detox and aftercare. Discuss 
referral in MDT.
Detoxification on MHOA&D ward − If physically 
dependent, refer to Trust guidelines for detox 
regime. Nursing staff monitor using CIWA-Ar 
(withdrawal assessment scale). Check for signs 
of Wernicke’s Encephalopathy. Offer pabrinex. 
If after detox the person wants to remain 
abstinent offer relapse prevention medication.
For higher risk alcohol use and dependence if 
the person is unwilling to engage with  alcohol 
services. Offer harm minimisation   information, 
e.g. don’t stop drinking suddenly.  Seek 
specialist advice from Dual Diagnosis Nurse 
consultant. Provide information on support 
systems in community (AA, SMART recovery). 
Family and carer support – discuss  accessing  
AA, SMART Family and Friends.  Complete 
engagement and support plan.
 
MHOA&D Dual Diagnosis Pathway Alcohol
South London and Maudsley NHS Foundation Trust Clinical Academic Group for Mental Health of Older 
Adults and Dementia (MHOA&D) “Dual diagnosis” Care Pathway for Alcohol
College report CR211 187
Good practice examples from the CQC Report: Building Bridges, Breaking Barriers (July 2016)
Good Practice – Example 1
Currently, 75% of primary care records and all community health and mental heath care records provided by 
Solent NHS Trust recorded on one electronic system.
Access to a shared clinical record means that people can be triaged by phone by a professional who has full 
access to the patient’s notes, regardless of where they are registered.
In the future, it will be able to offer electronic referral and discharge processes on the same system. And it will 
make it quicker and easier for practices to refer, and make sure that discharge notes are fed back directly into a 
person’s own medical records
Good Practice – Example 2
Cambridgeshire and Peterborough Clinical Commissioning Group has established a ‘Joint Emergency Team’ 
(JET) and ‘neighbourhood teams’ to support older people.
JET provides a rapid response for people over 65 who need support to access urgent care but do not need to 
go to hospital. The neighbourhood teams have brought together GP services, acute care and mental health 
services so that people using adult community services, and patients over 65 years old, have their care 
delivered by teams working together, rather than being seen separately by each service.
South Gloucestershire opioid analgesics dependency pilot project 
The South Gloucestershire opioid analgesics dependency pilot project is the first service in the UK that focuses 
specifically on patients with an opiate painkiller problematic use pattern. A dedicated care worker works 
with patients and GPs to treat patients’ addictions and help GPs reduce prescription of opiate painkillers. 
The pilot was launched in two local GP practices in 2016 and is currently running. The results of the pilot are 
awaiting evaluation. 
The Geriatric Addictions Programme 
The Geriatric Addiction Program (GAP) was developed in the United States as a response to increasing 
OPDP referrals and specifically to meet the needs of older adults experiencing a multitude of problems related 
to addictions and their comorbidities (D’Agostino et al, 2006). The majority of clients were referred to GAP 
for alcohol problems, but approximately 15% had comorbid drug problems (D’Agostino et al, 2006). The 
community-based intervention programme focuses on providing in-home geriatric substance use intervention, 
assessment and linkage services for older adults. The evidence suggests that, after more than a decade since 
GAP’s inception and despite positive outcomes, there is a dearth of similar programmes.
 
The Men’s Shed Programme 
‘Men’s shed’ programmes have been developed in Australia, Canada, Ireland and the United Kingdom (as ‘Men 
in Sheds’), which have allowed shed spaces to be established in communities. Men are encouraged to develop 
a ‘sense of identity, self-esteem and value’ by engaging in the programmes (Milligan et al, 2013, 1). Older men 
can come together, socialise and learn new skills in the safe ‘shed’ space. There are benefits in terms of tackling 
loneliness and isolation in developing shed programmes as a gendered intervention for male OPDP (Ballinger et 
al, 2009).  
